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Abstract 
The total chemical synthesis of a protein provides atomic-level control over its covalent 
structure, however polypeptides prepared by solid phase peptide synthesis are limited to 
approximately fifty amino acid residues. This limitation has been overcome by 'Native 
Chemical Ligation‘, which involves amide bond formation between two unprotected 
polypeptides: a peptide with a C-terminal thioester and an N-terminal cysteinyl peptide. 
Synthesis of the required peptide thioester is difficult, particularly by Fmoc-chemistry. 
During our studies towards the semisynthesis of erythropoietin, we discovered reaction 
conditions that reversed Native Chemical Ligation and generated peptide and protein 
thioesters through an N→S acyl transfer.  
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A peptide with both a Gly-Cys and an Ala-Cys-Pro-glycolate ester sequence was selectively 
thioesterified between the Gly-Cys sequence upon microwave-heating at 80 °C with 30 % v/v 
3-mercaptopropionic acid (MPA), to afford the peptide-Gly-MPA thioester (84 % yield). 
Recombinant erythropoietin containing 4(Xaa-Cys) sites was also selectively thioesterified 
between His-Cys and Gly-Cys sequences upon treatment with 20 % MPA at 60 °C to give the 
peptide-MPA thioesters. His-/Gly-/Cys-Cys sequences were found to be particularly prone to 
thioesterification but thioester hydrolysis and disulfide bond formation also occurred with 
MPA, and therefore optimisation studies were conducted using 
13
C NMR spectroscopy. 
Sodium 2-mercaptoethanesulfonate (MESNa) was found to be a better thiol because it 
resulted in 100 % conversion into the peptide thioester and no thioester hydrolysis. The first 
biological application of this new method was then completed with the total synthesis of 45-
amino acid Ser22His human β-defensin 3 (HBD3) for which a more complex 22-amino acid 
peptide thioester (22 % yield) was synthesised. Folded Ser22His HBD3 was assessed to have 
bioactivity equivalent to that reported: MBCs against P. aeruginosa = 0.9 μM, S. aureus = 
1.8 μM; and optimal chemoattraction concentration = 0.2 nM. Posttranslationally modified 
native N-linked glycopeptide thioesters were also synthesised using the new thioesterification 
method, containing protected (20 % yield) or deprotected monosaccharides (64 % yield). 
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1 Introduction 
 
1.1 Total Chemical Protein Synthesis 
 
 Proteins comprise one of the four major classes of biologically important macromolecules as 
well as nucleic acids, carbohydrates, and lipids, and have many diverse biochemical and 
structural roles. Each eukaryotic cell has been estimated via genomic sequencing to contain 
more than 20 000 genes
1,2
 and whilst each gene encodes the amino acid sequence of a 
protein, protein diversity is further enhanced by mRNA splicing before translation and 
posttranslational modification of specific amino acid residues after the polypeptide chain has 
been assembled. This vastly increases the total number and diversity of proteins.
3
  
 In 1978, Werner Arber, Daniel Nathans, and Hamilton Smith received the Nobel Prize in 
Physiology or Medicine for the discovery of restriction enzymes and their application to 
the problems of molecular genetics.
4-16
  
 Recombinant DNA-based technology was illustrated by Cohen et al. in 1973 with the 
construction of new plasmid DNA species through the in vitro joining of restriction 
endonuclease-generated fragments of separate plasmids.
17
 Specific sequences from 
prokaryotic or eukaryotic chromosomes or extrachromosomal DNA could be inserted by 
transformation into Escherichia coli, and the resulting recombinant plasmids were found 
to be biologically functional replicons with genetic properties and nucleotide base 
sequences present from both parent DNA molecules.
17
 Functional plasmids could be 
obtained by the reassociation of endonuclease-generated fragments of larger replicons, in 
addition to joining plasmid DNA molecules from different origins.
17
  
 Since the early 1980s, protein engineering using recombinant DNA-based technology has 
become a useful tool to elucidate the molecular basis of protein function.
18-20
 This has 
been achieved by sequentially changing the amino acid sequence of a polypeptide by 
expressing it in Escherichia coli, followed by folding the polypeptide and measuring the 
effect of the mutation on the properties of the mutant protein molecule.
21  
 Molecular biology techniques that enable site-directed mutagenesis, for example, are 
extremely useful but they also have certain limitations: only the twenty genetically-encoded 
amino acids can be incorporated within the protein molecule.
21,22
 The lack of atomic-level 
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control over the covalent structure of a protein molecule also makes it difficult to incorporate 
site-specific post-translational modifications or precise labels within a protein molecule.
21,22
 
Although Schultz and co-workers have described the use of engineered microorganisms and 
in vitro techniques to overcome these limitations by incorporating unnatural amino acid 
residues, these techniques are not yet commonly used to study the molecular basis of protein 
function.
23,24
 
 These limitations of molecular biology can be overcome through the total chemical  
synthesis of proteins. The total chemical synthesis of proteins provides atomic-level 
control over the chemical structure of a protein molecule, which in turn permits the 
installation of site-specific modifications
25
 including: isotopic labels;
26-32
 
posttranslational modifications such as glycosylation
33-35
 and phosphorylation;
36
 non-
genetically encoded amino acids;
37
 and fluorophores.
38,39
 The incorporation of such 
moieties enables us to further define the precise molecular basis of protein function 
through the use of various biophysical techniques,
40,41
 including: nuclear magnetic 
resonance (NMR) spectroscopy and X-ray crystallography (Figure 1.1).  
 
Figure 1.1 The total chemical synthesis of proteins enables the incorporation of various site-
specific modifications, which aid the elucidation of the molecular basis of protein function 
through the use of biophysical techniques inlcuding X-ray crystallography.
25-41
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1.2 Solution Phase Peptide Synthesis 
 
 Early in the twentieth century, Emil Fischer began with the pursuit of the total  chemical 
synthesis of enzymes and though he never succeeded in this goal, he did pioneer the field 
of chemical peptide synthesis.
42
 It was during that time that Fischer and Hofmeister also 
developed their theory of proteins being linear polymers comprised of α-amino acid 
subunits, which were termed polypeptides.
43,44
 Fischer developed methods for the 
chemical synthesis of peptides that contained even chiral amino acids, and this resulted in 
the synthesis of an 18 amino acid residue peptide which contained fifteen glycine and 
three leucine residues.
45,46 
 The total chemical synthesis of proteins became a major objective worldwide and 
culminated in the development of many synthetic peptide chemistry methods.  The first 
known biologically active peptide hormone to be synthesised was the 9 amino acid 
residue oxytocin by du Vigneaud and co-workers in 1953.
47
 Kenner et al. described a 
notable advance towards the total chemical synthesis of proteins by using twelve 
protected peptides to synthesise a 129 amino acid residue lysozyme enzyme molecule.
48
 
The unambiguous total synthesis of the crystalline and fully biologically active 51 amino 
acid residue human insulin and its analogues,
49
 and the 124 amino acid residue 
ribonuclease A were also demonstrated.
50,51 
 ‗Classical‘ solution phase peptide synthesis usually involves the C→N terminal 
directional synthesis of peptides in organic solvents such as chloroform, dichloromethane, 
ethyl acetate, N,N-dimethylformamide, and methanol, for example.
52
 The amino acid 
building blocks used are otherwise fully-protected except at the reacting terminus 
(Scheme 1.1).
52,53
 An α-amino-protected amino acid with an activated α-carboxyl group 
reacts with a free amino group of an α-carboxyl-protected amino acid to afford a 
dipeptide. The α-amino protecting group is then selectively removed from the dipeptide 
and the next α-amino-protected amino acid with an activated α-carboxyl group is then 
coupled to form a tripeptide. This process is repeated until the desired fully-protected 
peptide chain has been assembled. In a final step all the protecting groups are removed to 
afford the desired peptide.
52,53 
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Scheme 1.1 Classical solution phase peptide synthesis employing maximal protecting 
groups. All non-reacting functional groups present within the amino acid building blocks 
are reversibly protected, and are removed in the final step to afford the full-length 
peptide. ‗PG‘ denotes protecting group and ‗X‘ is a leaving group.52,53 Purification via 
flash column chromatography and multiple re-crystallisations at each step prolong this 
synthetic route. 
 
 Protection is essential for the synthesis of peptides as the constituent amino acids are 
multifunctional. In 1932, Bergmann and Zervas introduced the first reversible protection 
of an α-amino group of an amino acid with the urethane derived protecting group: 
benzyloxycarbonyl ‗Z‘.54 This group could be easily introduced and selectively removed 
under certain conditions (HBr/TFA or H2/Pd-C), whilst being stable to other conditions 
(TFA or piperidine/DMF). This also led to the development of orthogonal protecting 
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groups by Barany and colleagues.
55,56
 Orthogonality in this context translates as: two or 
more protecting groups that belong to independent classes of molecules which can be 
removed by distinct mechanisms. Thus, the protecting groups can be removed in any 
order and in the presence of other functional groups. In general, orthogonal protection 
strategies are milder because their selective deprotection is governed by different removal 
mechanisms, rather than different reaction rates.
57
 
 
 Some common protecting groups used for the protection of the α-amino group in solution 
syntheses, and their removal conditions and compatibility with other protecting groups 
are shown in Table 1.1.
57
 Commonly used α-amino groups include: Z, Nps (2-
nitrophenylsulfenyl), and Bpoc [2-(4-biphenyl)isopropoxycarbonyl] in combination with 
the tBu (tert-butyl) side-chain protecting group, or the Boc (tert-butyloxycarbonyl) group 
in combination with the Bn (benzyl) side-chain protecting group.
57
  
 
 Equally, protection of the α-carboxyl group can be achieved by:94  
 
 Reaction of the free acid of an α-amino acid with an alcohol under acidic 
conditions (usually p-TsOH or HCl).
95
  
 
 Protecting the free acid with a tert-butyl group by reaction with isobutene under 
acidic conditions (usually p-TsOH or H2SO4).
96,97
  
 
 Reaction of an α-amino protected amino acid in the presence of a base or as a 
caesium salt, with the corresponding halide (typically bromide).
98,99
  
 
 Reaction of an α-amino protected amino acid with a condensing agent such as N, 
N’-dicylcohexylcarbodiimide (DCC) in the presence of DMAP and the alcohol 
derivative of the protecting group.
100
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Table 1.1 Common α-amino protecting groups employed during peptide synthesis are 
presented along with their removal conditions and potential orthogonal protecting 
groups.
57
  
Removal conditions Stable to removal of:
Triphenylmethyl (Trityl, Trt)
Name and structure
1) 1 % TFA-DCM
2) 0.1 M HOBt-TFE
3) 0.2 % TFA, 1 % H2O-DCM
4) 3 % TCA-DCM
1) Fmoc 
2) Alloc
2-(4-Biphenyl)isopropoxycarbonyl 
(Bpoc)
1) 0.2-0.5 % TFA 1) Fmoc 
2) Alloc
S
NO2
2-Nitrophenylsulfenyl (Nps)
1) Diluted solutions of 
HCl-CHCl3-AcOH
2) 2-Mercaptopyridine-AcOH-
MeOH, DMF or DCM
3) Ni Raney column in DMF
1) Fmoc
O
O
Benzyloxycarbonyl (Z)
1) cat. H2
2) Strong acids i.e.
   -HBr in AcOH,  
   -TFA at high temperatures,
   -TFA-thioanisole or liquid HF
3) BBr3
1) Boc
2) Fmoc
3) Trt
4) pNZ 
(except cat. hydrogenation)
O
O
Allyloxycarbonyl (Alloc)
1) cat. Pd(PPh3)4, scavengers:
H3N.BH3, Me2NH.BH3 or
PhSiH3 in organic solvents
1) Boc
2) Fmoc
3) Trt
4) Alloc
5) pNZ 
(except cat. hydrogenation)
O2N
O
O
p-Nitrobenzyloxycarbonyl (pNZ)
1) 1-6 M SnCl2, 1.6 mM 
HCl(dioxane) in DMF
2) cat. H2
1) Boc
2) Fmoc
3) Trt
4) Alloc
Ref.
58, 59, 60,
61, 62, 63
64, 65, 66,
67, 68, 69
70, 71, 72,
73
54, 74, 75,
76, 77, 78
79, 80, 81,
82, 83, 84,
85, 86, 87,
88, 89
89, 90, 91,
92, 93
O
O
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 Some α-carboxyl protecting groups are shown in Table 1.2 along with their removal 
conditions and compatibility with other orthogonal protecting groups.
57 
 
Table 1.2 α-Carboxyl protecting groups employed during peptide synthesis are presented 
along with their removal conditions and potential orthogonal protecting groups .
57
  
Removal conditions Stable to removal of:Name and structure Ref.
1) Fmoc
2) Z (by cat. hydrogenation)
3) Trt
4) Alloc
5) pNZtert-Butyl (
tBu)
1) 90 % TFA-DCM 
2) 4 M HCl in dioxane
Cl
2-Chlorotrityl (2-Cl-Trt)
1) 1 % TFA-DCM 1) Fmoc
2) Alloc
2, 4-Dimethoxybenzyl (Dmb)
MeO
OMe
1) 1 % TFA-DCM 1) Fmoc
2) Alloc
Allyl (Al)
1) Pd(PPh3)4 (0.1 equiv.) and
scavengers: PhSiH3, 10 equiv.,
DCM
1) Boc
2) Fmoc
3) pNZ 
(except cat. hydrogenation)
4) Trt
Benzyl (Bn)
1) HF
2) TFMSA
3) H2 cat.
4) NaOH in aqueous 
organic solvents
1) Boc (except repetitive removal)
2) Fmoc
3) pNZ 
(except cat. hydrogenation)
4) Trt
5) Alloc
97, 101
102
103
104, 105
101
 
 
 The formation of a peptide bond between two amino acids requires activation of the α -
carboxylic acid of an amino acid to facilitate nucleophilic attack by the α-amino group of 
another amino acid. This is because at ambient temperatures, carboxylic acids simply 
form salts with amines.
106
 These salts would require heating at high temperatures to 
generate an amide bond, and this is unfavourable due to the presence of other sensitive 
functional groups. Under heated acidic reaction conditions an equilibrium exists between 
the condensing amino acid starting materials and the amide bond-containing product. This 
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makes the peptide bond forming reaction difficult to drive to completion and increases the 
likelihood of peptide bond hydrolysis (Scheme 1.2i).
107,108
 
 Therefore, the formation of a peptide bond is favoured when the α-amino group of an 
amino acid is made more nucleophilic and the α-carboxyl group of another amino acid 
made more electrophilic.
106,109
 Consequently, activation of the α-carboxyl group by 
transforming it into an acyl chloride is also unfavourable because it is unstable and 
hydrolyses easily, and this also makes the amino acid prone to racemisation (Scheme 
1.2ii).
106,109
 A molecule of hydrochloric acid is also formed during each peptide coupling 
and this is also unfavourable for acid-sensitive peptides. 
 
 Better amino acid coupling methods include:
106,109
  
 
 Transformation of the α-carboxyl group into an acyl anhydride (either a mixed or a 
symmetrical anhydride), but along with the amide bonded product an equivalent of 
the free acid is also generated per coupling and this can be expensive (Scheme 
1.2iii). 
 
 Activation of the α-carboxyl group by transforming it into a pentafluorophenyl 
(Pfp) ester, which forms a stable anion leaving group during coupling with the α-
amino group (Scheme 1.2iv). 
 
 Generation of an active ester in situ by reaction of the α-carboxyl group with, for 
example, a coupling reagent mixture such as: 1-hydroxybenzotriazole (HOBt)/ 2-
(1H-Benzotriazol-1-yl)-1,1,3,3-tetramethyluronium-hexafluorophosphate (HBTU) 
to generate an HOBt-active ester in situ, which is a good leaving group and is 
displaced upon nucleophilic attack by the α-amino group (Scheme 1.2v). 
 
 Activation of the α-carboxyl group in situ with a carbodiimide derivative such as 
dicyclohexylcarbodiimide (DCC), which reacts with the α-amino group to generate 
the amide-containing product and urea by-product (Scheme 1.2vi).  
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Scheme 1.2 Methods of peptide bond formation tend to rely on α-carboxyl group 
activation of an amino acid followed by coupling with the free α-amino group of another 
amino acid. Generally, i and ii are disfavoured because they either use or generate acid, 
whereas iii-vi are more popular coupling methods.
106,109 
 
 Classical solution phase peptide synthesis using organic solvents and maximal, reversible 
side-chain protecting groups to prevent undesired reactions has many associated 
shortcomings.
52,53
 These include: racemisation via oxazolone formation of the α-carboxyl 
activated C-terminal amino acid of a protected peptide during its coupling with another 
protected peptide under basic conditions (Scheme 1.3).
106 
i) 
ii) 
iii) 
iv) 
v) 
vi) 
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Scheme 1.3 Racemisation of the C-terminal amino acid during peptide bond formation 
via oxazolone formation under basic conditions.
106,109
 Racemisation by this route is 
promoted by α-carboxyl activation, where ‗X‘ denotes a leaving group, which facilitates 
cyclisation. Deprotonation of the α-carbon followed by re-protonation from either face 
results in a racemic mixture and hence loss of chiral integrity. 
 
 The necessary presence of multiple, usually hydrophobic, protecting groups also makes 
peptide purification by silica gel chromatography more difficult . Characterisation of the 
fully-protected peptide can be difficult, and multiple recrystallisations to provide a 
homogeneous product often prove insufficient. Therefore characterisation can usually be 
achieved once the peptides are deprotected.
52,53 
 Fully-protected peptides often have a solubility problem,
48,51
 and as well as being poorly 
soluble in aqueous media they can also be sparingly soluble in organic media. This has 
led to low peptide concentrations being used in reactions, which has been observed to 
reduce the reaction rate. This also results in incomplete reactions and accumulation of 
side-reaction products.
53
  
 Generally, these disadvantages remain associated with many solution phase peptide 
syntheses though this approach has been successfully used in the synthesis of several 
proteins including the 123-mer human angiogenin,
110
 which is involved in angiogenesis 
and has ribonuclease enzymatic activity, and the largest protein synthesised to date the 
238 amino acid residue Aequoria victoria green fluorescent protein (GFP).
111,112
 
Generally, solution phase synthesis requires highly-skilled chemists to carry out the 
laborious, and often time-consuming, syntheses. 
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1.3 Solid Phase Peptide Synthesis 
 
 In 1963, Merrifield introduced the total chemical synthesis of peptides through the 
revolutionary concept of ‗solid phase peptide synthesis‘ (SPPS) (Scheme 1.4).113 It has 
since become a reliable method for peptide synthesis, and has been estimated to be 
approximately fifty times less laborious than the solution phase synthesis of the same 
peptide.
53
 SPPS involves the C→N terminal directional synthesis of a peptide, in order to 
avoid oxazolone formation and hence racemisation (Scheme 1.3),
106
 whereas protein 
biosynthesis proceeds in the opposite N→C direction without racemisation.  
 
PG
H
N
X
O
R
X
X
-PG
X
(Repeat)n
PG PG PGPG PG PG
Polymeric support 'resin'
 
 
Scheme 1.4 Merrifield‘s solid phase peptide synthesis.113 A fully protected peptide chain 
is assembled stepwise on an insoluble polymer support in the C→N terminal direction. 
Protecting groups and the covalent linkage to the polymer support are cleaved in the final 
step to afford the full-length peptide. ‗PG‘ denotes protecting group and ‗X‘ is a leaving 
group. All reaction by-products can simply be filtered off after each coupling reaction.
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 During SPPS, an N-α protected amino acid is initially coupled through its C-terminus to 
a ―solid support‖, which consists of a cross-linked polymer that is macroscopically 
insoluble in the reaction solvents but microscopically soluble to allow coupling (Scheme 
1.4).
113
 The N-α protecting group of the first amino acid is then removed and the excess 
amino acid and soluble by-products are easily removed through filtration and washing. 
The consecutive N-α protected carboxyl-activated amino acid is then reacted with the 
resin-bound amino acid to form a new amide bond. The resin-bound dipeptide is then 
filtered and washed, and these steps are then repeated until the desired resin-bound 
protected peptide sequence has been attained. At the end of a synthesis, the covalent 
linkage to the resin is cleaved as well as undesired N-α and orthogonal side-chain 
protecting groups to afford the crude product.
114 
 
 The most common α-amino protecting groups employed during SPPS are: 9-
fluorenylmethoxycarbonyl (Fmoc) and Boc, which are used in either Fmoc/tert-butyl 
(
t
Bu) or Boc/benzyl (Bn) SPPS, respectively (Table 1.3).
115-117
  
 The C-terminus of an amino acid is usually linked to the solid support during SPPS, and 
therefore a linker or a handle usually acts as the α-carboxyl protecting group. However, in 
cases where the side-chain of the C-terminal amino acid is anchored to the resin, an α-
carboxyl protecting group
57
 is necessary and some examples of these have been shown in 
Table 1.2.  
 
 Coupling between consecutive amino acids during SPPS is usually achieved by 
activation of the α-carboxyl of the incoming amino acid into an active ester in situ. This is 
usually through generation of a benzotriazole ester with either: HOBt/HBTU and DIPEA, 
HOBt/PyBOP (benzotriazol-1-yl-oxy-tris-pyrrolidinophosphonium hexafluorophosphate 
salt) and DIPEA, or HOBt/DIC  (N, N’-diisopropylcarbodiimide) mixtures.131,132  
 
 Merrifield championed the use of Boc for the protection of the α-amino group when 
using polystyrene resins,
113,114
 whereas Sheppard favoured polyamide resins in 
combination with Fmoc as the α-amino protecting group.120,121 This was due to the 
differences in the swelling properties of the resins in different reaction solvents, which 
was thought to affect the coupling of the molecule to the resin.
106
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Table 1.3 Common α-amino protecting groups employed during solution and solid phase 
peptide synthesis are presented with their removal conditions and potential orthogonal 
protecting groups.
57
  
Removal conditions Stable to removal of:Name and structure Ref.
O
O
9-Fluorenylmethoxycarbonyl (Fmoc)
Solution phase:
1) NH3 (10 h)
2) Morpholine or piperidine in 
organic solvents (min)
3) Polymeric secondary amines
(i.e. piperidine, piperazines) in
organic solvents
Solid phase:
1) 20 % piperidine-DMF
2) 1-5 % DBU-DMF
3) Morpholine-DMF (1:1)
4) 2 % HOBt, 2 % 
hexamethyleneimine, 25 % 
N-methylpyrrolidine in 
DMSO-NMP (1:1)
1) Boc
2) Z 
(except cat. hydrogenation)
3) Trt
4) Alloc
5) pNZ 
(except cat. hydrogenation)
O
O
tert-Butyloxycarbonyl (Boc)
1) 25-50 % TFA-DCM
2) 4 M HCl in dioxane
3) 2 M MeSO3H in dioxane
4) 1 M TMS-Cl, 1 M phenol-DCM
1) Fmoc 
2) Z (by cat. hydrogenation)
3) Trt
4) Alloc
5) pNZ
118, 119, 120,
121, 122, 
123, 124, 
125
113, 126,
127, 128,
129, 130
 
  
 If the peptide synthesis has been designed and conducted efficiently then the majority of 
the crude product should be the desired product. The crude product can then be precisely 
characterised using high-resolution physical techniques such as: LC-MS (liquid 
chromatography-mass spectrometry) and NMR spectroscopy. However, if the crude 
peptide is analysed to contain by-products then it can be further purified by reversed-
phase high performance liquid chromatography (RP)HPLC, which often results in a loss 
of yield, to better attain a homogeneous peptide product.
133 
 Key advantages of SPPS are that linkage of the growing peptide chain to an insoluble 
resin facilitates simple purification through filtration and washing. Rapid and complete 
reactions are promoted by the addition of excess (typically five to ten equivalents) 
activated amino acids that can be easily removed after each amino acid coupling step, but 
this is expensive. Handling losses that are usually associated with solution phase 
chemistry are minimised and the inherent solubility problem in solution phase synthesis, 
where fully-protected peptide chains are assembled, is also chiefly avoided by SPPS. This 
is because a heterogeneous reaction mixture is required to perform the stepwise synthesis 
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of a protected peptide chain. The chiral integrity of peptide products is also usually 
retained.
113,114
  
 Once a polypeptide has been assembled, its purification can be precluded by the presence 
of by-products due to intermediates and incomplete reactions. In practical terms, this 
often translates into similar retention times for the by-products and the product 
polypeptide during (RP)HPLC purification. Preparative (RP)HPLC is a facile high 
resolution technique commonly used to purify unprotected peptides, provided they are 
transferable in HPLC solvent mixtures.
133
 These are typically water: acetonitrile: 0.1 % 
trifluoroacetic acid. Deprotected peptides can also be readily characterised by 
electrospray ionisation mass spectrometry (ESI-MS). 
 A severe disadvantage of SPPS is that only small protein molecules that are comprised of 
a maximum of approximately fifty amino acids in length can be efficiently synthesised. 
This can be attributed to many factors including the swelling properties of the resin in the 
reaction solvent which can affect amino acid couplings, and also the coupling time 
allowed. Even if the synthetic route to the target polypeptide was highly optimised, the 
accretion of by-products attached to the resin due to incomplete reactions, and the 
presence of any remnant impurities within the reactants, reagents, or solvents used, 
renders SPPS impractical for the preparation of larger protein molecules in good yield 
and of satisfactory homogeneity, with unambiguously characterised covalent structures.
133
 
However, this limitation has not prevented the utilisation of SPPS in the synthesis of 
thousands of biologically active proteins.  
 Merrifield also developed an instrument for the automated solid phase synthesis of 
peptides
134
 and utilised this new approach in the first synthesis of the enzyme ribonuclease A 
(RNase A), albeit in a low overall yield.
135,136 
 
1.4 Convergent Synthesis 
  
 The restrictions imposed by stepwise peptide syntheses led to the development of the 
convergent synthesis approach. This involves a coupling reaction between shorter 
synthetic peptides that join to produce a full-length polypeptide. This strategy is favoured 
as it overcomes the poorer quality of larger polypeptides attainable by stepwise peptide 
syntheses.
52,53
 The precursor peptides are small and can therefore be highly pure and 
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precisely characterised molecules.
133
  
 A fully convergent strategy is generally considered better than stepwise peptide synthesis 
because an equal number of steps separate all the starting materials from the product. The 
product usually has different chemical properties to the starting material which makes 
isolation during (RP)HPLC easier. Another useful outcome of using convergent peptide 
synthesis is that it allows the synthesis of a variety of polypeptide analogues.  
 A successful coupling reaction should occur in the presence of all the other functional 
groups that are commonly found in proteinogenic amino acids, and proceed rapidly to 
give the product with no side-reactions. Unprotected peptides are also soluble at high 
(millimolar) concentrations in chaotropic solvents such as: 6 M guanidine hydrochloride 
and 8 M urea, which can be beneficial in promoting rapid and high yielding reactions.  
 Employing unprotected peptide segments in a convergent reaction route will provide 
intermediates that are also unprotected, and these are preferred because they are easier to 
handle, purify, and characterise than protected peptides.
133
 This is because the presence of 
hydrophobic and bulky protecting groups tends to decrease the solubility of the peptide in 
typical HPLC solvents, and this makes it difficult to handle, purify, and characterise any 
intermediates and products. 
 Overall, a convergent synthesis strategy for polypeptide synthesis can overcome many of 
the shortcomings related to classical solution phase synthesis using protected peptides. 
Importantly, convergent synthesis can avoid the accumulation of resin-bound impurities 
that otherwise limits stepwise solid phase peptide synthesis to chains containing 
approximately fifty amino acid residues. For these reasons, chemoselective ligation forms 
the basis of modern chemical protein synthesis and has been used in the synthesis of 
classic protein molecules such as HIV-1 protease
38
 and human lysozyme.
137 
 
1.5 Dibenzofuran-Assisted Chemoselective Ligation 
 
 Auxiliaries have been employed to assist chemoselective ligation by facilitating a high 
local concentration of both the N- and C-terminus of the peptide. Kemp and co-workers 
developed an auxiliary with an interjecting dibenzofuran group,
138
 and the resulting 
proximity of the reactive termini was proposed to encourage ligation (Scheme 1.5).  
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 The reactive α-amino group attacks the carbonyl group via a 12-membered-ring 
transition state, rather than a more conventional 5- or a 6-membered-ring transition 
state.
138
  
O
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Scheme 1.5 Kemp‘s prior thiol capture auxiliary incorporates a dibenzofuran scaffold to 
increase the proximity between the ligating termini. This in turn facilitates amide bond 
formation, and the dibenzofuran moiety can subsequently be removed with a reducing 
agent.
138 
 
1.6 Non-Native Bond Formation in Chemoselective Ligation  
 
 In 1992, the concept of chemoselective condensation of unprotected peptides was 
demonstrated by Schnölzer and Kent.
139
 Principally, a chemoselective condensation 
reaction involves the reaction of two exclusive functional groups that are present on two 
different molecules. The functional groups are specifically designed to react with each 
other in the presence of all the other functional groups within the molecules, to give a 
sole product. 
 Schnölzer and Kent envisaged that a reaction that enabled the formation of a non-native 
covalent linkage between two reacting peptide segments greatly simplified the problem of 
joining two peptides, and also readily generated analogues of the native polypeptide.
139
 
Henceforth the term ‗chemical ligation‘ was introduced to describe the chemoselective 
condensation of two unprotected peptides to produce a unique covalent polypeptide 
product.  
 Initial chemistry developed under the ‗chemical ligation‘ banner  included a nucleophilic 
substitution reaction between a peptide-α-carboxy thioacid (-αCOSH) and a bromoacetyl 
peptide, which was conducted at low pH and in aqueous media (Scheme 1.6).
139
 The 
resulting product was the thioester-linked analogue of the desired polypeptide and various 
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protein analogues have been synthesised using this non-native bond forming reaction,
140
 
including ‗backbone engineered‘ HIV-1 protease which was used to determine the role of 
the backbone hydrogen bonds during enzymatic catalysis.
141
 However despite these 
significant advances, the fact remained that a non-peptide bond was retained in the 
product. 
SH
O
O
Br S
O
O  
Scheme 1.6 A non-native thioester linkage can be formed between two unprotected 
peptides through thioacid alkylation to provide access to protein analogues.
139-141 
 
1.7 Native Chemical Ligation 
 
 Chemical ligation is by definition a chemoselective reaction between unprotected 
peptides in solution, and was introduced for the total synthesis of proteins. A significant 
advantage in the total chemical synthesis of proteins is the potential to utilise organic 
chemistry to introduce precise modifications.  
 Therefore, an efficient chemoselective reaction should make use of the highly pure, fully 
characterised unprotected peptides that can be readily prepared by SPPS. It should form 
the full-length ligated product rapidly with no side-reactions, and allow the purification 
and characterisation of any intermediates. Wieland et al. had previously observed that an 
amide bond formed upon the reaction of Val-SPh with Cys,
142,143
 and in 1994 ‗Native 
Chemical Ligation‘ (NCL) was introduced by the Kent laboratory as a method for 
polypeptide synthesis.
144
 This was a significant advance because NCL overcame the SPPS 
limitation of peptide chains containing a maximum of approximately fifty amino acid 
residues.
52,53 
 Native Chemical Ligation has since become an extremely powerful method for the routine 
synthesis of small to moderate-sized proteins (approximately 150 amino acids), and it 
involves a chemoselective reaction between two polypeptides in solution: an unprotected 
peptide-α-carboxy thioester (-αCOSR) and an unprotected peptide with an N-terminal 
cysteine residue.
144
 These two appropriately functionalised fragments react to form a native 
amide bond at the ligation junction (Scheme 1.7).
144,145
 Key agreeable aspects of this reaction 
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include that it occurs in water, using unprotected peptides, at neutral pH and room 
temperature.
144,145
 An early illustration of the utility of NCL was demonstrated with the 
synthesis of a 72 amino acid chemokine protein [Ala
33
]IL-8 which was prepared from two 
unprotected peptides.
144 
O
SR H3N
HS
-RSH O
H2N
S
O
N
H
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O
pH 6.5-8.0
OO  
Scheme 1.7 The most extensively used and reliable method for protein synthesis: Native 
Chemical Ligation (NCL).
144
 The first step of NCL is transthioesterification which is 
reversible and also rate-determining. The second step is an intramolecular S→N acyl transfer 
which results in a native amide linkage between the two ligated peptides.
144,145
 
 
 Hence, SPPS can be used to synthesise the appropriately functionalised peptides of up to 
approximately fifty amino acids in length. Two such synthetically pure and fully-
characterised peptides can then be ligated in an NCL reaction to produce a polypeptide chain 
of about 100 amino acids in length. Convergent chemical ligations of unprotected peptides 
can also be conducted in aqueous media, to provide access to polypeptides that contain 
approximately 200 amino acids.
145
  
 Mechanistically, the first step in NCL is the intermolecular exchange of the Xaa-thioester 
with the thiol moiety of the N-terminal cysteine side chain to give a thioester-linked branched 
intermediate (Scheme 1.7).
144,145
 Under the same reaction conditions throughout, this initial 
covalent product then undergoes a rapid intramolecular S→N acyl rearrangement to form the 
thermodynamically favoured more stable amide bond at the Xaa-Cys ligation site.
144,145
 
Under the NCL reaction conditions, the first thiol-thioester exchange is reversible but the 
subsequent rearrangement to the amide is irreversible, and this affords the ligated product in 
high yield.
144,145
 Consequently, the rate of NCL depends upon the nature of the peptide-α-
thioester thiol leaving group in the initial transthioesterification step and the nature of the 
amino acid thioester, whereas the rearrangement is rapid.
144,145
 NCL also permits the use of 
high peptide concentrations (usually greater than 1 mM) under the denaturing reaction 
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conditions used, usually 6 M guanidine hydrochloride, to give clean ligation products in high 
yields.
144,145 
 Many peptide thioesters have been shown to be successful in NCL reactions, however the 
synthetically most convenient is considered to be the benzyl thioester.
144
 Alkylation of crude 
peptide thioacid with benzyl bromide in aqueous buffer at pH 4.0 can be used to generate the 
α-carboxy benzyl thioester. The utility of such a peptide benzyl thioester was demonstrated 
during the synthesis of interleukin 8 (IL-8).
144
 The NCL reaction of the benzyl thioester 
peptide was shown to be about 60 % complete after 3 days. During the ligation, a large 
excess of benzyl mercaptan (BnSH) was employed to keep all the cysteine thiol side chains 
reduced and also reverse the formation of any unproductive thioesters that cannot further 
rearrange to produce the desired ligated product.
144,145
 
 As the first intermolecular transthioesterification step in NCL is the rate-determining step, 
the rate of NCL can be accelerated through the addition of an excess of a thiol additive which 
consequently increases the yields of the ligated product. Generally, aryl thioesters are more 
reactive than the alkyl thioesters due to their lower pKa values which make them better 
leaving groups. Therefore, a phenyl thioester is more reactive than a benzyl thioester and can 
be produced in situ by adding an excess of thiophenol (PhSH) which undergoes 
intermolecular thiol-thioester exchange.
146 
 The transthioesterification of a model peptide with a highly reactive thioester Leu-Tyr-
Arg-Ala-Gly-
α
COS-(2-nitrobenzoic acid) into the less activated thioester Leu-Tyr-Arg-
Ala-Gly-
α
COSBn, was conducted by treatment with excess (2 % v/v) benzyl mercaptan in 
aqueous 100 mM sodium phosphate buffer at pH 6.5. After less than 30 min the 
transthioesterification was about 50 % complete, with negligible hydrolysis. Under the 
same reaction conditions but with excess (2 % v/v) thiophenol, a different peptide Ala-
Glu-Ile-Ala-Ala-
α
COSBn was about 50 % converted within 3 h into the more reactive 
peptide phenyl thioester Ala-Glu-Ile-Ala-Ala-
α
COSPh. Additionally, a weakly activated 
peptide 2-mercaptoacetic acid (MAA) thioester Leu-Tyr-Arg-Ala-Gly-
α
COSCH2CO2H 
was about 50 % converted into the more reactive peptide phenyl thioester Leu-Tyr-Arg-
Ala-Gly-
α
COSPh within 1 h, under identical reaction conditions.
146
 Hence, the reactivity 
of the peptide thioester can be tuned by the addition of a thiol additive to produce a better 
or worse leaving group in the initial transthioesterification step, to control the rate of 
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NCL.
146 
 The synthesis of analogues of the enzyme barnase, which is a 110 amino acid residue 
microbial ribonuclease and is extensively used to study protein folding, were undertaken 
to test the application of in situ transthioesterification.
146
 NCL requires a peptide thioester 
and an N-terminal cysteinyl peptide, however barnase contains no native cysteine 
residues and therefore 
49
Lys was replaced by 
49
Cys to create a 
48
Gly-
49
Cys ligation site, 
with little or no effect expected on protein folding or enzyme activity. Barnase(1-
48)
α
COSBn and [Lys49Cys]barnase(49-110) were initially prepared by Boc-based 
SPPS.
147
  
 [Lys49Cys]barnase was synthesised by NCL using nearly equimolar quantities of 
barnase(1-48)
α
COSBn and [Lys49Cys]barnase(49-110), which were dissolved in 6 M 
guanidine hydrochloride to a concentration of 1 mM in each, with 100 mM sodium 
phosphate (pH 7.5) containing excess thiophenol (2 % v/v). After 4.5 h the ligation was 
judged to be complete, and (RP)HPLC purification followed by characterisation and 
folding of the synthetic [Lys49Cys]barnase allowed the enzyme activity to be assessed as 
being equivalent to that of wild-type barnase.
146 
 Hence, NCL is a robust method that has been used to synthesise many proteins, however 
a problem that can be encountered is if a peptide were to contain both an unmasked N-
terminal cysteine and a C-terminal thioester. Under typical NCL conditions the expected 
product would be the cyclic peptide.
148
 Therefore, if multiple ligations are to be 
conducted for the synthesis of long polypeptide chains then the unreacting functionality 
needs to be temporarily protected to prevent undesirable intramolecular cyclisation. This 
includes, for example, the reversible protection of an N-terminal cysteine residue with a 
1,3-thiazolidine group (Thz)
149
 which is stable to treatment with TFA and anhydrous HF. 
Acylated thiazolidine rings can be opened with mercury(II) acetate to afford cysteine and 
non-acylated thiazolidine rings can be opened under mildly acidic conditions (pH 4.0) 
with 0.2 M methoxylamine hydrochloride.
149,150 
 
1.8 Inteins 
 
 In 1990, a biological NS acyl shift was identified in the mechanism of natural protein 
splicing elements termed inteins (Scheme 1.8).
151-154
 An intein is named by analogy to an 
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intron in nucleic acids and consists of an internal protein domain that is flanked by two 
polypeptides, commonly termed the N-extein and the C-extein.  
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 Scheme 1.8 The accepted mechanism of protein splicing.
151-154
 (a) An initial N→S acyl 
shift at the N-terminus of the intein results in a thioester-linked branched intermediate 
which then undergoes (b) intramolecular transthioesterification with a C-terminal cysteine 
residue. (c) At the C-terminus of the intein, asparagine cyclisation occurs to form a 
succinimide which detaches the intein from the ligating exteins. (d) The succinimide can 
then hydrolyse and (e) the N- and C-terminal exteins undergo an intramolecular S→N 
acyl shift to afford a native amide bond between the ligated exteins. 
 
 Inteins mediate protein splicing through a sequence of highly regulated acyl transfers 
beginning with a self-catalysed intramolecular rearrangement of the intein N-terminal 
(a) 
(b) 
(c) 
(d) (e) 
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cysteine residue. This forms a thioester at the N-intein splice junction, which further 
undergoes transthioesterification by nucleophilic attack of the first residue (cysteine) in 
the C-extein to form a branched intermediate. The intein is then excised by cyclisat ion of 
asparagine (or glutamate) at the C-terminus of the intein splice junction. The resulting 
thioester linked exteins ligate through an NCL-like SN acyl shift to form a stable amide 
bond (Scheme 1.8).
151-154
 Over 350 members of the intein family are known and mutant 
inteins have been developed that participate only in the initial or final stages of protein 
splicing.
155
   
 An NCL reaction between an intein-generated protein thioester with a synthetic cysteinyl 
peptide to provide access to larger proteins (greater than about 150 amino acids) is termed 
Expressed Protein Ligation (EPL) (or semisynthesis), and was introduced by the Muir 
laboratory (Scheme 1.9).
156
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Scheme 1.9 Expressed Protein Ligation (EPL) is an NCL reaction between a recombinant 
protein thioester and a synthetic cysteinyl peptide, and it proceeds by resembling the initial 
stages of protein splicing.
156
 (a) An initial N→S acyl shift occurs at the N-terminus of an 
intein which is bound through its C-terminus to a solid support, to afford a thioester-linked 
branched intermediate. (b) The presence of a thiol (i.e. MESNa) promotes 
transthioesterification to give the protein thioester. (c) The protein thioester can then 
participate in an NCL reaction with a synthetic cysteinyl peptide to afford a new amide bond. 
 Generally, EPL requires the expression of a protein of interest that is fused at its C-terminus 
to a mutant intein that is often associated with an affinity tag, such as a chitin binding domain 
(a) 
(b) (c) 
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(CBD), for ease of purification. The protein expressed corresponds to the N-terminal extein 
and after an initial NS acyl transfer, the protein thioester can be released from the intein via 
an intermolecular thiol-thioester exchange. This transthioesterification step is driven by the 
addition of a thiol (RSH) such as sodium 2-mercaptoethanesulfonate (MESNa). The resulting 
protein thioester can then participate in NCL.
157
 
 Alternatively, if the protein were to correspond to the C-extein, it would require N-
terminal cleavage of the intein, which can be promoted by changing the pH and 
temperature of the solution, to generate a protein with an N-terminal cysteine.
158
 Other 
methods to generate a recombinant N-terminal cysteinyl protein,
159
 include:  
 Cyanogen bromide (CNBr) mediated cleavage of chemically methylated cysteine 
residues by formic acid to expose the N-terminal cysteine residue.
160,161
 
 An N-terminal methionine residue can be cleaved with an endogenous methionyl 
aminopeptidase to generate an N-terminal cysteinyl protein.
162,163
  
 Factor Xa protease is commercially available and it requires a four amino acid 
residue recognition sequence (IEGR) after which it cleaves to release the N-
terminal cysteinyl protein.
164
  
 TEV protease can be over-expressed in E. coli and can be used to produce the N-
terminal cysteinyl protein, though it does require a specific seven amino acid 
residue recognition sequence {ENLYFQ(S/G)} where S/G can be mutated to C.
165
  
 The 3C protease (3Cpro) from Foot-and-Mouth Disease Virus (FMDV) has also 
been shown to produce an N-terminal cysteinyl protein for NCL reactions through 
selective proteolytic cleavage.
166
  
 
 Therefore, intein fusion systems provide a source of recombinant proteins that can be 
functionalised with either an N-terminal cysteine or a C-terminal thioester to be used as 
precursors in NCL or EPL,
167
 and are commercially available.   
 In addition to the use of the so-called cis-splicing intein elements, protein trans-splicing 
(PTS) occurs through the use of split inteins.
168-171
 These inteins are split (either naturally 
or engineered) into their complementary ―halves‖ and each pair of halves has a different 
affinity for subsequent reassociation and this selectivity can be exploited to conduct 
multiple simultaneous ligations, as crossover reactions do not occur in PTS. Interestingly, 
split inteins have also been used to synthesise cyclic proteins (Scheme 1.10).
172
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 Commercially available intein technology is often used in conjunction with labelled 
synthetic peptide fragments to act as biotechnology tools which provide valuable insight 
into the structure and function of a protein.
173-177
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Scheme 1.10 Protein cyclisation mediated by a split intein system.
151-154
 (a) An N→S acyl 
shift occurs to afford the thioester-linked branched intermediate. (b) The intermediate is 
then transthioesterified. (c) Asparagine cyclisation occurs to detach the intein from the 
extein. (d) An S→N acyl shift occurs to provide a circularised extein. 
 
 High-resolution N-extein-intein crystallographic structures have provided insight into the 
mechanism of the first step of protein splicing. The N→S acyl shift occurs at a scissile 
amide bond at the N-terminus of a functional intein, which is situated close to highly 
conserved ―block B‖ histidine and threonine residues. The imidazole side chain of the 
conserved histidine appears to function as a general acid or base catalyst to facilitate the 
acyl transfer.
31,178,179
  
 The conformation of the scissile amide bond itself has been the subject of considerable 
debate, and it has been shown to adopt many conformations including the normal and 
most stable trans, distorted trans, and cis configuration. Conformational backbone 
distortion from the ideal 180° may occur as a result of strain from specific interactions  
with conserved intein residues, which activate the scissile peptide bond and hence 
(a) 
(b) 
(c) 
(d) 
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promote nucleophilic attack by the adjacent cysteine thiolate anion due to loss of π 
symmetry to form a twisted amide bond,
178
 and is generally referred to as ground-state 
destabilisation, which is thought to be the driving force for cleavage. The resulting 
tetrahedral intermediate can then be stabilised by other intein active site side-chain 
interactions such as backbone hydrogen bonding, analogous to those observed in an 
oxyanion hole. 
 An unusual amide bond conformation has not been unanimously reported for all the N-
extein-intein crystal structures solved to date,
179
 but this may be explained by the use of 
modified inactive inteins. The conformation of the scissile amide bond within an active 
N-extein-intein precursor possesses a short half-life, and has been investigated by 
solution NMR spectroscopy and segmental isotopic labelling.
31
  
 Semisynthesis was used to generate active and inactive fused inteins. An N-extein 
peptide (AAMRF) was ligated to either wild-type or a mutant Mycobacterium xenopi 
DNA gyrase A (Mxe GyrA) miniintein lacking a homing endonuclease domain to afford 
two new constructs: (1) N-extein-WT Mxe GyrA intein with His-75 intact, or (2) N-
extein-Mxe GyrA intein with a His75Ala mutation. The imidazole ring in the conserved 
His-75 was well positioned to donate a proton and break down the tetrahedral 
intermediate from an N→S acyl shift, and was shown to be hydrogen bonded to the amide 
nitrogen of the scissile peptide bond.
31
 
 The N-extein contained a single 
13
C-1 labelled phenylalanine, whereas the recombinant 
intein was uniformly 
15
N labelled. However, because only the scissile amide bond was 
dual-labelled (
13
CO
15
NH) for both ligated constructs, 2D-HNCO NMR spectra were 
compared and showed a shift in the amide signals from an unusally upfield chemical shift 
of δH 6.61 ppm (
1
JNC‘ ~12 Hz) in the active intein, to δH 10.01 ppm (
1
JNC‘ ~16 Hz) in the 
mutant construct.
31
 In general, proteins have been found to have 
1
JNC‘ coupling constants 
between 13-17 Hz,
180,181
 but hydrogen bonding to the amide NH has been shown to 
decrease the 
1
JNC‘ value.
31
 This occurs as a result of the resonance stabilised amide bond 
containing highly polarised π electrons. Increased rotation about the C(O)-N bond has 
also been predicted to decrease the 
1
JNC‘ value through an increased C(O)-N bond length. 
This study revealed an unusually low 
1
JNC‘ coupling value for the scissile amide bond 
within an active intein.
31
 It was attributed to unusual peptide bond polarisation for which 
the conserved His-75 was essential, and provided further evidence for the N→S acyl 
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transfer proceeding with a contribution from destabilisation of the scissile amide bond 
and an adjacent conserved histidine residue.
31 
 Overall, despite the prominent role of inteins in protein engineering relatively little is 
understood about their mechanistic details at the atomic-level. This is presumably due to 
the practical difficulty in studying an active splicing precursor. Consequently, most 
mechanistic studies have employed inactive mutants. Several mutagenesis, biophysical 
and biochemical studies have served to elucidate the overall sequence of steps, and have 
identified conserved proximal residues (particularly histidine residues) to be essential for 
the early and late stages of the splicing process. These results have suggested that 
histidine plays an important role as a general acid and base catalyst, whilst the amide 
bond is believed to have atypical geometry.
31,178,179
 It has therefore been proposed that 
protein splicing occurs as a consequence of a combination of intein-mediated amide 
distortion, generally termed ground state destabilisation (evidenced by the unusually low 
1
JNC‘ coupling constant of ~12 Hz),
31
 and the catalytic features of proximal (mainly 
histidine) residues.
182
 
 
1.9 Kinetically Controlled Ligation 
 
 Kinetically controlled ligation was also developed by the Kent laboratory and it exploits 
differences in thioester reactivity during convergent NCLs, and the order of the NCLs is 
influenced by the choice of the added thiol catalyst.
183
 For example, the aryl thiol 
thiophenol has a lower sulfhydryl group pKa = 6.6, and therefore is a better leaving group 
during the initial rate-determining transthioesterification step than the alkyl thiol sodium 
2-mercaptoethanesulfonate (MESNa), which has a higher sulfhydryl group pKa = 9.2.
183
  
 Kent and colleagues showed that the incorporation of a new 4-mercaptophenyl acetic 
acid (MPAA)-based linker during Boc-SPPS enabled the quantitative installation of the 
aryl thioester at the C-terminus of a peptide (Scheme 1.11).
183
 They also demonstrated the 
difference in reactivity between aryl and alkyl thioesters by conducting a one-pot 
experiment. They showed that a peptide with this MPAA-derived C-terminal aryl 
thioester preferentially reacted with an N-terminal cysteinyl peptide in high yield, without 
the use of aryl thiol additives, whilst the alkyl thioester could be recovered without 
having undergone ligation.
183 
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Scheme 1.11 The 4-mercaptophenylacetic acid (MPAA) linker was incorporated during 
the Boc-based solid phase peptide synthesis of a peptide with a C-terminal MPAA-
derived thioester.
183
 
 
 A study was conducted that screened several potential thiol catalysts and their effect on 
the rate of NCL. Of particular note was the water-soluble thiol 4-mercaptophenyl acetic 
acid, MPAA, which was also the main constituent of the linker that furnished the aryl 
thioester on solid support (Scheme 1.11), and was observed to promote the most rapid 
NCL reactions.
184 
 The utility of kinetically controlled ligation (Scheme 1.12) was demonstrated with the 
synthesis of the 46 amino acid small protein crambin,
150
 which was convergently 
assembled from six peptide segments. During the convergent ligations, only two of the N-
terminal cysteine residues were protected with a thiazolidine (Thz) group to prevent 
undesired ligations. Unwanted side reactions resulting from the intramolecular formation 
of cyclic peptides or intermolecular reactions to form oligomeric peptides comprised less 
than 2 % of the reaction mixture. The use of methoxylamine hydrochloride at pH 4.0 
(rather than pH 6.0) was sufficient to deprotect the cysteine residues when required 
without decomposition of the thioesters.
185
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Scheme 1.12 Kinetically controlled ligation allows the researcher to pre-organise the 
order of NCL reactions by strategically incorporating within an unprotected peptide a 
more reactive aryl thioester (-COSAr) where NCL should occur first, rather than an alkyl 
thioester (-COSR).
184 
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1.10 Sugar-Assisted Ligation 
 
 Sugar-assisted ligation was established by Wong et al. and proceeds through an 
intramolecular S→N acyl transfer via a fourteen-membered-ring transition state (Scheme 
1.13).
186
 The enlarged fourteen-membered-ring transition state may be expected to 
proceed less efficiently than a five- or a six-membered ring transition state, however a 
templating effect of the carbohydrate is proposed to facilitate ligation. Ligation is 
achieved in a peptide that has a thioester substituted onto the N-acetyl group of a 2-
acetamido-2-deoxy sugar moiety, which in turn is attached to an N-terminal penultimate 
serine residue of the peptide through a β-O-glycosidic linkage.186  
 The scope of sugar-assisted ligation was tested with glycine, histidine, alanine, and 
valine thioesters that were successfully ligated to an N-terminal glycine residue adjacent 
to the required glyco-serine.
186
 Other less sterically demanding amino acids, alanine and 
serine, were also stated as acceptable at the N-terminus of the peptide.
186 
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Scheme 1.13 Sugar-assisted ligation.
186
 An S→N acyl rearrangement occurs initially to 
form a native amide bond, which is followed by desulfurisation to afford the O-linked 
glycopeptide.
186,188 
 
 Certain issues have however been raised with regards to the necessity of the β-
stereochemistry in the O-glycosidic linkage; the toleration of other carbohydrates in the 
allegedly template-driven ligation; and also whether the unsuccessful ligation of an N-
terminal glycoamino acid can be attributed to steric or conformational strain.
187 
 An important limitation of sugar-assisted ligation is that after ligation, the thiol moiety 
on the sugar needs to be desulfurised to release the native N-acetyl group, which is 
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incompatible with the presence of any free cysteine side-chain thiols within the 
peptide.
186
 However, if a glycosidase can be used to remove the sugar that is linked to the 
peptide after ligation, then sugar-assisted ligation has the potential to become a traceless 
reaction.
187
 Nonetheless, disadvantages of this method include the initial synthesis of the 
sugar bearing the ‗thiol handle‘ and its subsequent stereospecific linkage to a serine 
residue.
187
  
 Sugar-assisted ligation was also found to be limited to certain types of extended 
glycosylation.
188
 Extended glycosylation at the C-3 position of the existing sugar bearing 
the thiol handle prevented ligation from occurring, whereas it was possible to ligate with 
extended glycosylation at positions C-4 and C-6 of the existing sugar.
188
 
 
1.11 Phenolic Esters in the Synthesis of Posttranslationally Modified Peptides 
 
 Danishefsky and co-workers employed a peptide with a C-terminal phenolic ester, which 
was ortho- substituted with a protected disulfide group, in chemical ligations (Scheme 
1.14).
189,190
 Solution-phase syntheses of short, complex glycopeptides (containing 
potentially acid-labile glycosidic linkages) were accomplished using the phenolic ester, 
which are otherwise considered incompatible with the acidic conditions used during Boc-
based solid phase peptide synthesis. 
 In principle, native N-linked glycopeptides can be prepared through the incorporation of 
an N-linked glycoamino acid (i.e. glycosylated asparagine) during stepwise peptide 
synthesis, though the attached sugars are often (acetate) protected. Alternatively, 
oligosaccharides can be globally introduced after the peptide chain has been assembled. 
Danishefsky et al. utilised the latter approach to synthesise an N-linked glycopeptide with 
a C-terminal phenolic ester.
189,190 
 A C-terminal phenolic ester was chosen because coupling of the glycosyl amine with the 
side-chain carboxylic acid of, for example, aspartic acid in the presence of a C-terminal 
thioester is disfavoured as it provides two competing sites of reaction. However, phenolic 
esters are comparatively less reactive than thioesters.
189
 
 After peptide chain assembly, the side-chain of the aspartic acid residue was then 
selectively deprotected.
189
 The oligosaccharide was then coupled to the aspartic acid 
residue within the peptide sequence. Initially, the aspartic acid side-chain carboxylic acid 
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was converted into an active ester in situ (i.e. reaction conditions: HATU, DIPEA, 
DMSO, 72 % yield).
190
 The glycosyl amine was then coupled to the active ester to afford 
the N-linked glycopeptide with a C-terminal phenolic ester.
190 
 A trifunctional peptide was also prepared through sequential chemical ligations.
190
 The 
disaccharide chitobiose was coupled to an aspartic acid residue in a peptide containing an 
N-terminal thiazolidine (Thz), which reversibly masked the cysteine, and a C-terminal 
phenolic ester bearing a protected ortho-disulfide substituent. The disulfide substituent on 
the phenyl ring was then reduced with the phosphine-based reducing agent tris(2-
carboxyethyl)phosphine (TCEP), which allowed an O→S acyl shift to occur and produced 
the C-terminal thioester in situ (Scheme 1.14). 
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Scheme 1.14 Proposed mechanism of auxiliary-mediated ligation with a C-terminal 
phenolic ester rather than a thioester.
189,190
 After reduction of the disulfide bond with 
TCEP, an intramolecular O→S acyl shift occurs to form a thioester. 
Transthioesterification then occurs between the thioester and the thiol group in the 4,5,6-
trimethoxy-2-mercaptobenzyl (Tmmb) auxiliary. An intramolecular S→N acyl shift then 
occurs to form the native peptide bond, and the auxiliary is finally removed with TFA. 
 
 Another peptide with an N-terminal disulfide protected 4,5,6-trimethoxy-2-
mercaptobenzyl (Tmmb) auxiliary present within the mixture was concomitantly reduced 
by TCEP to afford the free thiol, which then enabled auxiliary-mediated NCL to take 
place.
190
 The ligated trifunctional glycopeptide contained: an N-terminal thiazolidine 
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group; two sites of N-linked glycosylation; and a glutamine residue bearing the Tmmb 
auxiliary (Scheme 1.15).
190
 The thiazolidine group could be further deprotected with 
methoxylamine.HCl and reacted further in an NCL reaction. The solid-phase production 
of thioesters from esters through an O→S acyl transfer has also been shown though it is 
not commonly used.
191
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Scheme 1.15 A C-terminal phenolic ester was used in the synthesis of a trifunctional N-
linked glycopeptide by Danishefsky et al. which contained an N-terminal thiazolidine 
group; two sites of N-linked glycosylation; and a glutamine residue bearing a Tmmb 
auxiliary.
190
 Reagents and conditions: a) HATU, iPr2NEt, DMSO; b) TCEP, DMF, 
Na2HPO4; c) methyl p-nitrobenzene sulfonate; d) 95 % TFA.
190 
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1.12 Other Strategies: Oxime-Forming Ligation and Staudinger Ligation 
 
 Alternative ligation chemistries have also been developed including oxime-bond forming 
ligation by Rose et al., which involves the reaction of an amino-oxyacetyl-peptide with a 
glyoxylyl-peptide.
192
 The reaction is conducted in aqueous solution at low pH and results 
in the formation of an oxime-linked ligated product that is stable at neutral pH. Oxime-
forming ligation was used in conjunction with thioester-forming ligation to prepare 
topological analogues of the transcription factors cMyc and Max.
193
  
 A more recently developed chemoselective ligation method is Staudinger ligation which 
involves the formation of a native amide bond at approximately neutral pH. Initially, 
Saxon and Bertozzi showed that a phosphine derivative can function as an acyl donor 
when reacted with a glycosyl azide (Scheme 1.16i).
194
 However, a phosphine oxide 
functionality remained in the ligated product. Therefore, a traceless version of the 
Staudinger ligation was developed for the chemical synthesis of proteins by Raines et al., 
and it involved the reaction of a peptide carrying a C-terminal (phosphino)thioester with 
an N-terminal azido-peptide (Scheme 1.16ii).
195,196
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Scheme 1.16 (i) Staudinger ligation.
194 
(ii) Traceless Staudinger ligation of peptides,
195,196
 
the loss of nitrogen and phosphine oxide drives the reaction. ‗X‘ is a phenyl ring.195 
i) 
ii) 
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 Initially, an iminophosphorane is formed which allows the nitrogen of the 
iminophosphorane to attack the thioester to form an acyclic amidophosphonium salt. This 
salt is then hydrolysed to form an amide bond between the two peptides and generates 
phosphine oxide as a by-product. 
  
 Of all the chemical ligation strategies discussed here, by far the most extensively used 
method for the total chemical synthesis of proteins is Native Chemical Ligation.
144
 
However, whilst the N-terminal cysteinyl peptide for NCL can be readily prepared by 
standard stepwise peptide synthesis; preparation of the thioester is considerably more 
difficult. 
 
1.13 Peptide Thioesters 
 
 Peptide and protein thioesters are extremely useful in chemistry and chemical biology, 
and are essential for the synthesis of site-specifically modified peptides and proteins by 
NCL.
144
 Methods to synthesise thioesters have traditionally been based on activating the 
α-carboxylic acid of an amino acid, rather than the N→S acyl shift employed by inteins to 
produce thioesters. 
 Thioesters can be prepared by Boc-based solid-phase peptide synthesis on a thioester 
resin.
144
 However, the harsh acidic conditions (usually anhydrous hydrogen fluoride, HF) 
employed in Boc-based SPPS used to cleave the peptide thioester from the solid support, 
despite being a generally high yielding method with demonstrated application to 
chemically fragile modifications such as N-linked glycopeptides,
197,198
 has led to this 
chemistry being eclipsed by the more amenable Fmoc-based SPPS, which utilises a mild 
base, usually piperidine, during synthesis.
199-202
 As a result, several methods to afford 
peptide thioesters using Fmoc-SPPS have been explored. 
 Since thioesters are unstable to piperidine, other non-nucleophilic bases have been 
investigated for the removal of the N-α-Fmoc group during peptide elongation with 
reasonable success; these have included 1-methylpyrrolidine/ 
hexamethyleneimine/HOBt
124,203
 or DBU/ HOBt mixtures.
204
 Use of low nucleophilic 
bases used during Fmoc-SPPS have however been shown to racemise chiral amino acids 
adjacent to the thioester.  
Native Chemical Thioesterification: Synthesis of Peptide and Protein Thioesters through an N→S Acyl Shift 
 
46 
 
 A popular route for peptide thioester synthesis is a modification of Kenner‘s sulfonamide 
safety-catch linker method, and it employs standard Fmoc/t-Bu SPPS followed by 
sulfonamide alkylation to aid the release of the peptide thioester from the solid support 
(Scheme 1.17i).
199
  
 
 
N
H
S
O O O
peptide N
H
N
S
O O O
peptide N
H
CN
a) b, c)
SR
O
peptide
HN
HN
O
N
H
O
O
O2N
O
R1
N
H
peptide
N
H
N
O
NH2
O
R1
N
H
peptide
O
d, e) f)
R1
N
H
peptide
H
N
O
N
H
R1
N
H
peptide g, h) i, j) R1
N
H
peptide
OO
O
Pg
Pg
Pg
N
H
R1
N
H
peptide O
Pg
Pg
Pg
N
O
O
SAr
O
SR
O
O O
 
 
Scheme 1.17 i) The typical sulfonamide safety-catch approach to peptide thioester synthesis 
employing Fmoc-based SPPS.
199
 Reagents and conditions: a) ICH2CN, DIPEA, DMF, 16 h 
r.t; b) RSH (often benzylmercaptan), NaSPh, DMF, 16 h, r.t; c) 95 % v/v TFA + scavengers.  
Recent developments in Fmoc-based peptide thioester formation: ii) N-acylisoureas.
210
 
Reagents and conditions: d) 0.5 M DIPEA in DMF, 15 min r.t; e) 95 % v/v TFA + 
scavengers; f) 200 mM MPAA (the thioester is generated in situ).  iii) Peptide pyroglutamyl 
imide formation.
211
 Reagents and conditions: g) 2 % v/v TFA + scavengers, DCM; h) 
PyBrOP, DIPEA, NMP, microwave 60 °C, 3 × 1 h; i) RSH, PhSNa, [15]crown-5, MeCN, 40 
°C overnight; j) 95 % v/v TFA + scavengers. Pg = protecting group. 
i) 
ii) 
iii) 
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 The resulting peptide thioesters are often isolated in low yield
205
 and for post-
translationally modified peptides such as glycopeptides, the activating alkylation step can 
also result in the undesirable alkylation of unprotected hydroxyl groups on an attached 
carbohydrate as well as on methionine residues.
199
 Consequently, synthetic strategies that 
release fully protected peptides with C-terminal carboxylic acids or carboxamides from 
the solid-support prior to conversion to thioesters have been established. This is because 
preparation of such species is generally higher yielding and easier to monitor (Scheme 
1.17).
206-211
  
 A backbone amide linker (BAL) with Fmoc-SPPS has also been used to prepare peptide 
thioesters with a masked thioester incorporated as a trithioortho ester.
212,213
 Alternatively, 
peptide thioesters can be introduced after chain assembly to avoid exposure of the 
thioester to basic conditions during synthesis. This has been shown with a BAL extended 
by orthogonal allyl protection of the C-terminal α-carboxylic group.214 
 
1.14 N→S Acyl Transfer Using the Sulfonamide-Linker  
 
 The past half a decade has seen an emergence in methods to produce peptide thioesters 
through an elegant N→S acyl transfer, as employed by inteins.151-154 Melnyk and co-
workers reported a solid-phase N→S acyl transfer for thioester synthesis after peptide 
chain assembly using Fmoc/t-Bu chemistry in combination with the sulfonamide safety-
catch linker (Scheme 1.18).
215
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Scheme 1.18 Rink amide resin is loaded with 3-carboxypropanesulfonic acid before peptide 
assembly. After peptide assembly, the silyl protecting group is removed and this allows an 
N→S acyl shift to occur to afford the peptide thioester. Reagents and conditions: a) 
TBAF/AcOH; b) 95 % v/v TFA + scavengers.
215 
 The acylsulfonamide group within a linker has already enjoyed widespread use in the 
modified safety-catch linker method for thioester synthesis,
199,216 
but in this case it can 
undergo additional Mitsunobu alkylation with a mercaptoethanol derivative, which allows the 
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introduction of the prerequisite β-amino thiol component to facilitate the subsequent 
intramolecular N→S acyl shift.215 
 The isolated yield of the thioester was found to be dependent upon the degree of 
alkylation, which was independent of steric influence from the first amino acid due to the 
remoteness of the alkylation site from C-α.215 This synthetic methodology also has the 
advantage of allowing NCL to potentially proceed on solid-support, though the N→S acyl 
shift can proceed with concomitant cleavage from the resin to allow isolation of the 
thioester.
215
 A disadvantage of this method is that formation of the resin-bound 
acylsulfonamide can be inefficient and the subsequent Mitsunobu reaction can be 
relatively difficult to monitor, especially when using the commercially available 4-
sulfamylbutyryl-linked resins. 
 
1.15 N→S Shift in Acyl-Transfer Auxiliaries  
 
 The natural abundance of cysteine residues in proteins is relatively low (less than 2 %) 
and cysteine is therefore not always conveniently situated at desired ligation junctions.  
Strategies to overcome this limitation include ligation between thioester peptides and N-
terminal homocysteinyl or homoselenocysteinyl peptides, followed by methylation to 
afford Xaa-Met or Xaa-Seleno-Met sequences respectively.
217,218
 Similarly, the utilisation 
of an N-terminal cysteinyl peptide for NCL followed by desulfurisation has been shown 
to afford an Xaa-Ala ligated junction
219,220
 and analogous strategies have evolved for 
several additional amino acid residues.
221-224
 
 NCL was further extended by the use of cleavable auxiliaries that could be appended to 
potentially any N-terminal amino acid, though most commonly at the least hindered 
glycine or alanine residues, to facilitate cysteine-free NCL.
225-231
  
 Peptides are synthesised to contain an N-terminal amino acid attached to the acyl transfer 
auxiliary via N-α. Under typical NCL conditions, the peptide thioester undergoes 
transthioesterification with the thiol moiety of the auxiliary-linked peptide, and an S→N 
acyl transfer ensues to afford the full-length polypeptide. Usually, removal of the 
auxiliary is accomplished upon treatment with acid
232
 (or by photolysis)
233
 to give the 
desired polypeptide. An important feature within the carbon skeleton of the auxiliary is 
that an NCL-like β, or γ amino-substituted thiol motif is retained to facilitate ligation via 
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a pre-organised five- or six-membered ring intermediate (Scheme 1.19a).
225,228
  
 The first transthioesterification step in NCL is the rate-determining step; however in 
auxiliary-mediated ligation, if the C-α of the thioester or the N-terminal amino acid 
attached to the auxiliary is substituted then the S→N acyl rearrangement becomes rate-
determining.
187
 Overall, the slower formation of the amide bond results in increased 
competition from thioester hydrolysis.
187
 The sensitivity of thiol-containing auxiliaries to 
steric hindrance at the ligation site has also meant that cysteine-free NCL has not been as 
effective as NCL.
187
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Scheme 1.19 (a) Kent et al.‘s 1-aryl-2-mercaptoethyl acyl transfer auxiliary is used in 
cysteine-free NCL,
225 
which involves an initial transthioesterification step with the thiol 
moiety in the auxiliary. This is followed by an intramolecular S→N acyl shift to afford 
the native peptide bond, and the auxiliary is then removed. (b) Dawson et al.‘s 4,5,6-
trimethoxy-2-mercaptobenzyl (Tmmb) auxiliary is also used in cysteine-free NCL 
however the S→N acyl shift proceeds through a six- rather than a five-membered ring 
transition state.
228
  
 
 As described earlier (Section 1.11) Danishefsky et al. used the 4,5,6-trimethoxy-2-
mercaptobenzyl (Tmmb) auxiliary disclosed by Dawson et al. (Scheme 1.19b)
228
 in an 
auxiliary-mediated ligation across a glycine-glutamine junction, to synthesise a 
glycopeptide containing multiple asparagine-linked disaccharides in over 58 % yield.
190
 
However, after cysteine-free NCL of the glycopeptide Danishefsky et al. recounted an 
interesting observation upon cleaving the Tmmb auxiliary.
190
 When the ligated product 
(b) 
(a) 
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was immersed in TFA to remove the Tmmb auxiliary, mass spectrometry revealed two 
species with identical molecular weight.
190
 Interestingly, the two species were the desired 
auxiliary-free ligated ‗N-peptide‘ and also the ‗S-peptide‘, which was produced through 
an intramolecular N→S acyl shift and was driven by the liberation of the protonated 
amine (Scheme 1.20).
190
 With no other free cysteine side chain thiols in the amino acid 
sequence, the N→S acyl transfer at the ligation junction was prohibited by methylation of 
the thiol in the auxiliary with methyl-p-nitrobenzenesulfonate before cleavage, and this 
allowed a glycopeptide comprised of 17 amino acid residues to be isolated.
190
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Scheme 1.20 An N→S acyl shift was observed during the cleavage of the 4,5,6-
trimethoxy-2-mercaptobenzyl (Tmmb) auxiliary with TFA by Danishefsky et al.; 
however, prior methylation of the thiol group in the auxiliary before cleavage afforded 
the desired ligated product.
190 
 
 This type of rearrangement was previously documented by Vorherr and Aimoto with the 
2-mercapto-4,5-dimethoxybenzyl (Dmmb) auxiliary and has since been developed into a 
method for thioester synthesis (Scheme 1.21).
234,235 
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Scheme 1.21 Peptide thioester synthesis using a solid-supported Dmmb auxiliary was shown 
to proceed through an N→S acyl shift under acidic conditions by Vorherr et al.234 The solid-
supported thioester was afterwards intercepted by 2-mercaptoethanesulfonic acid. Reagents 
and conditions: a) 88 % v/v TFA + scavengers, 1 h; b) 0.1 M 2-mercaptoethanesulfonic acid, 
DMF.
234,235 
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 The existence of the N→S acyl transfer was subsequently verified using 13C NMR 
spectroscopy, (RP)HPLC, and mass spectrometry.
236
 This was achieved through a two-
part study of model systems: (i) a Dmmb containing dipeptide, Fmoc-Gly(
13
C-1)-
Ala(Dmmb)-OMe and (ii) a Cys containing pentapeptide, Fmoc-Ile-Ala-Gly(
13
C-1)-Cys-
Arg-NH2, both of which were subjected to acid treatment.
236
 Interestingly, while both 
peptides were shown to form thioesters by 
13
C NMR, the glycinyl thioester formed in (ii) 
was shown to rapidly revert to the starting material upon attempted isolation, whereas the 
Dmmb-linked thioester could be isolated by (RP)HPLC.
236 
 Dmmb auxiliary-assisted thioester synthesis, in solution or on solid phase, has recently 
been shown to produce peptide thioesters with up to 41 amino acid residues.
237,238
 An 
Fmoc-Leu-D,L-[Dmmb(Trt)]-Ala motif was coupled to H-Phe-Alko-PEG resin and then 
extended by Fmoc-SPPS before being cleaved from the resin.
238
 The Dmmb-attached 
peptide was then treated with dilute acid {0.25 M hydrochloric acid (HCl), pH ~0.6} 
containing 0.5 % TCEP at 37 °C for 3 h, followed by removal of the solvent under 
reduced pressure.
238
 This created the S-peptide, which upon treatment with MESNa in an 
aqueous sodium acetate/ acetonitrile mixture, at elevated pH 6.0-7.0, produced the 
peptide-SCH2CH2SO3H thioester via intermolecular thiol-thioester exchange, with N-D,L-
(Dmmb)Ala-Phe-OH as the by-product.
238
  
 The isolated yield for a bovine pancreatic trypsin inhibitor thioester BPTI(1-29)-
SCH2CH2SO3H was 82 % based on the reacting S-peptide.
238
 When 85 % v/v aqueous 
trifluoroacetic acid (TFA) was used in place of 0.25 M HCl, the peptide thioester yield 
was 44 % and the side products: [BPTI(1-29)-D,L-Ala-Phe-OH and BPTI(1-29)-D,L-
(Dmmb)Ala-OH] were also identified by mass spectrometry.
238
 The use of 0.25 M HCl 
suppressed such side reactions as well as deamination, also observed with 1.0 M HCl, 
which resulted in the conversion of Asn-24 to Asp-24 within the BPTI(1-29) sequence.
238
 
The milder acid appears to selectively protonate the Dmmb-linked amide which is again 
attributed to the conjugate acid of an N,N-dialkylamide having a higher pKa value than 
that for primary amines.  
 A similar yield was reported for the BPTI(1-29)-SCH2CH2SO3H thioester prepared with 
the N→S acyl shift occurring on-resin and no racemisation of the terminal Leu-29 residue 
was detected.
238
 On-resin thioesterification with the Dmmb auxiliary was further used to 
synthesise a thrombopoietin receptor thioester (TpoR)(461-481)-SCH2CH2SO3H with 
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acid-sensitive linkages such as: tryptophan and the aspartate-proline sequence, in 34 % 
yield based on initial resin loading.
238
 A telomere repeat-binding factor 2 thioester 
(TRF2)(1-41)-SCH2CH2SO3H was also prepared in 12 % yield.
238 
 Additional peptides prepared also included modifications such as phosphorylation 
[Ser(PO3H2)
10
]-histone H3(1-12)-SCH2CH2SO3H (31 %),
238
 and methylation 
[Lys(Me3)
9
]-histone H3(1-33)-SCH2CH2SO3H (19 %).
238
 Although some deamination of 
glutamine to glutamic acid could be observed in small amounts (less than 1.5 %) for 
certain peptides, the desired peptide thioesters could be separated by (RP)HPLC.
238
 These 
results appear highly promising though drawbacks include the several synthetic steps 
required to prepare the auxiliary-linked resin, and loading of the first amino acid. Ideally, 
preloaded resins that allow the reasearcher to choose the amino acid thioester would 
become commercially available. 
 
1.16 3-Mercaptopropionic Acid (MPA)-Mediated Thioesterification 
 
 Nakahara and co-workers described a post-peptide chain assembly thioesterification 
method that was used to produce a 61 amino acid glycopeptide from its 25 amino acid 
thioester.
239
 The method involved a peptide bearing a C-terminal 5-mercaptomethylated 
proline derivative that was converted into a thioester upon treatment with aqueous 3-
mercaptopropionic acid (MPA) (Scheme 1.22).
239 
 Originally the peptide was prepared to comply with diketopiperazine (DKP) formation 
which is known to occur in peptides containing C-terminal proline-ester sequences.
239
 
The reaction occurs when a deprotected amine is able to react with an ―activated‖ 
carboxylic acid to afford a bicyclic intermediate. However, the formation of the 
diketopiperazine tricyclic intermediate did not proceed as envisaged.
239
 This was 
attributed to the diketopiperazine formation on-resin being slower than the reverse (S→N) 
acyl transfer, in weakly acidic or basic solution.
239 
 The peptide with the C-terminal prolyl-prolyl ester motif was however successfully 
thioesterified via intermolecular thioester exchange with excess MPA.
239
 At room 
temperature, the thioester of MPA could be observed within 12 h, using 40 % v/v MPA 
(pH 1.3) without any serious side reactions.
239
 Extending the reaction time to 168 h 
resulted in complete consumption of the starting material.
239
 Hydrolysis was reported to 
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be less than 15 %,
239
 which nevertheless decreased the efficiency of the reaction. The 
reaction rate increased with microwave irradiation (150 W, 80 °C) and reactions were 
complete between 0.5-1 h, depending on the MPA concentration used.
239 
 Decreased MPA concentrations (less than or equal to 20 % v/v) were correlated with 
increased reaction times, although the thioester purification was notably more facile.
239
 
Varying time and MPA concentration suggested that an impressive 70 % yield of 
thioester could be attained in only 10 min, using 40 % v/v MPA.
239 
 Thus, the original peptide containing the C-terminal ‗Pro-Pro ester‘ motif was 
experimentally concluded to be irrelevant because MPA transthioesterified all the S-
peptide formed through an initial N→S acyl transfer.239 The synthesis of an N-
acetylglucosaminylated peptide thioester of emmprin(34-58) was achieved with 20 % v/v 
MPA and afforded yields that were over twice as high as those previously reported,
239
 
which showcased the efficiency of this MPA-thioesterification method.  
 A stated drawback of this method was the lengthy preparation of the initial 5-
mercaptomethyl proline to be incorporated at the C-terminus of the peptide.
239
 In 
addition, MPA thioesterification without microwave irradiation was observed to be 
considerably slower and increased the timescale to a week.
239
 Furthermore, an aspartate-
serine peptide bond was found to be sensitive to treatment with 10-20 % v/v MPA,
239
 
though a possible solution could be the employment of a suitable protecting group 
strategy. The driving force for the initial intramolecular N→S acyl transfer was stated as 
being the lability of the amide bond in the imino acid proline.
240
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Scheme 1.22 Nakahara et al.‘s proposed thioesterification of a peptide with a C-terminal 
5-mercaptomethyl prolyl-prolyl ester motif did not proceed as envisaged through route (a) 
via a diketopiperazine.
239
 Instead, a peptide thioester was formed upon treatment with 3-
mercaptopropionic acid (MPA). Reagents and conditions: a) mild H3O
+
 (or mild 
-
OH); b) 
Reagent K, 60 °C, 4 h;  c) 10 % v/v aqueous MPA, microwave, 40 
o
C, 1 h.
239 
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1.17 N-Alkyl Cysteine-Assisted Thioesterification 
 
 Having accredited the N→S acyl shift to the presence of the imino acid proline, Nakahara 
et al. diverted their attention to the use of other imino acid ―devices‖ that might promote 
thioesterification. N-alkylation of a C-terminal cysteine residue was devised as an 
alternative to facilitating the intramolecular N→S acyl migration under acidic conditions, 
which could be followed by intermolecular transthioesterification with MPA to afford the 
peptide thioester (Scheme 1.23).
240
 
 N-Ethyl cysteine was incorporated into the synthesis of emmprin(49-58) and evidence of 
an equilibrium between the N- and S-peptide was presented.
240
 Both isomers could 
subsequently be transthioesterified with 5 % v/v MPA without any serious side 
reactions.
240 
 The reaction rate with MPA was found to increase with increasing bulk of the R group 
attached to cysteine in the following order: Me< Et< iBu.
240
 The installation of an N-alkyl 
cysteine instead of a mercaptomethylated proline was shown to markedly increase the 
reaction rate of thioesterification using a lower MPA concentration (5 % v/v) and lower 
temperature (25 °C).
240
 However, steric hindrance associated with the bulkier N-alkyl 
cysteine derivatives (iBu and Bn) compromised the coupling of the adjacent glycine 
residue during synthesis, and hence the overall MPA thioester yield (28 % and 17 %) 
compared to N-Me Cys (33 %) and N-Et Cys (34 %).
240 
 The N-ethyl cysteine derivative produced the highest peptide thioester yield and was 
relatively simple to prepare, although it did require HPLC purification.
240
 This method 
was shown to be applicable for the preparation of peptide thioesters with chiral amino 
acids at the C-terminus in acceptable yields and levels of epimerisation.
240 
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Scheme 1.23 Nakahara et al. demonstrated substituent effects during N-alkyl cysteine-
mediated thioesterification. N-Me Cys and N-Et Cys were found to be particularly favourable 
compared to the bulkier substituents N-iBu Cys and N-Bn Cys. Reagents and conditions: a) 5 
% v/v MPA, r.t., 2-3 days.
240 
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 N-Alkyl cysteine-mediated thioesterifcation was used to assemble a 95-amino acid 
chemokine, CCL27,
241
 utilising the silver ion (Ag
+
) promoted thioester method.
242
 
Notably, after cleavage from the solid-support followed by treatment with aqueous 
acetonitrile containing 6 M urea and 2 % MPAA, the more reactive MPAA aryl thioesters 
were obtained rather than the MPA-derived alkyl thioesters.
187
 Recently, the N-alkyl 
cysteine thioesterification method has also been applied to the synthesis of a 22 kDa 
octameric glycopeptide dendrimer.
243
 
 The observed selectivity in N-alkyl cysteine-mediated thioesterification was attributed to 
a combination of distortion of the planarity of the amide bond due to N-alkylation, and 
liberation of a secondary amine which is a stronger base and thus favours protonation.
240
  
 
1.18 Acyl Oxazolidinone and Aniline Linker-Mediated Thioesterification  
 
 Otaka and co-workers have additionally shown that a C-terminal cysteine residue when 
part of an acyl oxazolidinone moiety, can undergo an intramolecular N→S acyl transfer to 
yield thioesters (Scheme 1.24i).
244
 In this case the ground state geometry of the exocyclic 
amide is considered compromised as a consequence of steric factors, imposed by the 
cysteine side chain, and electronic factors, since the nN→π*CO interaction is additionally 
weakened by delocalisation of the nitrogen lone pair into the oxazolidinone carbonyl 
which lowers the energy barrier for the N→S acyl transfer.244 
 Despite the relatively long synthetic route employed to obtain the solid-supported 
oxazolidinone and its sensitivity to piperidine during peptide chain assembly prompting 
the use of Aimoto‘s reagent mixture [1-methylpyrrolidine/-hexamethyleneimine/1-
hydroxybenzotriazole in NMP/ DMSO (1:1)] for Nα-Fmoc removal, this method was 
successfully applied to the synthesis of a 9-residue peptide thioester derived from human 
brain natriuretic peptide-32 (hBNP-32).
244
 An NCL reaction between the 9-mer thioester 
and a synthetic N-terminal cysteine peptide, hBNP32-NH2(10-32), was conducted in 
phosphate buffer at pH 7.6 containing 6 M guanidine hydrochloride in the presence of 1 
% v/v thiophenol, and afforded hBNP32-NH2 in 76 % yield for the NCL step.
244 
 Racemisation of thioesters derived from chiral amino acids occurs with Aimoto‘s Fmoc 
removal reagent mixture during synthesis, and therefore only the Fmoc-glycyl 
oxazolidinone was successfully employed.
244 
Native Chemical Thioesterification: Synthesis of Peptide and Protein Thioesters through an N→S Acyl Shift 
 
56 
 
 Otaka et al. have also recently developed another device to facilitate an intramolecular 
N→S acyl shift for peptide thioester synthesis: an N-substituted aniline linker (Scheme 
1.24ii).
245
 It was hypothesised that anilide nitrogen rehybridisation could be effected by 
the introduction of two adjacent sp
2
 hybridised atoms, ultimately causing activation of the 
scissile amide bond.
245
 The core motif was based on para-(2-sulfanylethylamino)benzoic 
acid rather than the previously used acyloxazolidinone. 
 
 
 
 
 
 
 
Scheme 1.24 Otaka et al. proposed ground state destabilisation to be a significant 
contributing factor to thioester formation using: (i) N-acyloxazolidinones
244
 and ii) an N-
substituted aniline linker.
245
 Reagents and conditions: (i) a) phosphate buffer; pH 7.6, r.t. (ii) 
an isolable thioester is produced upon exposure to 4 M HCl/DMF, 1 % w/v TCEP, 8 h, 37 
°C. 
 Consequently ground state destabilisation once more facilitated nucleophilic attack of the 
adjacent thiol onto the distorted amide carbonyl carbon, and the undesired reverse S→N acyl 
shift was only observed in small amounts.
245
 This is because the aniline nitrogen is a poor 
nucleophile and this allows the equilibrium to favour the thioester. 
 The synthesis of a pentapeptide thioester (H-HRFAG-SCH2CH2SO3Na) was demonstrated 
using an Fmoc-glycyl aniline derivative.
245
 The N→S acyl shift for this was achieved by 
treatment with 4 M HCl/DMF in the presence of 1 % w/v TCEP for 8 h at 37 °C.
245
 The 
resulting isolable thioester was then finally converted into the MESNa thioester.
245 
 The aniline linker was also used to demonstrate an on-resin N→S acyl transfer.245 This was 
shown with the synthesis of up to 9 amino acid residue peptide thioesters upon thiolysis in 
a)ON
O
HS
peptide
O
OHN
S
O
O
peptideCONH2
CONH2
CO2H
N
HS
O
FmocHN NH
CO2H
N-S acyl shift
S
O
FmocHN
i) 
ii) 
Native Chemical Thioesterification: Synthesis of Peptide and Protein Thioesters through an N→S Acyl Shift 
 
57 
 
approximately 70 % yields.
245
 A small 9 residue phosphorylated serine-containing peptide 
thioester was also synthesised using the aniline linker in 67 % yield.
245
 However, an 
unexplained partial racemisation occurred upon treating the H-FAA-Ar peptide with 4 M 
HCl/DMF, which was suppressed when TFA was used for the N→S acyl shift.245   
 
1.19 Cysteinylprolyl Esters  
 
 Zanotti et al. initially observed that a para-nitrophenyl (Np) ester, PhCH2CO-Cys(StBu)-
Pro-ONp, when reacted with tributylphosphine produced a diketopiperazine thioester, cyclo(-
Cys(COCH2Ph)-Pro-).
246
 Kawakami and Aimoto then adopted this approach to generate a 
peptide thioester in situ by functionalising a peptide with a C-terminal ―autoactivating‖ 
cysteinylprolyl ester (CPE) (Scheme 1.25).
247-249
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Scheme 1.25 Kawakami and Aimoto introduced the cysteinylprolyl ester (CPE) method for 
synthesising peptide thioesters in situ for use in NCL reactions.
247
 An ―autoactivating‖ N→S 
acyl shift occurs initially, which is then followed by diketopiperazine formation. Then, 
transthioesterification occurs with an added thiol to afford a thioester, which then participates 
in an NCL reaction to afford a new amide bond. Reagents and conditions: 0.1 M buffer, pH 
8.2, 6 M guanidine.HCl, 20 mM tris-(hydroxypropyl)phosphine (THP), N-terminal cysteinyl 
peptide, r.t., 24 h.
247,248 
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 Mechanistically, Kawakami and Aimoto proposed that an intramolecular N→S acyl transfer 
occurs to form the S-peptide, which then promotes diketopiperazine formation.
247-249
 The 
resulting diketopiperazine peptide can then participate in intermolecular thiol-mediated 
thioester exchange, which can then be followed by ligation with, for example, a cysteinyl 
peptide under standard NCL conditions to afford a full-length polypeptide and the liberation 
of cyclo(-Cys-Pro-) (Scheme 1.25).
247
  
 The proline residue within the CPE unit may be exchanged with sarcosine (N-
methylglycine); however the ester is important as a C-terminal cysteinyl-prolyl-carboxylic 
acid or a cysteinyl-prolyl-carboxamide has been shown to not ligate under the same 
conditions.
247
 The diketopiperazine peptide has not been isolated but the by-product cyclo(-
Cys-Pro-) has been observed by mass spectrometry.
247
 Glycolic acid is also typically 
incorporated to form the ‗ester‘ component of the CPE.247 
 This CPE method circumvents the need for a peptide thioester building block and uses 
Fmoc-SPPS to potentially offer a higher yielding starting material.
247-249
 This is because it 
relies instead upon the entrapment of the S-peptide generated at equilibrium by a thiol.
247
 The 
reaction is reported to occur at room temperature and between pH 7.0 and 8.0, under 
denaturing conditions,
247
 which is ideal for peptides that contain heat- or acid-sensitive 
linkages and are prone to aggregation. Whilst a pH lower than 7.0 would be expected to 
favour the initial N→S acyl transfer, the conditions adopted are reasoned to favour thioester 
formation at the Xaa-Cys site because the amino group released is then free to form the 
diketopiperazine in slightly basic solution. The N→S acyl transfer reaction rate in the 
cysteine-containing peptides appeared to be slow when analysed by (RP)HPLC in weakly 
acidic solution (aqueous acetonitrile containing 0.1 % TFA), but even if the S-peptide was 
produced it rapidly reverted back to the N-peptide upon attemped isolation.
247
  
 Ligation yields recorded when the C-terminal amino acid was varied in a model peptide-CPE 
from glycine to alanine, leucine, or valine, were similarly good (49-60 %), and epimerisation 
during ligation was found to be negligible, though CPE-mediated ligation was also 
accompanied by a small amount of peptide hydrolysis.
247 
 A key advantage of the CPE device over the N-alkyl cysteine device is that it utilises 
standard, readily available materials that are typically associated with Fmoc/tBu chemistry. A 
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minor synthetic inconvenience is that the Xaa-Cys motif (within the C-terminal Xaa-Cys-Pro-
glycolyl sequence) needs to be introduced as a pre-prepared dipeptide in order to prevent 
premature on-resin diketopiperazine formation during peptide chain assembly.
247
 The 
protecting groups for any free α-amino groups or side-chain lysine ε-amino groups are also 
usually retained throughout,
247
 which is most likely to prevent unwanted intramolecular 
cyclisation or intermolecular reactions with other thioester intermediates. The removal of 
such protecting groups therefore involves an additional step after ligation. 
 Nonetheless, this CPE method does appear to overcome many disadvantages that are 
typically associated with thioester synthesis, because the thioester is only produced 
transiently under the reaction conditions at room temperature and at approximately neutral 
pH. After peptide synthesis, the peptide-CPEs are cleaved from the resin with a C-terminal 
carboxamide group,
247
 which are typically high yielding.  
 Peptide-CPEs can also be used to directly generate thioesters rather than allowing them to 
participate in ligation. This has been achieved by exposure to a thiol (i.e. MESNa) at pH less 
than 8.0, to minimise hydrolysis, with an elevated temperature of 37 °C for 6 h, to give the 
peptide thioester in good yields.
248,249
 In general, the degree of racemisation has been 
assessed to be low except when serine thioesters were synthesised from peptide-CPEs, in 
which case it was found to be greater than 20 %.
248,249 
 More recently, Aimoto et al. have also demonstrated the transformation of a peptide 
containing a Cys-Pro-Cys (CPC) sequence into a peptide diketopiperazine thioester through 
an N→S acyl shift under acidic conditions.250 The authors propose that since a Cys-Pro-Cys 
sequence can be readily encoded within proteins by recombinant DNA technology, it offers 
an alternative means to produce protein thioesters.
250 
 Kawakami et al. recently disclosed a fascinating extension of the CPE method to provide 
a recombinant route to cyclic peptides called ―backbone-cyclic peptide synthesis using 
recombinant elements‖ (bcPURE).251 It involved the use of the CPE method in 
conjunction with codon reprogramming through in vitro transcription followed by 
translation to allow recombinant expression, which was then followed by non-enzymatic 
cyclic peptide synthesis.
251
 Peptide cyclisation was promoted by the familiar formation of 
a cyclo(-Cys-Pro)- diketopiperazine thioester. Several target cyclic peptides were 
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prepared including Eptidemnamide, Scleramide, Rhesus-θ-defensin-1, and Sunflower 
trypsin inhibitor.
251 
 
1.20  Conclusion 
 
 Whilst many methods exist for the preparation of thioesters, they often result in low or 
variable isolated yields of the thioesters and tend to require a specialised linker, resin, device, 
or a cleavage cocktail.
199,200,208,210,214,252-256
 Recently, several laboratories have reported the 
synthesis of peptide thioesters based on an initial N→S acyl transfer, resembling the initial 
stages of protein splicing.
215,234-241,243-245,247-250
 These approaches provide an alternative 
source of peptide thioester that may in the future prove a more viable route than conventional 
carboxylic acid activation chemistries. 
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1.21 Scope of Thesis 
 
 The initial aim of this project was to explore the structure-activity relationships of the 
glycoprotein hormone erythropoietin (EPO). This was to be achieved by synthesising 
analogues of EPO and subsequently studying the effect of the introduced amino acid 
modifications on protein function. EPO was to be semi-synthesised through an NCL reaction 
between a synthetic peptide thioester and a biologically-derived fragment. Consequently, the 
synthetic peptide thioester would allow us to incorporate unnatural, glycosylated amino acids 
(Scheme 1.26). 
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Scheme 1.26 The synthetic peptide thioester corresponds to the N-terminus of erythropoietin 
(EPO). It contains three points of variation: a C-terminal cysteinylprolyl ester (CPE) unit for 
in situ thioester formation, an oligosaccharide mimic attached to the peptide backbone via an 
unnatural linkage, and an unnatural amino acid. 
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 Chapter 2 describes the unexpected discovery of a novel peptide and protein 
thioesterification method which was observed whilst experimenting with the 
cysteinylprolyl ester method for peptide thioester synthesis during our studies towards 
the semisynthesis of EPO. 3-Mercaptopropionic acid (MPA) was found to selectively 
fragment histidine-cysteine, cysteine-cysteine, and glycine-cysteine sequences to 
afford the corresponding MPA thioesters through an initial N→S acyl transfer. 
Selective thioesterification was demonstrated on several short EPO-based peptides 
and recombinant human EPO.
263
 
 
 Chapter 3 focuses on optimising the new thioesterification reaction discovered by 
introducing a site-specific 
13
C isotopic label within a model peptide. The labelled 
peptide was then reacted under various reaction conditions and the resulting 
conversion into peptide thioesters was measured. The optimised thioesterification 
conditions were then used in the first application of a biologically active protein, a 45 
amino acid residue analogue of human β-defensin 3.267 
 
 Chapter 4 demonstrates the compatibility of the new thioesterification procedure 
with the first synthesis of protected and deprotected native N-linked glycopeptide 
thioesters for potential use in the semisynthesis of glycoproteins. 
 
 Chapter 5 provides a summary of the main findings of the work presented in this 
thesis.
296
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2 Discovery of a Novel Peptide and Protein Thioesterification Reaction: Native 
Chemical Thioesterification 
 
2.1 Introduction 
 
 Native Chemical Ligation is an extremely powerful method that is routinely used for the 
synthesis of small to moderate-sized proteins.
144,145,187,257
 However, since approximately fifty 
amino acids represents the maximum for an efficient solid phase peptide synthesis, 
recombinant means to attain the required thioester and cysteine-containing components have 
been explored.
152,156,158,258
 
 
 Larger polypeptides can be accessed through semisynthesis, which involves an NCL reaction 
between a biologically-derived fragment and a synthetic fragment. Our main interest was in 
using organic chemistry to try and understand biological processes and therefore, we geared 
our studies towards the semisynthesis of the glycoprotein hormone erythropoietin (EPO). 
Erythropoietin is comprised of 166 amino acid residues and its role in the regulation of 
erythrocyte production has led to its common use in the treatment of anaemia, but it has also 
gained notoriety for being the illegal doping agent used in many competitive sports.
259-262
  
 
 Our semisynthetic strategy towards erythropoietin involved the chemical synthesis of a 
glycosylated peptide thioester that corresponded to the N-terminus of erythropoietin: EPO(1-
32)-COSR, which would then be ligated to a biologically expressed cysteinyl fragment that 
corresponded to the C-terminus of erythropoietin: EPO(33-166) (Scheme 2.1). 
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        10         20         30         40         50         60 
APPRLICDSR VLERYLLEAK EAENITTGCA EHCSLNENIT VPDTKVNFYA WKRMEVGQQA  
        70         80         90        100        110        120 
VEVWQGLALL SEAVLRGQAL LVNSSQPWEP LQLHVDKAVS GLRSLTTLLR ALGAQKEAIS  
       130        140        150        160         
PPDAASAAPL RTITADTFRK LFRVYSNFLR GKLKLYTGEA CRTGDR 
 
Scheme 2.1 (a) Amino acid sequence of human erythropoietin EPO(1-166).
259-262
 Disulfide 
bonds exists between 
7
Cys-
161
Cys and 
29
Cys-
33
Cys; 
24
Asn is N-linked to GlcNAc; 
38
Asn is N-
linked to GlcNAc; 
83
Asn is N-linked to GlcNAc; and 
126
Ser is O-linked to GalNAc.
259-262
  (b) 
The semisynthetic strategy towards EPO involved an NCL reaction between a synthetic N-
terminal EPO(1-32) peptide thioester and a biologically-derived C-terminal cysteinyl 
EPO(33-166) fragment.  
 
 The number of methods available to synthesise the required thioester has risen dramatically, 
however these methods often result in low or variable isolated yields of the thioester and tend 
to require a specialised linker, resin, device, or a cleavage cocktail.
199,200,208,210,214,252-256
 These 
requirements are disadvantageous because, as well as being synthetically inconvenient, they 
(a) 
(b) 
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often limit the amino acid sequence of the peptide thioester; limit the synthesis of 
posttranslationally modified peptide thioesters; and increase the number of synthetic steps 
from the commercially available starting materials to the product, which inevitably impacts 
on the overall yield and efficiency of the route. In general, the synthesis of peptide thioesters 
is notoriously difficult, particularly in larger quantities for use in industrial scale NCL 
reactions for the total synthesis of potentially therapeutic proteins. Therefore a more efficient 
and scalable route to produce (ideally posttranslationally modified) peptide thioesters using 
Fmoc-based chemistry was very much required. 
 Recently, several variations on the synthesis of thioesters via an N→S acyl shift that 
mechanistically resemble the initial stages of protein splicing using inteins have been 
reported (Scheme 2.2).
215,234-241,243-245,247-250 
 
O
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SR H2N
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R1
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pH 6.5-8.0
R1  
Scheme 2.2 (a) The most extensively used method for protein synthesis: Native Chemical 
Ligation,
144
 compared to (b) an acid-mediated N→S acyl transfer at cysteine residues used for 
thioester formation. R1 denotes an acyl-transfer facilitating group such as: alkyl, benzyl, δ-
mercaptomethyl prolyl.
215,234-241,243-245,247-250
 
 
 We began by looking at Kawakami and Aimoto‘s cysteinylprolyl ester (CPE) 
methodology.
247,248
 Their reaction involved a peptide functionalised with a C-terminal CPE 
undergoing an initial ―autoactivating‖ N→S acyl transfer to transiently produce thioesters for 
use in NCL reactions (Scheme 1.25). The term ‗N→S acyl shift‘ is used to describe an acyl 
a) 
b) 
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rearrangement from an amide bond (-CONH-) or ‗N-peptide‘, into a thioester (-COS-) or ‗S-
peptide‘. Mechanistically, CPE ligation proceeds via an initial reversible N→S acyl shift to 
produce the S-peptide. This is followed by diketopiperazine formation which is irreversible 
and hence drives the equilibrium to the right. Overall, the process is driven by the formation 
of the thermodynamically more stable amide bond after NCL. 
 We were intrigued by the CPE methodology and so we adopted it in our studies geared 
towards the semisynthesis of EPO. Peptide-CPEs had previously not been used for the 
semisynthesis of a protein and also seemed ideal because a peptide carboxamide is initially 
prepared (which is high yielding) through Fmoc-SPPS (which is preferable for appending 
acid-sensitive posttranslational modifications such as glycosylation), and the entire CPE 
mediated ligation reaction is conducted at approximately neutral pH (7.0-8.0). 
 
2.2 Results and Discussion 
 
2.2.1 Synthesis of a Model Peptide-CPE with Two Unprotected Cysteine Residues 
  
 Our ultimate aim was to prepare the N-terminal EPO fragment (amino acid sequence: 1-32) 
with a C-terminal CPE to facilitate semisynthesis (Scheme 2.1), and for this purpose we 
initially conducted some model CPE ligation experiments. We first synthesised a model 
peptide based on a short sequence of erythropoietin with a C-terminal cysteinylprolyl ester: 
EPO(22-32)-CPE, which encoded the following amino acid sequence: H-AENITTGCAEA-
CPE. Notably, this 13 amino acid sequence contained two cysteine residues, one of which 
was required for the CPE, and the other was a native cysteine present within the full-length 
EPO(1-166) at position-29. The native cysteine at position-29 is involved in disulfide 
bonding within the folded full-length protein.
259-261
 The Fmoc-based solid phase peptide 
synthesis strategy employed to prepare the model peptide-CPE 11 is shown in Scheme 2.3. 
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Scheme 2.3 Synthesis of the model peptide-cysteinylprolyl ester EPO(22-32)-CPE with the 
sequence: H-AENITTGCAEA-CPE 11, for use in test CPE ligations with the ultimate aim of 
EPO(1-166) semisynthesis.
263
  
 
 The peptide-CPE was assembled using Fmoc-based SPPS on Rink Amide MBHA resin 
7, to produce the C-terminal carboxamide after peptide chain assembly. The synthesis 
was carried out on a 0.1 mmol scale. Once the Fmoc protecting group had been removed 
from the amino group of the resin with 20 % v/v piperidine in N,N-dimethylformamide 
(DMF), the ―ester‖ component of the CPE was subsequently incorporated. This was 
achieved by initially forming the active ester of glycolic acid (Gc) using DIC and HOBt 
in DMF,
247,248
 and this reaction mixture was then reacted with the resin to give 8 (Scheme 
2.4). 
 
 The prolinyl component of the CPE was formed by coupling Fmoc-Pro-OH to 8, using 
HBTU/HOBt as the coupling reagents, to give Fmoc-Pro-Gc-resin. Proline is an imino 
acid and therefore the removal of the N-α-Fmoc group from this secondary amino group 
was difficult to monitor by the standard Kaiser Ninhydrin colour-test.
115
 The resin beads 
appeared red-orange in colour both before and after piperidine treatment, as opposed to 
the characteristic yellow (protected amine) and indigo (free amine).  
7 
8 9 
10 
6 
11 
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Scheme 2.4 Mechanism of the standard coupling reaction between an HOBt-activated 
carboxylic acid ester and an amine to form a new amide bond in 8 and a urea by-
product.
106 
 
 Therefore, in order to quantify the amount of the first amino acid, proline, that had been 
successfully loaded onto the resin, a quick UV absorbance assay was conducted.
115
 This 
involved the addition of a 20 % v/v piperidine in DMF solution to a few milligrams (1.5–
3.0 mg) of Fmoc-Pro-Gc-resin, followed by measurement of the absorbance of the 
solution directly above the beads inside a quartz cuvette. Fmoc deprotection with 
piperidine is rapid and thus the loading of the first amino acid onto the resin was 
determined by Fmoc analysis to be 85 % (0.544 mmolg
-1
/0.64 mmolg
-1
) (Equation 1,
115
 
Table 2.1). This value was used after peptide chain assembly was complete, to calculate 
the final isolated yield of the peptide-CPE. 
                                   Resin loading (mmolg
-1
) = 
)/()75.1( sin
290
mgMass
Abs
re
nm

 (1)
 
Table 2.1 Absorbance data for the determination of the loading of the first amino acid, Fmoc-
Pro-OH, onto the resin by Fmoc analysis using Equation 1.
115
  
Sample Mass /mg Abs290 nm Loading/ mmolg
-1
 
1 2.00 1.9720 0.563 
2 2.10 1.9290 0.525 
Ref - 0.0000 - 
Mean 2.05 1.9505 0.544 
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 The N-α-Fmoc group was then removed from proline with 20 % v/v piperidine in DMF to 
afford 9. In order to prevent premature on-resin diketopiperazine formation as a result of the 
sequential coupling of Fmoc-Cys(Trt)-OH to 9, the cysteine residue of the growing peptide-
CPE was incorporated as part of a pre-synthesised dipeptide 6.  
 On-resin diketopiperazine formation could occur upon removal of the Fmoc group from N-α 
of cysteine (Scheme 2.5). The free α-amino group of cysteine can then cyclise onto the 
carbonyl group between the prolyl-glycolyl sequence to afford the undesired 
diketopiperazine. If the synthesis was to be continued in this way then the product would 
contain a C-terminal cysteine-proline deletion. Therefore, to circumvent the possibility of 
synthesising a peptide without the essential cysteine-proline sequence within the peptide-
CPE, cysteine-containing dipeptides were synthesised. 
 
H
N
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N
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H2N
STrt
H
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Rn
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N
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Scheme 2.5 An undesirable side reaction: premature on-resin diketopiperazine formation 
resulting in a peptide containing a C-terminal cysteine-proline deleted sequence. This can be 
overcome by incorporating Fmoc-Xaa-Cys(Trt)-OH as a dipeptide during solid-phase 
synthesis, rather than sequential Fmoc amino acids. 
 
 Kawakami and Aimoto have demonstrated the scope of the CPE method with various C-
terminal amino acid residues.
247,248
 However, we chose to prepare a peptide-CPE that 
contained one of the least hindered amino acids (glycine or alanine) at its C-terminus. The 
dipeptide Fmoc-Xaa-Cys(Trt)-OH where Xaa was either glycine or alanine, was initially 
synthesised for incorporation into the growing peptide-CPE chain (Scheme 2.6). This was 
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achieved through triphenylmethyl (Trt) protection of the side-chain sulfhydryl group of 
cysteine. L-Cysteine hydrochloride, 1, was reacted with triphenylmethyl chloride to afford the 
side-chain protected amino acid 2 in 70 % yield (Scheme 2.6). Trityl-protected cysteine 2 was 
then coupled to the pre-activated α-carboxylic acid group of 3 to give 4 in 18 % yield, or 
coupled with 5 to give 6 in 78 % yield. Therefore, peptide-CPE synthesis was continued with 
6. 
N
H
O
O R
O
OH a) HOSu, DMF, EDCI.HCl
b) H-Cys(Trt)-OH, DIPEA
N
H
O
O R
O
H
N
OH
O
STrt
R = H (18 %)
    = CH3 (78 %)
H2N CO2H
SH
HCl
Ph3CCl, DMF
70 % H2N CO2H
S
R = H
    = CH3  
Scheme 2.6 Synthesis of the cysteine-containing Fmoc-Xaa-Cys(Trt)-OH dipeptides to avoid 
premature diketopiperazine formation on-resin during peptide-CPE solid phase synthesis. 
Xaa represents a sterically less hindered amino acid: either glycine 4 or alanine 6. 
 
 The cysteine-containing dipeptide 6 was then coupled to the proline-linked resin 9 using 
HBTU/HOBt, to give the resin-bound tripeptide 10. The peptide chain was then elongated 
by automated Fmoc-SPPS, with double-coupling of isoleucine, to give the protected 
resin-bound peptide: AE(O
t
Bu)N(Trt)IT(
t
Bu)T(
t
Bu)GC(Trt)AE(O
t
Bu)AC(Trt)P-Gc-resin. 
 This resin-bound peptide was then deprotected and concomitantly cleaved from the resin 
by treatment with the standard cleavage cocktail comprised of 95 % trifluoroacetic acid, 
2.5 % ethanedithiol and 2.5 % water (v/v/v),
115
 to afford the crude peptide-CPE with a C-
terminal carboxamide. During the cleavage reaction ethanedithiol acts as a scavenger for 
the cleaved by-products of acid-labile protecting groups (Scheme 2.7). 
1 2 
4 
6 
3 
5 
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Scheme 2.7 An example of the cleavage mechanism of the tert-butyl side-chain 
protecting group of glutamic acid using a cleavage cocktail comprised of 95 % 
trifluoroacetic acid, 2.5 % ethanedithiol, and 2.5 % water (v/v/v).
106
 Ethanedithiol acts as 
a scavenger of any electrophiles generated. 
 
 The 13 amino acid deprotected peptide-CPE corresponding to the sequence EPO(22-32)-
CPE: H-AENITTGCAEA-CPE was then purified by (RP)HPLC and rather interestingly, but 
not surprisingly, the peptide-CPE eluted as an asymmetric ‗doublet‘ at 23.0 min (Figure 2.1). 
The doublet peptide fractions were found to have an identical mass by ESI
+
 LC-MS, which 
corresponded to the expected mass of the desired model peptide EPO(22-32)-CPE 11. 
Therefore, the observed doublet was most likely due to the presence of diastereoisomers in 
the peptide; one possibility is cysteine diastereoisomers which could have formed upon 
coupling 6 to 9 (Scheme 2.8); another possibility is proline diastereoisomers. However, 
because the CPE unit is excised during ligation, the diastereoisomers were not separated. 
 
Figure 2.1 (RP)HPLC purification chromatogram of the proposed diastereoisomer-
containing peptide-CPE 11, tR = 23.0 min. ESI
+
 MS m/z calculated for EPO(22-32)-CPE 
[M]: 1335.6 Da; found [MH]
+
: 1336.7 Da. 
AENITTGCAEA
H
N
O
N
HS
OCH2CONH2
O
 11 
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Scheme 2.8 Mechanism of possible cysteine diastereoisomerisation during peptide-CPE 
synthesis. The activation of the α-carboxyl group of the dipeptide Fmoc-Ala-Cys(Trt)-OR 
during its coupling to H-Pro-Gc-resin under basic conditions can cause racemisation of 
the cysteine residue, and both diastereoisomers can continue in Fmoc-SPPS. 
 
 
 Diastereoisomerisation of the C-terminal cysteine may have occurred as a consequence 
of pre-activation of the cysteinyl α-carboxylic acid to the HOBt-ester under basic reaction 
conditions (Scheme 2.8).
106
 The lone pair of electrons on the cysteinyl α-amino group can 
participate in oxazolone formation. Nucleophilic attack of the carbonyl oxygen onto the 
activated ester can form a five-membered oxazolone ring. Base-mediated deprotonation 
of the α-hydrogen atom, followed by reprotonation of the α-carbon from the opposite face 
can cause diastereoisomer formation. The oxazolone ring can then be re-opened by 
nucleophilic attack of the secondary amino group of proline, to afford the dipeptide as a 
mixture of diastereoisomers. Hence, the peptide-CPE product may contain cysteine 
diastereoisomers.  
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 (b) (a) 
 The model peptide-CPE 11 was isolated in 22 % overall yield (Figure 2.2) and it was 
then reacted in model CPE ligations. 
 
 
 
 
 
   
 
 
 
 
Figure 2.2 Characterisation of the synthesised, isolated model peptide-CPE 11 (sequence = 
AENITTGCAEA-CPE) for subsequent CPE-mediated ligation studies. (a) LC-MS UV 
absorbance trace of EPO(22-32)-CPE 11, absorbance was detected at 254 nm. (b) ESI
+
 MS 
m/z calculated for EPO(22-32)-CPE [M]: 1335.6 Da, observed [MH]
+
: 1336.7 Da.
263 
 
 
2.2.2 Attempted CPE ligation  
 
 Model CPE ligations were conducted between 11 and an N-terminal cysteinyl peptide that 
corresponded to a short sequence of erythropoietin EPO(33-40): H-CSLNENIT-OH, 50 
(Scheme 2.9). A new Ala-Cys amide bond was expected in the full-length ligated peptide 
EPO(22-40): H-AENITTGCAEACSLNENIT-OH, 12. 
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Scheme 2.9 Attempted CPE ligation between the model peptide-CPE: EPO(22-32)-CPE 11 
and the N-terminal cysteinyl peptide: EPO(33-40) 50 to give the ligated product: EPO(22-40) 
12, under typical NCL conditions: 6 M guanidine hydrochloride, 0.3 M sodium phosphate 
buffer; pH 8.0, 2 % MESNa, and 10 mM TCEP.
263
 The reaction was monitored by LC-MS 
between t = 1 and 122 h, however the ligated product 12 was not observed.
263 
 
 Three different CPE ligation conditions were devised in which the thiol additive and pH 
were varied. The thiol additive is known to influence the ligation rate
146
 and was chosen to be 
either the alkyl thiol sodium 2-mercaptoethanesulfonate (MESNa), or the aryl thiol 4-
mercaptophenyl acetic acid (MPAA).
184
 The ligation was conducted at either pH 7.0 or 8.0. 
The higher pH facilitates deprotonation of the cysteine sulfhydryl within the CPE, and 
therefore promotes the N→S acyl shift and increases the rate of the diketopiperazine 
formation (Scheme 1.25).
247,248
 Conversely, a slightly lower pH also promotes the initial 
N→S acyl shift because it increases the amount of the protonated amine present at 
equilibrium. A lower pH would however mean that the second diketopiperazine formation 
step would be expected to proceed slower than at pH 8.0. 
 Analytical scale ligation reactions were set up between 11 and 50 at 25 °C in aqueous buffer. 
The reaction conditions for three parallel experiments were as follows: (A) 50 mM MPAA, 
10 mM TCEP, pH 7.0; (B) 50 mM MESNa, 10 mM TCEP, pH 7.0; or (C) 50 mM MPAA, 10 
mM TCEP, pH 8.0. The reactions were monitored by LC-MS at regular intervals from t = 1 
to 122 h. It was expected that the rate of ligation would be fastest when the thiol was MPAA 
and the pH 8.0.  
 
50 
11 
12 
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 After 18 h, an aliquot was removed from each of the three reaction mixtures for LC-MS 
analysis. The LC-MS traces for all three experiments looked noticeably different after 18 
h than those after 1 h. Reaction vessel ‗A‘ contained 50 mM MPAA at pH 7.0 and after 
18 h it showed the presence of two major species with longer retention times than the 
starting material model peptides. However, neither of these peaks corresponded to the 
ligated product EPO(22-40) 12. The earlier eluting of these peaks had an observed mass 
which corresponded to the calculated value for the cysteinyl peptide disulfide bonded to 
MPAA (Figure 2.3). It was possible that the reducing agent tris(2-
carboxyethyl)phosphine (TCEP) had been rapidly consumed since the reaction was not 
conducted under strictly inert conditions and both starting peptides contained a total of 
three cysteine residues. Hence more TCEP was added to give a final concentration of 40 
mM. 
 
 
Figure 2.3 ESI
+
 mass spectrum of the main component of the test CPE ligation between 
11 and 50, analysed after 18 h; the reaction contained 50 mM MPAA, 10 mM TCEP; pH 
7.0. Calculated mass for the cysteinyl-peptide EPO(33-40) 50 being disulfide-bonded to 
MPAA: 1058.4; observed [MH]
+
: 1058.5.   
 
 The proposed mechanism for the reduction of disulfide bonds by TCEP is shown in 
Scheme 2.10. Initially, the nucleophilic phosphorus(III) attacks the more electropositive 
sulfur atom of the disulfide and releases a free sulfide group. Nucleophilic attack from an 
oxygen atom of water then occurs onto the phosphonium ion to release the other free 
sulfide. The formation of the strong phosphonium oxide P=O double bond in the co-
product drives the reaction to afford the two free sulfhydryl groups. 
H-CSLNENIT-OH
S
S
CO2H
 
 
Native Chemical Thioesterification: Synthesis of Peptide and Protein Thioesters through an N→S Acyl Shift 
 
76 
 
P OH
O
OHO
HO
O
S
S
P OH
O
OHO
HO
O
S
S
H
O
H
P OH
O
OHO
HO
O
SH
S
O
H
P
O
HO2C CO2H
CO2H
SH
HS
 
Scheme 2.10 The proposed mechanism of reduction of disulfide bonds using tris(2-
carboxyethyl)phosphine (TCEP) to afford two free sulfhydryl groups. The reaction is 
proposed to be driven by the formation of the strong phosphorus-oxygen double bond. 
 Therefore, CPE ligation to give 12 was unsuccessful when 50 mM MPAA and 10 mM 
TCEP (pH 7.0) were used. This was likely due to the formation of intermolecular 
disulfide bonds between MPAA molecules and the three cysteine residues present within 
11 and 50. If the sulfhydryl group of the C-terminal cysteine residue within peptide-CPE 
11 was oxidised, it would therefore be unable to undergo an initial N→S acyl shift. 
Similarly, if N-terminal cysteinyl peptide 50 was oxidised it would also be unable to 
undergo transthioesterification with any existing peptide thioester.  
 
 Reaction vessel ‗B‘ contained 50 mM MESNa at pH 7.0 and after 18 h it showed the 
presence of unreacted 11 and 50 by LC-MS analysis (Figure 2.4). The peptide-CPE 11 
was observed to have a slightly longer retention time of 1.32 min than the shorter 
cysteinyl peptide 50 (1.11 min), using a 5–95 % acetonitrile gradient over 8 min during 
LC-MS analysis. It appeared that at pH 7.0, MESNa was less prone to oxidation than 
MPAA. After 18 h both starting material peptides were still available for CPE-mediated 
ligation but no ligated product was observed. Therefore, for reasons unknown, CPE 
ligation to give 12 was also unsuccessful when 50 mM MESNa and 10 mM TCEP (pH 
7.0) were employed. 
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Figure 2.4 The LC-MS (TIC) chromatogram of the test CPE ligation reaction between 
EPO(22-32)-CPE 11 and EPO(33-40) 50 in vessel ‗B‘, which contained 50 mM MESNa; 
pH 7.0, and was analysed after 18 h. No ligated product 12 was observed, only unreacted 
starting peptide-CPE 11 and N-terminal cysteinyl peptide 50 were observed. 
 
 After 18 h, reaction vessel ‗C‘ which contained 50 mM MPAA at pH 8.0 was also shown 
by LC-MS analysis to be mainly comprised of 50 being disulfide bonded to MPAA. 
Oxidation of 11 was also observed, therefore the amount of the reducing agent TCEP was 
increased to 40 mM to allow ligation to prevail. However, CPE ligation to give 12 was 
unsuccessful when 50 mM MPAA and 10 mM TCEP (pH 8.0) were used.  
 
 Overall, the ligated product 12 was not observed by LC-MS analysis under any of the 
three reaction conditions studied, even after 122 h, which is an uncommonly long 
duration of time for a ligation reaction because of potential side-reactions that can occur, 
including thioester hydrolysis. Both of the starting materials remained intact after 122 h 
in the reactions that contained MPAA or MESNa at pH 7.0. However peptide-CPE 11 was 
found to degrade after 122 h in the reaction that contained 50 mM MPAA at pH 8.0. 
 A plausible explanation is that ligation at the alanine-cysteine junction is slow. The 
presence of multiple cysteine residues within both of the starting materials also likely 
hindered the ligation due to undesirable oxidation, particularly in reactions containing 
MPAA. It was also proposed that the presence of an additional internal cysteine and its 
position within the sequence of 11 may have inhibited the reaction. 
 
2.2.3 MPA-Mediated Peptide Thioesterification  
 
 The CPE ligation reactions were unsuccessful possibly due to the two cysteine residues 
present within 11, so we turned our attention to ―rescuing‖ 11 by using the same forcing 
conditions that were employed by Nakahara et al.
239
  
50 11 
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 Recently, Nakahara and co-workers reported the thioesterification of peptides that were 
furnished with a C-terminal 5-mercaptomethyl prolyl-prolyl ester, upon treatment with 3-
mercaptopropionic acid (MPA) (Scheme 1.22).
239
 They had originally proposed a route 
via diketopiperazine formation at the C-terminal prolyl-prolyl-ester sequence, however 
this was not observed.
239
 Instead, when their peptide carrying the C-terminal 5-
mercaptomethyl prolyl-prolyl-ester moiety was treated with 40 % aqueous MPA and 
heated at 80 °C using microwave irradiation for 48 h, they observed the formation of the 
peptide-SCH2CH2CO2H MPA thioester.
239
 Therefore, we decided to treat our model 
peptide-CPE 11, which had two free cysteine residues, with the same forcing reaction 
conditions that Nakahara et al. employed (Scheme 2.11). 
 
AENITT N
H
O
H
N
N
H
HS
O
H
N
N
H
O
O OH
O
H
N
N
O
HS
O
O
O
O
H2N
30 % MPA, microwave irradiation,
80 °C, 16 h, 84 %
AENITT N
H
O
S
O
OH
HS
O
OH
MPA
 
Scheme 2.11 Unexpectedly, when the model peptide-CPE 11 was treated with 30 % v/v 
3-mercaptopropionic acid (MPA) using microwave irradiation, it selectively fragmented 
between the internal glycine-cysteine sequence rather than at the expected C-terminal 
alanine-cysteine sequence, to afford the glycine-MPA thioester 13.
263 
 
 Therefore, 11 was treated with 40 % v/v aqueous MPA at an elevated temperature of 80 
°C under microwave irradiation, at an apparent pH of 1.0, and the reaction progress was 
monitored by LC-MS analysis. We expected 11 to undergo thioesterification at the C-
terminal alanine-cysteine-proline-ester sequence, analogous to the observation that had 
been made with Nakahara et al.‘s 5-mercaptomethyl prolyl-prolyl-ester upon treatment 
with MPA.
239
 
 After four hours of treatment of 11 with MPA, we found that the main component of the 
reaction mixture was unreacted 11. However, we also detected fragmentation of 11 
between the internal 
28
Gly-
29
Cys sequence to afford the glycine MPA thioester 13: H-
AENITTG-MPA. Surprisingly, thioesterification had occurred selectively at the internal 
glycine-cysteine sequence rather than at the C-terminal alanine-cysteine sequence in 11 to 
give the MPA thioester 13.
263 
13 11 
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 The thioesterification of the model peptide-CPE 11 with 40 % v/v aqueous MPA after 12 
h showed three main peaks by LC-MS analysis in an approximately 1:1:1 ratio (Figure 
2.5). The earliest eluting peak was characterised to be the hydrolysed peptide thioester H-
AENITTG-OH, which was followed by the glycine-MPA thioester 13, and finally the co-
eluting unreacted starting material 11 and the full-length alanine-MPA thioester H-
AENITTGCAEA-MPA. Peptide thioester hydrolysis is an undesirable side-reaction that 
decreased the overall yield of the desired peptide thioester. 
 
 
 
Figure 2.5 LC-MS (TIC) chromatogram of the reaction of EPO(22-32)-CPE 11 with 40 
% v/v aqueous MPA with microwave heating at 80 °C. LC-MS analysis showed the 
presence of the hydrolysed thioester H-AENITTG-OH with an observed mass of 705.5 
Da, the glycine-MPA thioester H-AENITTG-SCH2CH2CO2H 13 with an observed mass 
of 793.4 Da, the alanine-MPA thioester H-AENITTGCAEA-SCH2CH2CO2H with an 
observed mass of 1167.6 Da, and the unreacted peptide-CPE H-AENITTGCAEA-CPE 11 
with an observed mass of 1336.8. 
 
 After elongating the reaction time to 24 h, LC-MS analysis revealed the main component 
of the reaction mixture to be the undesirable hydrolysed thioester. Therefore, to prevent 
thioester hydrolysis becoming the main product, thioesterification under these forcing 
reaction conditions should be terminated before 12 h. 
 This new thioesterification reaction was discovered using an excess of MPA (40 % v/v). 
However, MPA was found to have several strong absorbance peaks in UV chromatograms 
during HPLC purification, which were attributed to both the free MPA thiol and its 
disulfide-bonded dimer (HO2C-CH2-CH2-S-S-CH2-CH2-CO2H), and these peaks often 
precluded product thioester isolation.  
H-AENITTGCAEA-MPA + 11 
 
H-AENITTG-OH 
13 
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 The accumulation of a white precipitate within the reaction mixture was also observed 
over time, and this was isolated and characterised by NMR spectroscopy to be oxidised 
MPA. The precipitate produced was unproductive because it decreased the amount of the 
free MPA thiol available to participate in the reaction. The use of lower MPA 
concentrations was then explored to convert 11 into thioester 13.  
 
 Hence, thioesterification of 11 was tested with the lower, though still in excess, 
concentration of 30 % v/v aqueous MPA and the reaction mixture was heated at 80 °C 
with microwave irradiation for 16 h. The glycine-MPA thioester 13 was isolated in 84 % 
yield (0.5 mg).
263 
 
 Overall, the glycine-MPA thioester 13 appeared to be a kinetically favoured product. The 
expected C-terminal alanine-MPA thioester was also detected within the reaction mixture 
though only in trace amounts by LC-MS. It appeared that over time the alanine-MPA 
thioester was further ―processed‖ into the glycine-MPA thioester 13.  
 
 Under these reaction conditions 13 was found to be undesirably hydrolysed over time. 
We also observed undesirable disulfide bond formation between the cysteine residues in 
11 and MPA by LC-MS. Therefore the reaction required optimisation, but it was the first 
time we unexpectedly observed thioester formation selectively at a glycine-cysteine 
sequence rather than at an alanine-cysteine sequence. This suggested that the CPE 
device,
247,248
 or any other device such as 5-mercaptomethyl proline
239
 or N-alkyl 
cysteine,
240,241
 was not required to promote thioesterification, because the internal 
―device-free‖ glycine-cysteine sequence in 11 was thioesterified. The preference of MPA-
mediated thioesterification taking place at the internal glycine-cysteine site can be 
explained in terms of steric hindrance, because the amide bond between the least hindered 
glycine and cysteine was broken. 
 
 Therefore, this observation of ―device-free thioesterification‖ was an exciting new 
discovery that appeared to triumph on account of its sheer simplicity. However, we first 
needed to verify that the glycine-MPA thioester 13 had indeed been formed. To do this 
NCL reactions were conducted. 
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2.2.4 Glycine-MPA Thioester Ligation 
 
 One of the ways in which a thioester can be verified is through its participation in an 
NCL reaction. The isolated glycine-MPA thioester 13 was therefore reacted in an NCL 
reaction with the model cysteinyl peptide 50 (Scheme 2.12). The reaction was monitored 
by LC-MS and the ligated product 14 was observed in the first LC-MS analysis after 25 h 
(Figure 2.6). The observed mass for 14, AENITTGCSLNENIT, was 1578.7 Da which was 
in good agreement with the expected value. 
 
6 M Guanidine.HCl,
0.3 M Na Phosphate; pH 8.0,
2 % MESNa, 10 mM TCEP
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Scheme 2.12 Successful ligation between the glycine-MPA thioester: EPO(22-28)-MPA 
13 and the cysteinyl peptide: EPO(33-40) 50, under typical NCL conditions, to afford the 
ligated peptide: EPO(22-28)-(33-40) 14.
263 
 
 
 
Figure 2.6 LC-MS analysis at t = 25 h of the NCL reaction between the glycine-MPA 
thioester: EPO(22-28)-MPA 13 and excess cysteinyl peptide: EPO(33-40) 50 to give the 
ligated product: EPO(22-28)-(33-40) 14 with an observed mass of 1578.7 Da. 
 
 
 
13 
50 
50 (S-S) bonded to MPA  
14 
13 
50 
14 
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1406.6 
 
 
 
 
2.2.5 Synthesis of the Model Peptide-CPE with an Internally Capped Cysteine 
 
 The model peptide-CPEs employed by Kawakami and Aimoto in ligation reactions 
contained a sole free cysteine residue within the C-terminal CPE moiety.
247,248
 Our 
attempted CPE ligations were unsuccessful which we proposed could have been attributed 
to the presence of, or the distance between, the two cysteine residues in 11. This 
proposition was supported to a certain extent by the unexpected, selective fragmentation 
of 11 at the less hindered glycine-cysteine sequence compared to the relatively more 
hindered alanine-cysteine sequence upon treatment with MPA.      
 To deduce whether the internal cysteine residue was indeed problematic during ligation, 
the same model EPO peptide-CPE 11 was synthesised, though this time an 
acetamidomethyl (Acm)-protected internal cysteine was incorporated within the same 
EPO(22-32) sequence, to prevent any side reactions at the internal 
28
Gly-
29
Cys site. The 
resulting peptide EPO(22-
29
C(Acm)-32)-CPE had the sequence: H-
AENITTGC(Acm)AEA-CPE (16) and was prepared by Fmoc-SPPS in 20 % yield, based 
on the resin loading of the first amino acid proline (Figure 2.7).  
 
 
  
 
 
 
 
Figure 2.7 Characterisation of the synthesised, internal cysteine acetamidomethyl-protected 
model peptide-CPE 16 with the sequence: H-AENITTGC(Acm)AEA-CPE. (a) LC-MS UV 
absorbance trace of EPO(22-
29
C(Acm)-32)CPE: 16, absorbance detected at 254 nm. (b) ESI
+
 
MS m/z calculated for 16 [M]: 1406.6, observed [MH]
+
: 1407.8. 
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2.2.6 CPE-Mediated Ligation with an Internally Capped Cysteine 
 
 The Cys(Acm) protected peptide-CPE 16 was then tested in a model CPE-mediated ligation 
reaction with the cysteinyl peptide 50 (Scheme 2.13). The reaction conditions were: 50 mM 
MPAA, 10 mM TCEP, and aqueous buffer at pH 8.0, 25 °C. The reaction was monitored by 
LC-MS analysis and continued until the CPE had been consumed.  
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Scheme 2.13 Successful CPE ligation between the model peptide-CPE containing an 
internally acetamidomethyl (Acm) protected cysteine 16 and the N-terminal cysteinyl peptide 
50 to give the ligated product 19.  
 
 Interestingly, this time when the internal cysteine was capped, the expected full-length 
ligated product: EPO(22-
29
C(Acm)-40) 19 was detected by LC-MS after 24 h. The observed 
mass for the ligated product was in good agreement with the expected value, and it had a 
retention time during LC-MS analysis that was longer than either 16 or 50 (Figure 2.8). This 
provided some evidence to support the hypothesis that the internal free cysteine obstructed 
the previous attempted CPE-mediated ligation (Scheme 2.9).  
 
 
16 
50 
19 
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 However, as well as the desired ligated product 19, a further unexpected peak corresponding 
to a species that was 200 mass units larger than the ligated product was also observed (Figure 
2.8).  
 
 
 
Figure 2.8 LC-MS (TIC) analysis of the ligation reaction between the internally capped 
cysteine containing peptide-CPE 16 (AENITTGC(Acm)AEA-CPE) and the cysteinyl 
peptide EPO(33-40) 50 (CSLNENIT) after 69 h to give 19 
(AENITTGC(Acm)AEACSLNENIT). The ligated peptide 19 had an observed mass of 
[MNa + 2H]
2+
 1024.3 Da, which was in good agreement with the calculated mass for the 
ligated peptide 19 [M] = 2023.9 Da. However, a species that was 200 Da larger than 19 
with [M] = 2223.9 Da was also observed at 1.77 min. 
 
 
 The additional product had a longer retention time during analytical liquid 
chromatography than the full-length ligated product 19, and had an observed mass that 
was 200 Da larger than 19. This had not been previously reported by the Aimoto 
laboratory.
247,248
 We initially hypothesised that this species could be the full-length 
ligated product 19 disulfide bonded to the excised diketopiperazine to give 19a (Scheme 
2.14). 
 Therefore, the more powerful reductant DTT was added to the isolated 200 Da larger 
species to reduce any potential disulfide bonds present and produce the cyclic-DTT by-
product. However, we found that the 200 Da larger species persisted despite treatment 
with DTT, which suggested that an irreversible covalent bond had been formed. 
 
19 + 200 Da 
[O] MPAA  
 
19  
50  
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Scheme 2.14 Reduction of the proposed disulfide bond in 19a by DTT, which may be 
present between the ligated peptide 19 and the excised diketopiperazine by-product. 
Expected mass of the disulfide-containing 19a [M] = 2221.9 Da, however this was not in 
agreement with the observed mass [M + 2H]
2+
 1113.3 Da which corresponded to [M] = 
2223.0 Da. 
 
 Another plausible explanation for the presence of this 200 Da larger species was that a 
competing nucleophilic substitution reaction was taking place at the C-terminal prolyl-
glycolyl site in 16 (Scheme 2.15, pathway b), instead of transthioesterification of any S-
peptide produced (Scheme 2.15, pathway a).  
 
 The sulfhydryl group of the cysteinyl peptide 50 can attack the electrophilic carbonyl 
carbon of the C-terminal ester in 16 to displace the alkoxy group, which results in the 
formation of a full-length product but with an additional cysteine-proline insertion 
between the two reacting peptides (Scheme 2.15, pathway b). The calculated mass of the 
product expected from reaction pathway b ([M] = 2223.9 Da) was in good agreement with 
that observed for the 200 Da larger species, whereas the calculated mass expected from 
the ligated product being disulfide bonded to the excised diketopiperazine ([M] = 2221.9  
Da) was not observed.  
 
 This competing substitution side-reaction appeared to act as fast as the CPE ligation 
proceeding via pathway a, as determined by LC-MS analysis, because after 89 h the 
mixture was comprised of an approximately 1:1 ratio of the desired ligated product 19 
and the ligated product containing the cysteine-proline insertion. However, we did not 
analyse the sequence of the 200 Da larger species via MS-MS to verify that it was the 
product of pathway b. 
19 
19a 
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Scheme 2.15 Two possible competing reaction pathways were proposed to occur during 
CPE-mediated ligation: a) an initial N→S acyl shift occurs to produce the expected 
ligation product 19 and the diketopiperazine by-product; however b) an addition- 
elimination reaction can occur between the thiol of the cysteinyl peptide 50 and the ester 
of the peptide-CPE 16 to provide an undesired product that is 200 Da larger than the 
expected product 19, and contains a Cys-Pro insertion. 
 
 
2.2.7 MPA-Mediated Thioesterification of a Peptide-CPE with an Internally Capped 
Cysteine  
 
 
 A further verification of selective fragmentation of peptides at Xaa-Cys sequences upon 
treatment with MPA was achieved by reacting the protected internal cysteine containing 
peptide-CPE 16 with MPA (Scheme 2.16). The peptide-CPE 16 was treated with 20 % 
aqueous MPA and the reaction was heated at 80 °C with microwave irradiation.  
 
 
 
19 
16 50 
Native Chemical Thioesterification: Synthesis of Peptide and Protein Thioesters through an N→S Acyl Shift 
 
87 
 
20 % MPA, microwave irradiation,
80 °C, 16 h, 57 %
N
H
O
S
O
OHAENITT N
H
O
H
N
N
H
S
O
H
N
N
H
O
O OH
O
H
N
N
O
HS
O
O
O
O
H2N
NH
O
AENITTGCAE
Acm
 
 
Scheme 2.16 Reaction of the partially protected model peptide-CPE 16 
(AENITTGC(Acm)AEA-CPE) with 3-mercaptopropionic acid (MPA) afforded the full-
length alanine-MPA thioester 17 (AENITTGC(Acm)AEA-MPA).
263 
 
 After 18 h LC-MS analysis showed the presence of two major species, the desired full-
length alanine-MPA thioester 17 and the unreacted starting material 16. However, a small 
amount of peptide thioester hydrolysis was also observed as a result of initial 
thioesterification at the internal 
28
Gly-
29
Cys site, which occurred due to the cleavage of 
the acetamidomethyl group from the internal cysteine under the heated acidic reaction 
conditions used (80 °C, an apparent pH of 1.0).  
 
 Although the desired alanine-MPA thioester 16 was still the major product after 42 h, 
and some starting material remained unconverted, the amount of the undesirable glycine-
MPA thioester side-product EPO(22-28)-MPA had begun to increase (Figure 2.9). 
Therefore, the reaction was terminated and purified by RP(HPLC) to afford the isolated 
alanine-MPA thioester 17 in 57 % yield. 
 
 Another detected undesirable side-product was the full-length hydrolysed peptide 
thioester: H-AENITTGC(Acm)AEA-OH, for which a mass of 1150.7 Da was observed 
(Figure 2.9). This occurred either as a consequence of hydrolysis of 17 or, and equally as 
plausible, hydrolysis of the S-peptide produced via an N→S acyl shift at the C-terminal 
alanine-cysteine sequence of 16. 
 
 
 
 
 
17 16 
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Figure 2.9 LC-MS analysis after 42 h of MPA-mediated thioesterification of the partially 
protected peptide-CPE 16 (AENITTGC(Acm)AEA-CPE) with 20 % v/v MPA at 80 °C to 
give the alanine-MPA thioester 17 (AENITTGC(Acm)AEA-MPA) as the main 
component. 
 
H-AENITTGCAEA-MPA 
H-AENITTG-MPA 
H-AENITTG-OH 
16 
2+ of (16 + K) 
 17 
2+ of (17 + K) 
H-AENITTGC(Acm)AEA-OH 
16: H-AENITTGC(Acm)AEA-CPE 
17: H-AENITTGC(Acm)AEA-MPA 
H-AENITTG-MPA 
H-AENITTG-OH 
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2.2.8 Native Chemical Ligation of the Alanine-MPA thioester  
 
 The production of the full-length alanine-MPA thioester 17 was also verified in an 
analytical NCL reaction with the cysteinyl peptide 50 (Scheme 2.17). This produced the 
full-length ligated peptide 18 and further substantiated the hypothesis that internal 
cysteine residues, especially those comprising glycine-cysteine sequences were 
problematic during the initial attempted CPE ligation (Scheme 2.9).  
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Scheme 2.17 An NCL reaction between the full-length alanine-MPA thioester EPO(22-
29
C(Acm)-32)-MPA: (AENITTGC(Acm)AEA-SCH2CH2CO2H) 17 and the cysteinyl 
peptide EPO(33-40): (CSLNENIT) 50 was conducted and it afforded the ligated product 
(AENITTGC(Acm)AEACSLNENIT) 18, under typical ligation conditions. 
 
2.2.9 Protein Thioesterification  
 
 In a fascinating extension of the MPA-mediated peptide thioesterification method 
described above,
263
 wider application of MPA-mediated thioesterification was 
investigated with a recombinant 21 kDa sample of His-tagged wild-type (His10-WT) 
recombinant human erythropoietin (recombinant human erythropoietin was provided by 
Dr Jonathan P. Richardson). Erythropoietin is comprised of 166 amino acids and contains 
four Xaa-Cys sequences: 
6
Ile-
7
Cys, 
28
Gly-
29
Cys, 
32
His-
33
Cys, and 
160
Ala-
161
Cys (Figure 
2.10a).
259-261 
 Data provided by Dr Derek Macmillan showed that when erythropoietin was treated with 
20 % v/v aqueous MPA, at temperatures ranging from 40-80 °C, fragmentation of the 
protein was observed at temperatures as low as 40 °C. Over time, accumulation of the 
His10-EPO(1-28)-Gly-MPA and His10-EPO(1-32)-His-MPA peptide thioesters were 
observed (Figure 2.10).
263
 Of these two thioesters the His10-EPO(1-32)-histidine-MPA 
17 
50 
18 
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peptide thioester appeared to be the most abundant.
263
 The glycine- and histidine-MPA 
thioesters were subsequently isolated and ligated in an NCL reaction to the model 
cysteinyl peptide  EPO(33-40) 50 using: 6 M guanidine.HCl, 300 mM sodium phosphate 
buffer; pH 7.4, 25 mM MPAA, 20 mM TCEP, to afford the ligated peptides.
263
 The 
ligation experiments served to verify that the protein had indeed selectively fragmented 
upon exposure to MPA, to produce the corresponding thioesters.
263
 
 
        10         20         30         40         50         60 
APPRLICDSR VLERYLLEAK EAENITTGCA EHCSLNENIT VPDTKVNFYA WKRMEVGQQA  
        70         80         90        100        110        120 
VEVWQGLALL SEAVLRGQAL LVNSSQPWEP LQLHVDKAVS GLRSLTTLLR ALGAQKEAIS  
       130        140        150        160         
PPDAASAAPL RTITADTFRK LFRVYSNFLR GKLKLYTGEA CRTGDR 
 
 
 
 
 
 
 
 
 
Figure 2.10 (a) Amino acid sequence of human EPO(1-166) showing the four XC sequences. 
His10-tagged wild type recombinant human erythropoietin was observed to selectively 
fragment upon treatment with 20 % v/v 3-mercaptopropionic acid (MPA) at 50 °C for 16 
h.
263
 (b) 
28
Gly-
29
Cys and 
32
His-
33
Cys sequences within EPO were selectively thioesterified by 
MPA rather than 
6
Ile-
7
Cys or 
160
Ala-
161
Cys sequences. (c) Gly28Ala His10-tagged wild type 
recombinant human erythropoietin was selectively thioesterified between the histidine-
cysteine sequence by MPA as expected (data provided by Dr Derek Macmillan).
263 
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%
0
100
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 Of the four possible Xaa-Cys sequences within erythropoietin, the least hindered 
28
Gly-
29
Cys site and the 
32
His-
33
Cys site were favourably thioesterified by MPA, rather than the 
more hindered 
6
Ile-
7
Cys and 
160
Ala-
161
Cys sites (Figure 2.10a).
263
 This further supported 
our working selectivity hypothesis and seemed to suggest that the sites within peptides 
and proteins could be ―tuned‖ to favourably fragment and provide MPA thioesters, 
depending on the nature of the amino acid adjacent to cysteine. Thus, amino acid residues 
adjacent to cysteine were thioesterified by MPA in the following order: His≥ Gly> Ala> 
Ile.
263 
 Dawson and co-workers showed a similar trend in the reactivity of peptide thioesters that 
had a C-terminal histidine, glycine, or a cysteine residue in NCL reactions,
264
 the reverse 
process. Fast ligation rates of peptide thioesters with a C-terminal histidine, glycine, or a 
cysteine residue were attributed to the electron withdrawing nature of these residues 
which resulted in activation of the thioester. This increased the reactivity of the thioester 
towards nucleophilic attack of the cysteinyl sulfhydryl group during the initial NCL 
transthioesterification step. Furthermore, the reactivity of histidine and cysteine residues 
can be evidenced by them being the two amino acids that are most prone to 
racemisation.
106
  
 Therefore, we proposed that MPA-mediated thioesterification may also be limited to 
same three residues that were observed to promote particularly fast kinetics in regular 
NCL reactions: histidine, glycine, and cysteine.
263 
 
2.2.10 Favoured Xaa-Cys Sequences Undergoing MPA-Mediated Thioesterification 
 
 Data provided by Dr Derek Macmillan showed that peptides could be specifically tuned 
to fragment at pre-determined Xaa-Cys sequences (Table 2.2).
263
 Short model peptides 
based on the sequence of EPO(22-32): H-AENITTXCAEXC-NH2 containing two 
potential competing Xaa-Cys cleavage sites were synthesised to test the scope of MPA-
mediated thioesterification. Peptides were treated with 20 % v/v MPA at 50 °C, and as 
predicted histidine, glycine, and cysteine-cysteine sequences were found to preferably 
fragment, rather than the isoleucine-cysteine sequence also present within the same 
peptide, to provide the corresponding MPA thioesters.
263
 Thioesters were isolated in 
approximately 30 % yield when two equally favoured sites for fragmentation were present 
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within the same peptide, such as: glycine-cysteine and histidine-cysteine or glycine-
cysteine and cysteine-cysteine sequences (Entries 1 and 2, Table 2.2), and 60 % yield 
when only one favoured fragmentation site was present, such as in the peptide containing 
both isoleucine-cysteine and histidine-cysteine (Entry 3, Table 2.2).
263
 Hence, isoleucine-
cysteine sequences were found to not fragment, whereas glycine-cysteine, histidine-
cysteine, and cysteine-cysteine sequences readily fragmented upon treatment with 
MPA.
263
 
 
Table 2.2 Preferred sites of MPA-mediated thioesterification within a single peptide were 
further explored by varying the amino acid adjacent to cysteine. Model peptides were based 
on a short sequence of EPO(22-32): H-AENITTXCAEXC-NH2, and contained two XC 
competing sites of thioesterification. These model peptides were treated with 20 % v/v MPA 
at 50 °C for 36 h. Reactions were monitored by LC-MS for the cleavage ratio at 36 h, and 
after 36 h were purified by semi-preparative (RP)HPLC for the isolated thioester yields (data 
provided by Dr Derek Macmillan).
263
  
Entry Peptide sequence   
                                             
H-AENITT
1
XCAE
2
XC-NH2 
Cleavage 
Ratio      
1
XC : 
2
XC 
Isolated yield
 a 
% 
Thioester 
formation         
1
X-MPA 
calc.           obs. 
m/z             m/z 
Thioester 
formation        
2
X-MPA 
calc.           obs. 
m/z             m/z 
1 H-AENITTGCAEHC-NH2 ≈ 1: 1 28 793.3        793.5 1233.5     1233.6 
2 H-AENITTGCAECC-NH2 ≈ 1: 1 28 793.3        793.5 1199.4     1199.6 
3 H-AENITTICAEHC-NH2 > 9: 1 60  849.4          n/o 1289.5     1289.7 
a
Isolated yield for the full-length 11-mer peptide MPA thioester.
263 
 In a bid to further probe amino acid residues that were favoured or unfavoured in MPA-
mediated thioesterification, another small screen of model peptides was undertaken by Dr 
Derek Macmillan (Table 2.3).
263
 The model peptides were based on the erythropoietin 
sequence: H-AENITTXC-NH2 where X was glycine, alanine, proline, glutamic acid, valine, 
serine, and aspartic acid; and were subjected to forcing thioesterification conditions: 20 % v/v 
MPA and heating at 80 °C for 24 h.
263
 After 20 h, glycine-MPA thioester formation was 
found to be almost complete (Entry 1, Table 2.3).
263
 However, only trace amounts of proline 
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and valine-MPA thioesters were formed (Entries 3 and 5, Table 2.3), and lysine and 
tryptophan were the least efficient amino acids adjacent to cysteine in promoting 
thioesterification.
263
 An approximately 1:1 mixture of the starting material to peptide 
thioester resulted after 20 h for peptides that contained a C-terminal glutamate-cysteine, 
alanine-cysteine, serine-cysteine, or phenylalanine-cysteine sequence (Entries 2, 4, and 6, 
Table 2.3).
263
 Both the serine-containing starting peptide and product thioester also appeared 
to form an MPA ester on the primary hydroxyl group of serine (Entry 6, Table 2.3).
263
 
Interestingly, the aspartate-cysteine containing model peptide did not give rise to the MPA 
thioester, instead the major product was analysed by LC-MS to correspond to the loss of both 
aspartate and cysteine residues (Entry 7, Table 2.3).
263 
Table 2.3 MPA-Mediated selective thioesterification of model peptides was further explored 
by varying the amino acid adjacent to cysteine. Model peptides were based on a short 
sequence of EPO(22-29): H-AENITTXC-NH2, and X was varied. The model peptides were 
treated with 20 % v/v MPA at 80 °C for 20 h. Reactions were monitored by LC-MS, and 
were purified by semi-preparative (RP)HPLC for the isolated yields (data provided by Dr 
Derek Macmillan).
263,a
 
Entry Peptide sequence 
H-AENITTXC-NH2 
Isolated yield of 
starting material  
% 
Isolated yield of 
thioester 
% 
Thioester formation    
X-MPA 
calc.            obs. 
m/z              m/z 
1 H-AENITTGC-NH2 0 33
b 
    793.3          793.5 
2 H-AENITTAC-NH2 40 42     807.4          807.6 
3 H-AENITTPC-NH2 49 0     833.4          833.5 
4 H-AENITTEC-NH2 n.d. n.d.     865.4          865.5 
5 H-AENITTVC-NH2 67 0     835.4          835.6 
6 H-AENITTSC-NH2 0 n.d. 823.4          911.5
c 
7 H-AENITTDC-NH2 0 n/o
d 
    851.3            n/o 
a
When XC = FC, KC, or WC, product isolation was difficult. 
b
Loss in yield due to thioester hydrolysis. 
c
Starting 
material and product thioester appeared further esterified by MPA. 
d
Peptide had been consumed during reaction 
but no thioester was observed.
263 
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2.2.11 Racemisation 
 
 Data provided by Dr Derek Macmillan showed that when a short model peptide: Ac-Ala-
(L)His-Cys-NH2 was treated with 20 % v/v MPA at 55 °C for 48 h, the resulting MPA 
thioester Ac-Ala-His-SCH2CH2CO2H exhibited undetectable racemisation by HPLC, when 
compared to the thioester that resulted upon reacting Ac-Ala-(D)His-Cys-NH2 to identical 
thioesterification conditions.
263
  
 Racemisation via oxazolone formation upon activation of the C-terminus of the peptide 
during MPA-mediated thioesterification was not expected to be problematic as the reactions 
were conducted at acidic pH (~1.0). 
 
2.2.12 MPA Thioester Characterisation by 
1
H NMR Spectroscopy 
 
 A model study was conducted to characterise the peptide MPA thioesters formed by 
1
H 
NMR spectroscopy.
263
 For this purpose two model peptides were synthesised based on the 
erythropoietin sequence EPO(22-29): H-AENITTXC-NH2, where X was either glycine or 
histidine. These peptides were treated with 20 % v/v MPA at 60 °C for 48 h. MPA-
mediated thioesterification was monitored by LC-MS and after 48 h the reaction mixtures 
were centrifuged to remove the MPA-derived precipitate, and the peptide-containing 
supernatant was purified by semi-preparative (RP)HPLC.  
 Data provided by Dr Derek Macmillan showed that the model peptide that terminated in 
a histidine-cysteine sequence was readily converted into the histidine-MPA thioester and 
could also be isolated by HPLC in several milligram quantities. Comparison of the 
1
H 
NMR spectrum of the histidine-cysteine containing starting peptide 54 into the histidine-
MPA product thioester 55 showed the expected disappearance of the cysteine β-CH2 
signals in the product, as well as the characteristic appearance of the MPA 2(CH2) signals 
(Figure 2.11 provided by Dr Derek Macmillan).
263
 A downfield shift in the α-CH signal 
of histidine in the 
1
H NMR spectra of 55 was also observed.  
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Figure 2.11 
1
H NMR spectra (500 MHz, solvent = D2O, number of scans = 16, room 
temperature) of the EPO(22-29) model peptide functionalised with a C-terminal histidine-
cysteine sequence: H-AENITTHC-NH2 54 (a) before and (b) after MPA-mediated 
thioesterification to afford the histidine-MPA thioester: H-AENITTH-SCH2CH2CO2H 55 
(data provided by Dr Derek Macmillan).
263 
 
 Similarly, comparison of the 
1
H NMR spectrum of the glycine-cysteine containing 
starting peptide 20 into the glycine-MPA product thioester 21 also showed the expected 
disappearance of the cysteine β-CH2 signals in the 
1
H NMR spectrum of 21, as well as the 
characteristic appearance of the MPA 2(CH2) signals (Figure 2.12a, b). The 
thioesterification reaction also resulted in the hydrolysis of 21 and the 
1
H NMR of the 
isolated hydrolysed thioester 21b showed the characteristic disappearance of the MPA 
2(CH2) signals (Figure 2.12c). 
 
H2N
H
N
N
H
H
N
N
H
H
N
N
H
H
N
O
O
O
OHO
O
NH2 O
OH
O
OH
O
O
SH
O
NH2
N
H
N
H2N
H
N
N
H
H
N
N
H
H
N
N
H
S
O
O
O
OHO
O
NH2 O
OH
O
OH
O
O
N
H
N
OH
O
20 % MPA, 60 °C,
48 h
°
 
54 55 
a) b) 
Native Chemical Thioesterification: Synthesis of Peptide and Protein Thioesters through an N→S Acyl Shift 
 
96 
 
H2N
H
N
N
H
H
N
N
H
H
N
N
H
H
N
O
O
O
OHO
O
NH2 O
OH
O
OH
O
O
SH
O
NH2 H2N
H
N
N
H
H
N
N
H
H
N
N
H
S
O
O
O
OHO
O
NH2 O
OH
O
OH
O
O O
OH
20 % MPA, 60 °C,
48 h
 
 
 
    
 
 
 
 
 
 
Figure 2.12 
1
H NMR spectra (500 MHz, solvent = D2O, number of scans = 16, room 
temperature) of MPA-mediated thioesterification of a short model EPO(22-29) peptide 
functionalised with a C-terminal glycine-cysteine sequence. (a) Starting material: H-
AENITTGC-NH2 20 (~5.0 mg/500 µL). (b) Glycine-MPA thioester: H-AENITTG-
SCH2CH2CO2H 21 (~3.0 mg/500 µL). (c) Undesirable side-product, the hydrolysed glycine 
thioester: H-AENITTG-OH 21b (~0.5 mg/500 µL). 
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2.2.13 Discussion 
 
 During our endeavours towards the semisynthesis of the glycoprotein erythropoietin, we 
experimented with the cysteinylprolyl ester method.
247,248
 We observed thioesterification 
as a consequence of the following model experiment. We had devised a parallel set of 
CPE ligation reactions employing identical peptide sequences (sequence: 
AENITTGCAEA-CPE).  The difference between the two peptides was that one contained 
free cysteine sulfhydryls throughout, and the other contained a single acetamidomethyl 
(Acm) protected internal cysteine. The partially protected peptide 16 was found to ligate 
to the corresponding cysteinyl peptide (CSLNENIT) 50 to afford the full-length peptide: 
AENITTGC(Acm)AEACSLNENIT 19 whereas the fully deprotected peptide did not. We 
reasoned that the presence, and more importantly the position,
265
 of the additional free 
internal cysteine residue may interfere with the desired ligation enough to limit this 
application of the CPE method. However, this was not further explored by changing the 
position of the internal cysteine.  
 
 Furthermore, two competing sites of reaction were proposed during CPE-mediated 
ligation of the partially protected peptide-CPE 16 with 50, which decreased the amount of 
the desired ligated product 19. One reaction pathway was the desired route: an N→S acyl 
shift followed by diketopiperazine formation; and the other was an undesired route: 
nucleophilic attack of the N-terminal cysteine of 50 onto the ester which resulted in a 
cysteine-proline insertion between 50 and 16. These findings led us to explore alternative 
strategies to attain peptide thioesters from the fully deprotected peptide-CPE 11. 
 
 In doing so, we recalled that Nakahara and co-workers had reported the use of aqueous 3-
mercaptopropionic acid (MPA) to produce peptide thioesters by means of an N→S acyl 
transfer.
239
 Upon reaction of our model peptide-CPEs 11 and 16 with MPA, we found 
thioesterification occurred selectively at the internal glycine-cysteine motif rather than at 
the expected C-terminal alanine-cysteine sequence (Scheme 2.18).
263
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Scheme 2.18 Upper route: attempted CPE ligation between EPO(22-32)-CPE: 
AENITTGCAEA-CPE 11 and EPO(33-40): CSLNENIT 50 to afford the ligated product 
EPO(22-40) 12. Lower route: an unexpected, novel MPA-mediated thioesterification 
reaction discovered. The model peptide-CPE 11, which contained two free cysteine 
residues, was selectively transformed into the glycine-MPA thioester: AENITTG-
SCH2CH2CO2H 13.
263 
 
 Delving deeper into the profile of favoured Xaa-Cys motifs led us to conclude that, 
rather surprisingly, peptide thioesters could be selectively formed between histidine-
cysteine, glycine-cysteine, and cysteine-cysteine sequences upon exposure to MPA.
263
 
Coincidentally, peptide thioesters with a C-terminal histidine, glycine, or a cysteine 
residue are also known to accelerate the rate of NCL,
264
 the reverse process. Selective 
thioesterification at histidine-cysteine and glycine-cysteine sequences was also illustrated 
in the context of the recombinant protein erythropoietin (EPO), which contained 166 
amino acids.
263
 Consequently, installation of a specific sequence potentially allows us to 
program the chemoselective fragmentation of peptides and proteins in the presence of 
aqueous MPA to afford the highly desirable thioesters.  
 Our studies resulted in the discovery of a new thioesterification method, termed ―Native 
Chemical Thioesterification‖ (NCT), which could in the future provide an alternative to 
the intein-mediated method of preparing protein thioesters, as it requires no additional 
stimulus other than the appropriate sequence. Existing methods to prepare synthetic 
13 
11 
50 
12 
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peptide thioesters often require the use of a specialised resin, linker, device, or a cleavage 
cocktail which tends to limit the general applicability of those methods. Hence, preparing 
peptide thioesters by simply installing a histidine-cysteine, glycine-cysteine, or a 
cysteine-cysteine sequence can be synthetically more convenient. 
 Mechanistically, it is likely that an initial N→S acyl shift occurs by reversible 
nucleophilic attack of the cysteine thiol onto the carbonyl carbon of the amide across the 
histidine-cysteine, glycine-cysteine or cysteine-cysteine junction to give a proposed 
hydroxythiazolidine intermediate,
266
 which then releases the protonated amine and 
undergoes an intermolecular thioester exchange with MPA to give the isolable thioester 
(Scheme 2.19). Thus, NCL is reversed.  
N
H
O
O
HS
S
O
H3N
O
SR
O
RSHH3O
+
 
Scheme 2.19 A novel thioester-forming reaction discovered, termed ―Native Chemical 
Thioesterification‖ (NCT), which proceeds through an N→S acyl shift site-specifically at 
histidine-cysteine, glycine-cysteine, and cysteine-cysteine sequences.
263
 ‗RSH‘ denotes a 
small molecular weight thiol such as 3-mercaptopropionic acid (MPA).
263 
 
 In this thioesterification reaction (Scheme 2.19), an amide bond is selectively disrupted 
to form a thioester through an N→S acyl shift. Energetically, this is an uphill process 
because a more stable and lower in energy amide bond is broken to form a less stable, 
higher in energy thioester. The half-life of a typical amide bond in aqueous solution to 
hydrolysis is extremely slow, approximately 10 to 1000 years in water at neutral pH and 
room temperature in the absence of a catalyst,
21,22,107
 despite being thermodynamically 
favoured. The driving force for the breakdown of an amide bond to afford a thioester can 
be explained by considering that the reaction overall is conducted at acidic pH. This 
favours breakdown of the amide bond through protonation, though whether backbone 
amide protonation is the first step in the reaction mechanism or not is unknown.  
 Peptide thioester hydrolysis was also observed to increase over time with MPA.
263
 Hence 
further optimisation of this new method was required to make it a more efficient and less 
wasteful process.  
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 MPA-mediated thioesterification at glycine-cysteine sequences can be attributed to 
glycine being the least hindered amino acid, but the reason for preferred fragmentation at 
histidine-cysteine and cysteine-cysteine sites remains unclear. It can be postulated that the 
histidine or cysteine residues adjacent to cysteine act as a general acid or base to 
protonate or deprotonate reacting species, which is acknowledged to be the role of 
histidine residues located proximal to the N→S acyl shift site within inteins.182 
Alternatively, and rather intriguingly, the amide bond between histidine-cysteine, 
glycine-cysteine, and cysteine-cysteine sequences may adopt an atypical geometry, 
particularly under the reaction conditions used, which could cause ground-state 
destabilisation and result in ―activation‖ of the scissile amide bond.31,178,179 Preferential 
fragmentation may also be attributable to the electron withdrawing nature of these amino 
acid residues which can activate the scissile amide bond towards nucleophilic attack.
264 
 
2.3 Conclusion 
 
 Our initial aim was to test Kawakami and Aimoto‘s cysteinylprolyl ester methodology in 
model peptide ligations,
247,248
 with an ultimate aim of utilising these CPEs for the 
semisynthesis of erythropoietin. A model peptide bearing a C-terminal CPE that was 
based on a short sequence of erythropoietin: H-AENITTGCAEA-CPE 11 was 
synthesised, and test ligations were conducted with the corresponding cysteinyl peptide: 
H-CSLNENIT-OH 50.
263
  
 When CPE-mediated ligation was not observed under archetypal ligation conditions it 
was concluded that the presence and also the position of the internal free cysteine residue 
within the model peptide-CPE played a part in prohibiting the ligation.
265
 Further 
supporting evidence for the internal cysteine being an inhibitory factor during model CPE 
ligations was provided upon treatment of the same peptide-CPE 11, which contained two 
free cysteine residues, with 3-mercaptopropionic acid (MPA). 
 MPA-mediated thioesterification was unexpectedly observed between the internal 
glycine-cysteine site rather than at the expected C-terminal alanine-cysteine site,
263
 and 
this selectivity was attributed to glycine being the sterically least hindered amino acid.    
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 Further studies were conducted on the preferred sites of MPA-mediated thioesterification 
and those found to be favoured were: histidine-cysteine, glycine-cysteine, and cysteine-
cysteine sequences.
263
 Of these three, histidine-cysteine sequences were found to be 
particularly prone to thioesterification.
263
 Placement of these three residues (histidine, 
glycine, or cysteine) at the C-terminus of a peptide thioester has also been previously 
shown to increase the rate of NCL,
264
 the reverse process. When bulkier amino acids 
(proline, valine, phenylalanine, isoleucine, tryptophan and lysine) were placed adjacent to 
the cysteine residue in model peptides, MPA-mediated thioesterification was not as 
efficient.
263 
 
 An overall reaction pathway was proposed to consist of an initial intramolecular N→S 
acyl shift occurring favourably at histidine-cysteine, glycine-cysteine, and cysteine-cysteine 
sequences to afford the S-peptide,
215,234-241,243-245,247-250
 which then undergoes 
intermolecular transthioesterification with MPA to form the isolable MPA thioester.
263
 
These initial experiments enlightened us to the possibility of extending this reaction to 
tune the sites within both peptides and proteins to selectively fragment and provide the 
highly desirable thioesters.
263
 However, optimisation of the reaction conditions was 
required since we observed thioester hydrolysis which decreased the yield of the 
thioester.
263
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3 Reaction Optimisation and First Biological Application of Native Chemical 
Thioesterification 
 
3.1 Introduction 
 
 We came across an interesting observation whereby synthetic peptides and a recombinant 
protein containing a histidine-cysteine, glycine-cysteine, or a cysteine-cysteine sequence 
selectively fragmented to produce thioesters upon exposure to 3-mercaptopropionic acid 
(MPA). The reaction was termed Native Chemical Thioesterification (NCT) since it reversed 
the process of Native Chemical Ligation (NCL) (Scheme 3.1).
263
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Scheme 3.1 (a) Native Chemical Ligation (NCL)
144
 compared to (b) Native Chemical 
Thioesterification (NCT), our novel thioester-forming reaction which proceeds via an 
initial N→S acyl shift followed by transthioesterification with a thiol (i.e. 3-
mercaptopropionic acid) to afford the isolable thioester.
263 
 
 However, certain disadvantages of using MPA as the thiol were observed. Thioester 
hydrolysis was a side-reaction that was observed to increase over time when samples were 
heated with aqueous MPA.
263
 Intermolecular disulfide bond formation between MPA and the 
starting material was also observed (Figure 3.1).
263
 MPA had several strong UV absorbance 
(a) 
(b) 
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peaks during HPLC purification that potentially precluded analysis and product isolation.
263
 
MPA was also observed to precipitate out of the reaction mixture over time due to disulfide 
bond formation, which decreased the effective concentration of the thiol available to 
implement the second transthioesterification step within our proposed mechanism (Scheme 
3.1 b).
263
 Therefore, this new thioesterification method required further optimisation.  
 
 
Figure 3.1 Typical LC-MS analysis of MPA-mediated thioesterification proceeding via an 
N→S acyl shift, analysed after t = 24 h. The starting material based on a short sequence of 
EPO(22-29): H-AENITTGC-NH2 (C) was converted into the MPA thioester: H-AENITTG-
SCH2CH2CO2H (B). Undesirable thioester hydrolysis: H-AENITTG-OH (D) and disulfide 
bond formation: H-AENITTGC(MPA)-NH2 (A) were also observed.
263 
 
 Another important goal we aimed to achieve was the application of optimised 
thioesterification reaction conditions to the synthesis of a biologically active protein, prepared 
from fully-characterised starting materials and intermediates.  
 
 
 
 
 
 
 
C= SM B= Thioester 
A= Disulfide 
 
 
 
 
 
t = 24 h 
D= Hydrolysis 
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3.2 Results and Discussion  
 
3.2.1 Optimisation of One-Pot Peptide Thioesterification 
 
 Our aims for optimising MPA-mediated Native Chemical Thioesterification (NCT) included 
the following: 
 Decrease the amount of the unproductive side-products: peptide thioester hydrolysis 
and peptide-disulfide bond formation. 
 Increase the isolated yields of simple and more complex peptide thioesters. 
 Increase the overall rate of peptide thioesterification so that peptides and proteins are 
not heated under acidic conditions for prolonged periods. 
 Decrease the reaction temperature to expand the potential application of NCT to 
peptides and proteins containing heat-sensitive moieties. 
 
 Preliminary experiments were conducted with the model peptide EPO(22-29): H-
AENITTGC-NH2 20 (Scheme 3.2). MPA-mediated peptide thioesterification was initially 
investigated by reacting 20 with 10 % v/v aqueous MPA and heating at 60 °C. The reaction 
was monitored at regular intervals by LC-MS analysis.  
 
AENITT
H
N
N
H
O
SH
O
NH2
AENITT
H
N
S
O
CO2H
10 % MPA, 60 °C
 
Scheme 3.2 Initial optimisation studies were conducted to determine the optimum reaction 
time of MPA-mediated peptide thioesterification. The model peptide H-AENITTGC-NH2 20 
was reacted with 10 % v/v MPA, at 60 °C, and the reaction was monitored by LC-MS. 
20 21 
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 After 24 h, the major component of the reaction was unreacted starting material 20 and 
whilst a significant amount of the product MPA thioester H-AENITTG-SCH2CH2CO2H 21 
had been formed, peptide thioester hydrolysis to give H-AENITTG-OH 21b and undesirable 
intermolecular disulfide bond formation H-AENITTGC(MPA)-NH2 21c were also detected. 
Elongating the reaction time to 48 h resulted in an increase in the amount of the peptide MPA 
thioester 21 formed, and the ratio of 20: 21 was observed to be approximately 1:1. However, 
increasing the reaction time to 72 h, to force the reaction to completion, resulted in a 
significant amount of peptide thioester hydrolysis 21b. The ratio of the unreacted starting 
material 20 to product thioester 21 and hydrolysed product 21b was approximately 1:1:1 after 
72 h (Figure 3.2). Hence, the reaction appeared to reach maximal conversion by 48 h, after 
which peptide hydrolysis became significant. 
 
Time
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TIC
3.55e9
0.690.56
0.47
0.23
0.85
1.37
1.02
1.22
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1.66
2.09
3.25
 
 
Figure 3.2 LC-MS analysis of peptide thioesterification of 20 upon exposure to 10 % v/v 
MPA at 60 °C after 72 h. The starting peptide (H-AENITTGC-NH2) 20, thioester (H-
AENITTG-SCH2CH2CO2H) 21, and hydrolysed product (H-AENITTG-OH) 21b were 
formed in an approximately 1:1:1 ratio. The starting peptide 20 was also found to be disulfide 
bonded to MPA through its C-terminal cysteine residue (21c). 
 
 
1
H NMR spectroscopy was previously used to characterise the peptide-MPA thioester which, 
although essential for characterisation, offered limited information about the connectivity of 
the MPA molecule to the peptide (Section 2.2.12).
263
 Therefore, 
13
C NMR spectroscopy was 
employed as a tool to optimise peptide thioester formation under various reaction conditions.  
20 21 21b 
21c 
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 For this purpose, a model peptide was synthesised with a site-specific 
13
C isotopic label 
(Scheme 3.3).
267
 
13
C-Labelled glycine 22 was incorporated into the Fmoc-SPPS of the EPO-
based peptide 26 with the sequence: H-AENITTG(
13
C-1)C-NH2.
267
 This resulted in a C-
terminal labelled amide bond within the C-terminal glycine-cysteine sequence in 26, which 
was chosen because we had previously shown that peptides containing histidine-cysteine, 
glycine-cysteine, and cysteine-cysteine sequences readily fragmented (Chapter 2).
263
  
 
  
 
 
 
 
 
 
 
 
Scheme 3.3 Synthesis of the 
13
C-labelled model peptide 26 (AENITTG(
13
C-1)C-NH2) with a 
C-terminal glycine-cysteine sequence for use in thioester optimisation studies.
267
 The α-
amino group of 
13
C-labelled glycine 22 was initially Fmoc-protected to afford 23, and this 
was then incorporated during the Fmoc-based solid phase peptide synthesis of 26 using 
standard coupling methodology (see Experimental Section 6 for further details). 
 
 It was reasoned that if the role of MPA was solely to act as a transthioesterification reagent 
in the latter part of the proposed mechanism (Scheme 3.1 b), then a peptide thioester could 
potentially be prepared by any thiol via an intermolecular thiol-thioester exchange. To test 
this hypothesis, thioesterification was investigated with a range of thiols and the significance 
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of having both acid and thiol functionalities present within the same reagent was also 
explored. The readily available, water-soluble transthioesterification reagents tested and 
certain notable chemical properties of these thiols are summarized in Table 3.1. 
 
Table 3.1 Selected readily-available, water-soluble thiols that were used in the optimisation 
studies are listed. The thiol, carbon chain length, and presence of a carboxylic acid 
functionality within the thiol was varied.  
Thiol (RSH) Structure Abbreviation Carbon chain length  pKa
268 
 
2-Mercaptoacetic acid 
 
OH
O
HS
 
 
MAA 
 
2 
 
10.3 (SH), 3.7 (CO2H) 
 
3-Mercaptopropionic 
acid 
 
OH
O
HS
 
 
MPA 
 
3 
 
10.3 (SH), 4.3 (CO2H) 
 
4-Mercaptobutyric acid
*
 
 
OH
O
HS
 
 
MBA 
 
4 
 
10.3 (SH), 4.7 (CO2H) 
 
β-Mercaptoethanol 
 
OH
HS  
 
BME 
 
2 
 
9.5 (SH) 
 
Sodium 2-
mercaptoethanesulfonate 
 
S
HS
O
O
+Na-O  
 
MESNa 
 
2 
 
9.1 (SH) 
* Synthesised from 4-bromobutyric acid (see Experimental Section 6). 
 
 MPA is comprised of a three carbon chain and in order to determine whether the distance 
between the acid and thiol functionalities within this thiol was important, the carbon chain 
length was varied with 2-mercaptoacetic acid (MAA) and 4-mercaptobutyric acid (MBA). 
The importance of the presence of the carboxylic acid functionality within MPA was also 
investigated by testing thiols that contained either a sulfonate group: sodium 2-
mercaptoethanesulfonate (MESNa), or a hydroxyl group: β-mercaptoethanol (BME). 
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 The general procedure for the optimisation studies involved dissolving the 
13
C-labelled 
model peptide 26 in a solution of 10 % thiol in D2O at a peptide concentration of 6 mM, with 
or without acid, to study a range of pH values (1.0 to 8.0) (Scheme 3.4).
267
 The reactions 
were heated at the fixed temperature of 60 °C by conventional heating and the reactions were 
continued for a total time of 72 h.
267
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Scheme 3.4 The optimisation studies involved thioesterification of the 
13
C-labelled model 
peptide H-AENITTG(
13
C-1)C-NH2 26 terminating in a glycine-cysteine sequence, under 
various reaction conditions to afford the corresponding 
13
C-labelled thioesters 29.
267
 The 
reactions were conducted in D2O and monitored by 
13
C NMR spectroscopy (125 MHz, 
number of scans = 256) at regular intervals between t = 0 and 72 h. The relative intensities of 
the 
13
C-labelled carbonyl carbon peaks were then used to determine the percentage 
conversion of the starting peptide 26 into the product(s). 
 
 Aliquots of the reaction mixture were removed at specific intervals for 
13
C NMR 
spectroscopic analysis. During that time, disappearance of the starting material amide 
chemical shift (CONH) δC ~171 ppm was observed, along with the appearance of the product 
thioester (COSR) δC ~200 ppm and/or hydrolysed peptide (CO2H) δC ~173 ppm.
267
 Examples 
of 
13
C NMR spectra acquired for various reaction conditions studied during the optimisation 
studies are shown in Figure 3.3.
267
  
 
 
 
26 29 
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Figure 3.3 Peptide thioesterification of the model peptide (H-AENITTG(
13
C-1)C-NH2) 26 
was monitored under various reaction conditions by 
13
C NMR spectroscopy. The labelled 
peptide 26 was dissolved in D2O at a concentration of 6 mM, and the thioesterification 
reaction was heated using conventional heating at 60 °C. 
13
C NMR spectra were acquired at 
regular intervals (125 Hz, number of scans = 256, room temperature). Reagents and 
conditions: a) 10 % MPA, pH ~1.0; b) 10 % MAA, pH 1.0-2.0; c) 10 % MESNa, 1 % AcOH, 
pH ~2.0; d) 10 % BME, 1 % TFA, pH ~1.0; e) 10 % BME, 1 % AcOH, pH ~2.0; f) 71 % 
TFA-d, 29 % CDCl3, (0.5 % TCEP.HCl added after 48 h).
267
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 The relative intensities of the peptide-derived carbonyl carbon signals during 
thioesterification of the 
13
C-labelled model peptide 26 under various reaction conditions, 
were then used to calculate the percentage of starting material converted into the peptide 
thioester 29 and the hydrolysed product (H-AENITTG(
13
C-1)-OH) 29b.
267
 These conversions 
were plotted in the graphs shown in Figure 3.4.
267 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4 Peptide thioesterification of H-AENITTG(
13
C-1)C-NH2 26 was monitored by 
13
C NMR 
spectroscopy (125 MHz, D2O, 256 scans) under various reaction conditions. Reactions were 
conducted at 60 °C using conventional heating and 6 mM labelled model peptide 26, 10 % thiol in 
D2O ± acid, between pH 1.0 and 8.0. The relative intensities of the 
13
C-labelled carbonyl carbons were 
then used from the 
13
C NMR spectra acquired to determine the percentage conversion of the starting 
material 26 into the product: (a) peptide thioester; (b) hydrolysed peptide thioester.
267 
(a) 
(b) 
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3.2.2 Optimisation Studies Using Conventional Heating 
 
 Key observations from the optimisation studies conducted using conventional heating and 
relating to Figure 3.4, are discussed in Table 3.2. 
 
Table 3.2. Key observations from the optimisation studies conducted by reacting the labelled 
model peptide H-AENITTG(
13
C-1)C-NH2 26 under various reaction conditions at 60 °C by 
conventional heating, and relating to Figure 3.4 are described.  
Conditions Observations 
10 % MPA (pH ~ 1.0) 
The maximum amount of peptide MPA thioester: H-AENITTG-
SCH2CH2CO2H (200 ppm) attained was about 60 % after 48 h. After 48 h, 
thioester hydrolysis (173 ppm) was detected and it increased to approximately 
10 % after 72 h. 
10 % MAA (pH 1.0-2.0) 
The maximum amount of MAA thioester: H-AENITTG-SCH2CO2H detected 
was approximately 20 % after 24 h. After 72 h, 100 % of the starting peptide 
had been hydrolysed to H-AENITTG-OH. 
10 % MBA (pH ~ 2.0) 
No peptide thioester hydrolysis was observed. Peptide-MBA thioester H-
AENITTG-SCH2CH2CH2CO2H formation reached approximately 40 % 
conversion after 48 h. The side-reaction of MBA thiolactone (210 ppm) 
precipitate formation was observed to increase over time (Figure 3.5). 
10 % BME, 1 % TFA  
(pH ~ 1.0) 
Thioester hydrolysis rapidly increased throughout the reaction to about 80 % 
after 72 h. TFA appeared to accelerate acid-mediated peptide thioester 
hydrolysis. 
10 % BME, 1 % AcOH  
(pH 2.0) 
More thioester was detected under these conditions than in the reaction 
containing TFA, but peptide thioester hydrolysis was about 20 % after 72 h. 
10 % BME (pH 5.0) The hydrolysed product increased to about 30 % after 72 h.  
10 % BME (pH 8.0) 
 
No peptide-SCH2CH2OH BME thioester formation was observed. Base-
mediated peptide thioester hydrolysis was observed to be more than 20 % after 
72 h. The reactions conducted with 10 % BME at pH 1.0, 2.0, 5.0, or 8.0, all 
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resulted in hydrolysis. 
10 % MESNa, 1 % AcOH  
(pH 2.0) 
100 % Conversion of the starting material into the product-SCH2CH2SO3H 
thioester was detected after 48 h. No peptide thioester hydrolysis was 
observed. 
10 % AcOH (pH 2.0) 
No peptide thioester hydrolysis as a result of breakdown of the thioester from 
an N→S acyl shift was observed. 
1 % TFA (pH 0.8) 
The ―S-peptide‖ from an N→S acyl shift was observed at 199 ppm. About 70 
% of the hydrolysed product was detected after 72 h.  
71 % TFA-d + 29 % CDCl3 
 
The S-peptide was present at room temperature
236
 but it was observed after 96 
h, when 0.5 % TCEP.HCl had been added which suggested that intramolecular 
disulfide bond formation had prevented the N→S acyl shift from occurring.  
  
 
Figure 3.5 
13
C NMR spectrum of the undesirable 4-mercaptobutyric acid (MBA) thiolactone with the 
characteristic chemical shift of ~210 ppm was isolated upon attempted distillation of the desired linear MBA. 
MBA thiolactone formation was also detected in 
13
C NMR spectra monitoring the thioesterification of peptide 
26 with 10 % MBA in D2O at 60 °C.  
 
3.2.12 Other Observations from Conventional Heating Experiments 
 
 Overall, the rate of peptide thioester hydrolysis with 10 % MAA was significantly higher 
than with 10 % MPA, and no hydrolysis was observed with 10 % MBA. For this observation 
we proposed a ‗neighbouring group participation‘ hypothesis for mercaptocarboxylic acids, 
which stated that the intramolecular acid functionality within these molecules can facilitate 
hydrolysis once the peptide thioester had been formed via anhydride formation
269
 (Scheme 
3.5). 
 The proposed anhydride has not been isolated, nor has it been detected by 
13
C NMR. 
Neighbouring group participation was proposed as an explanation for the increased rates of 
S
O
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hydrolysis observed with MAA and MPA thioesters, which are proposed to undergo 
anhydride formation via a five- or six-membered ring transition state. It follows that the 
absence of detectable hydrolysis in the reaction containing 10 % MBA could be attributed to 
decreased neighbouring group participation due to the slower formation of the larger seven-
membered ring transition state. Peptide-BME thioesters were also shown to hydrolyse, which 
can also be explained by participation of the neighbouring alcohol group to form an ester that 
subsequently hydrolyses. The increased stability of the sulfonate group within MESNa 
relative to the carboxylic acid group of MPA, could also account for the absence of detectable 
hydrolysis when MESNa was used as the thiol. 
R
O
S
O
O
Hpeptide
R
O
OH
R
O
O SH
O
H3O
+
peptide peptide
 
Scheme 3.5 Neighbouring group participation to form anhydrides
269
 during peptide 
thioesterification is proposed to contribute to the trend observed for peptide thioester 
hydrolysis: MAA> MPA> MBA. The MAA thioester is proposed to undergo anhydride 
formation via a five-membered ring transition state; the MPA thioester is shown to undergo 
anhydride formation via a six-membered ring transition state; and the MBA thioester is 
proposed to undergo anhydride formation via a large seven-membered ring transition state.  
 
 Therefore, from these optimisation studies conducted with conventional heating, sodium 2-
mercaptoethanesulfonate (MESNa) was found to be a superior transthioesterification reagent 
to MPA, whilst MPA was observed to be a better reagent than 4-mercaptobutyric acid 
(MBA), 2-mercaptoacetic acid (MAA), and β-mercaptoethanol (BME).267 The increased 
polarity of MESNa compared to MPA also greatly simplified HPLC purification.
267
 MESNa 
was found to elute within the first 5 min during HPLC purification and remained water-
soluble throughout the course of the reaction without precipitation. 
 Overall, the highest amount of hydrolysis was observed with 10 % BME + 1 % TFA at pH 
0.8 (about 80 % hydrolysed after 72 h), and also with 10 % MAA at pH 1.6 (100 % 
hydrolysed after 72 h).
267
 It appeared that over time peptide thioesterification became 
significantly disfavoured compared to peptide hydrolysis at pH lower than 2.0. No 
Native Chemical Thioesterification: Synthesis of Peptide and Protein Thioesters through an N→S Acyl Shift 
 
114 
 
background S-peptide hydrolysis was observed with 1-10 % aqueous AcOH alone (pH 2.0), 
however it was observed with 1 % aqueous TFA (pH 0.8). 
 
 The percentage conversions of the starting material 26 into the respective thioesters 29 under 
various thioesterification conditions using conventional heating, which were used to plot 
Figure 3.4a, are shown in Table 3.3. These percentages were used to determine the extent of 
peptide thioesterification at each time point (Table 3.4, Figure 3.6). In general, the extent of 
thioesterification of the labelled peptide 26 (H-AENITTG(
13
C-1)C-NH2) with an added thiol 
using conventional heating was observed to increase until 6 h, after which it decreased until 
the reaction was terminated after 72 h (Figure 3.6). Thus, the majority of the transformation 
of the starting material 26 into the thioester 29 (H-AENITTG(
13
C-1)-SR) occurred within the 
first 6 h of the reaction. 
 
Table 3.3 Percentage conversions of the starting labelled peptide 26 (H-AENITTG(
13
C-1)C-
NH2) into the peptide thioester 29 (H-AENITTG(
13
C-1)-SR) under various reaction 
conditions.
a
 These percentages were used to plot Figure 3.4a. 
Reaction conditions 
% COSR 
at t = 0 h 
% COSR 
at t = 6 h 
% COSR 
at t = 24 h 
% COSR 
at t = 48 h 
% COSR 
at t = 72 h 
10 % MPA 0.00 13.22 48.6 63.78 32.69 
10 % MAA
 
0.00 13.64 17.48 0.00
 
0.00 
10 % MBA 0.00 8.40 25.09 40.25 42.14 
10 % β-mercaptoethanol (pH 5.0) 0.00 9.29 16.85 13.67 12.13 
10 % β-mercaptoethanol + 1 % TFA 0.00 6.51 0.00 0.00 0.00 
10 % MESNa 0.00 18.37 58.25 100.00 100.00 
10 % β-mercaptoethanol (pH 8.0) 0.00 0.00 0.00 0.00 0.00 
10 % β-mercaptoethanol + 1 % AcOH 0.00 14.22 30.5 20.47 12.06 
 a
The relative intensities of the 
13
C-labelled carbonyl carbons in the 
13
C NMR spectra 
acquired to follow the conversion of 26 (H-AENITTG(
13
C-1)C-NH2) into 29 (H-
AENITTG(
13
C-1)-SR) over time, were used to determine the percentage conversions (% 
COSR). 
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Table 3.4 The extent of conversion of the starting labelled peptide 26 (H-AENITTG(
13
C-
1)C-NH2) into the peptide thioester 29 (H-AENITTG(
13
C-1)-SR) under various reaction 
conditions, was determined using the percentages shown in Table 3.3.
a
 
Reaction conditions t = 0 h t = 6 h t = 24 h t = 48 h t = 72 h 
10 % MPA 0.00 2.20 2.03 1.33 0.45 
10 % MAA 0.00 2.27 0.73 0.00 0.00 
10 % MBA 0.00 1.40 1.05 0.84 0.59 
10 % β-mercaptoethanol (pH 5.0) 0.00 1.55 0.70 0.28 0.17 
10 % β-mercaptoethanol + 1 % TFA 0.00 1.09 0.00 0.00 0.00 
10 % MESNa 0.00 3.06 2.43 2.08 1.39 
10 % β-mercaptoethanol (pH 8.0) 0.00 0.00 0.00 0.00 0.00 
10 % β-mercaptoethanol + 1 % AcOH 0.00 2.37 1.27 0.43 0.17 
a 
For each reaction condition, the percentage of thioester formed (from Table 3.3) at, for 
example, 24 h was divided by the time (24 h), and this ratio was plotted against that time 
point (i.e. 24 h) in Figure 3.6. 
 
 
Figure 3.6 Extent of peptide thioesterification. The percentage conversions of the starting 
labelled peptide 26 relative to time = 0 h were taken from Table 3.4. 
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3.2.15 Optimisation Studies Using Microwave Heating 
 
 The two best thiols from the initial optimisation studies using conventional heating were 
found to be MESNa and MPA,
267
 and these were then further investigated in microwave-
mediated reactions in an attempt to increase the reaction rate (Figure 3.7).
267
  
 
 Microwave-mediated thioesterification was expected to be useful if the reaction rate, when 
10 % MESNa and 1 % AcOH were used as the reagents, increased to result in 100 % 
conversion of the starting material into the product thioester within 24 h. Therefore, labelled 
peptide 26 was reacted with either 10 % MESNa and 1 % AcOH, or 10 % MPA at three 
different temperatures 40, 50 and 60 °C, and the reactions were monitored at regular intervals 
over 24 h (Figure 3.7).
267
 Microwave-mediated thioesterification reactions were conducted 
with low magnetic stirring and were also monitored by 
13
C NMR spectroscopy. 
 
 However, microwave irradiation was found to offer no advantage to peptide 
thioesterification since the results were comparable to those obtained with conventional 
heating (Figures 3.4a and 3.5).
267
 The percentage conversion into the peptide thioester with 
10 % MESNa in the presence of 1 % AcOH was found to be approximately 60 % in either 
case, when thioesterification was conducted at 60 °C after 24 h, with either microwave or 
conventional heating.
267 
 
 The role of certain additives was also explored and the addition of 0.5 % w/v TCEP was 
observed to be beneficial. This was concluded after it was found that microwave-mediated 
thioesterification with 10 % MESNa and 1 % AcOH at 50 °C resulted in approximately 50 % 
of the peptide thioester, but upon addition of 0.5 % TCEP the amount of the peptide thioester 
was noticeably higher than 50 % after the same duration of time (Figure 3.7).
267
 This was 
attributed to the reduction of unproductive intermolecular disulfide bonds formed during the 
reaction between the starting material and the thiol, since the reaction contained 0.7 M 
MESNa.
267 
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Figure 3.7 Peptide thioesterification of the labelled peptide H-AENITTG(
13
C-1)C-NH2 26 
was conducted using microwave irradiation and was monitored by 
13
C NMR spectroscopy 
(125 MHz, D2O, 256 scans), under various reaction conditions. Reactions were conducted 
with 6 mM labelled peptide 26 in D2O, 10 % MPA or MESNa, at 40/ 50/ 60 °C.
267
 The 
relative intensities of the 
13
C-labelled carbonyl carbons were then used from the 
13
C NMR 
spectra acquired, to determine the percentage conversion of the starting material 26 into the 
product peptide thioester 29.
267
 
 
 The role of the general base N-methyl imidazole (Me-Im) was also investigated. Microwave-
mediated thioesterification at 50 °C of the starting peptide 26 with 10 % MESNa and 1 % 
AcOH, 0.5 % Me-Im; pH 5.0, resulted in approximately 20 % thioester formation. Whereas 
identical reaction conditions but with the pH adjusted to 2.0 by the addition of 10 % AcOH 
resulted in greater than 30 % thioester formation. The same reaction conducted at pH 2.0 
without Me-Im as the additive resulted in about 50 % thioester. Thus, both of the reactions 
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with 0.5 % Me-Im, at either pH 2.0 or 5.0, produced less thioester than without this additive 
(Figure 3.7).
267
 This suggested that the addition of a general base to deprotonate the cysteine 
sulfhydryl group at the glycine-cysteine junction within the starting peptide, for example, was 
not required.  
 
 Peptide thioesterification was also conducted at the lower temperature of 40 °C and though 
thioester formation occurred, it was slower than that observed at 50 °C or 60 °C (Figure 
3.7).
267
 Nonetheless thioesterification at 40 °C may prove useful for some peptides and 
proteins that contain heat-sensitive moieties. 
 
3.2.13 Summary of Optimisation Studies 
 
 All of the optimisation studies were carried out using a starting peptide concentration of 6 
mM.
267
 Data supplied by Dr Derek Macmillan showed that a higher concentration of the 
starting peptide (16 mM) resulted in less thioester formation than when the reaction was 
conducted with a 4 mM concentration of the peptide.
267
 Hence, the peptide concentration was 
important since a lower peptide concentration resulted in a higher amount of thioester 
formation. This was likely due to an increased propensity of disulfide bond formation with 
the thiol at higher peptide concentrations, which was supported by the beneficial effect of the 
addition of the reducing agent TCEP.
267 
 
 In summary, the optimal conditions for peptide thioesterification from these studies were 
deduced to be the following: 6 mM [peptide], 10 % MESNa, 1 % AcOH, 0.5 % TCEP, 
heating at 60 °C at pH 2.0.
267
 These optimisation studies were conducted in deuterated water, 
however replacement of the reaction solvent from water to 6 M guanidine hydrochloride has 
been observed to be beneficial for insoluble samples.
267
 Having deduced optimised peptide 
thioesterification conditions, they were then applied to the total chemical synthesis of a 
biologically active protein.
267 
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3.3 The First Biological Application of Native Chemical Thioesterification: Human 
β-Defensin 3 (HBD3) 
 
3.3.1 Introduction 
 
 Defensins are characteristically small proteins with molecular weights ranging from 2-5 
kDa.
270,271
 Defensins are cationic, due to a net charge calculated from the total sum of the 
charged amino acids at neutral pH, and have also been described as ―cysteine-rich‖ peptides. 
Defensins are found in mammalian leukocytes and epithelial tissues and based on their 
disulfide connectivity are categorised into three different structural families: α, β, and θ. In 
2009, six human α-defensins: human neutrophil peptides (HNPs 1-4) and enteric defensins 
(HD5 and HD6) were identified. However, a larger number of β-defensins are believed to 
exist, predominantly in epithelia. 
 Distinct from α and β-defensins, θ-defensins are macrocyclic and are expressed in leukocytes 
and the bone marrow of specific non-human primates.
270,271
 Mammalian α- and β-defensins 
differ in their amino acid compositions, cysteine disulfide topology, and tissue distribution, 
but their three-dimensional structure is conserved. They adopt a three-stranded β-sheet core 
structure that is stabilised by three intramolecular disulfide bonds. Despite their overall 
structural similarity, defensins exhibit rather diverse functions.  
 Defensins are natural peptide antibiotics and they operate in the early stages of the innate 
immune defence system against invading infectious pathogens including: bacteria, fungi, and 
viruses.
270,271
 The cationic property of defensins is generally acknowledged as being 
responsible for killing bacteria due to the electrostatic attraction between the cationic 
defensins and the anionic microbial membrane. This results in cell death due to the 
disturbance of the microbial membrane which leads to leakage of cell contents. Defensins 
inhibit enveloped and non-enveloped viruses through diverse molecular mechanisms.  
 The synthesis of an analogue of human β-defensin 3 (HBD3) was undertaken, which is 
comprised of 45 amino acid residues and is an antimicrobial and chemoattractant polypeptide 
(Figure 3.8).
270,271
 HBD3 contains six cysteine residues which form three intramolecular 
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disulfide bonds in the characteristic β-defensin arrangement: CysI-CysV, CysII-CysIV, and 
Cys
III
-Cys
VI
.
270,271
  
 
Figure 3.8 (a) Amino acid sequence of human β-defensin 3 (HBD3) and the Ser22His 
analogue. (b) Known NMR structure of HBD3. (c) The native 
22
Ser-
23
Cys site is located on 
the surface of HBD3.
270,271 
 
3.6.2 Results and Discussion  
 
3.3.3 Total Chemical Synthesis of the HBD3 Analogue 
 
 The synthetic strategy for the total chemical synthesis of HBD3 involved the Fmoc-based 
SPPS of two ―halves‖ of the full-length HBD3 polypeptide: HBD3(1-22) and HBD3(23-45) 
(Scheme 3.6). The N-terminal fragment was to be functionalised with a C-terminal thioester 
and the C-terminal fragment would have an N-terminal cysteine. Histidine-cysteine 
(a) 
(b) (c) 
Native Chemical Thioesterification: Synthesis of Peptide and Protein Thioesters through an N→S Acyl Shift 
 
121 
 
sequences were found to be particularly prone to thioesterification (Chapter 2),
263
 therefore a 
histidine-cysteine motif could simply appended to the N-terminal HBD3 fragment by 
introducing a Ser22His mutation. Each half of HBD3 could then be ligated through an NCL 
reaction,
144
 and leave an amide bond at the ligation site.  
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Scheme 3.6 The synthesis of the folded analogue of HBD3: Ser22His HBD3(1-45) 36.
267
 
Ser22His HBD3 was assembled from two synthetic 23 amino acid peptide ―halves‖. 
Ser22His HBD3(1-21)-His-Cys-NH2 30 was initially thioesterified using the optimised 
conditions to afford a 22 amino acid thioester: Ser22His HBD3(1-21)-His-SCH2CH2SO3H 
31, which was then ligated to the cysteinyl peptide: HBD3(23-45) 33 to afford 34. The 
acetamidomethyl cysteine side-chain protecting groups present in the full-length polypeptide 
34 were then removed to give deprotected polypeptide 35, which was then oxidatively folded 
to afford 36 for subsequent biological evaluation.
267
 
 
 
 
30 31 
32 33 
31 33 
34 
35 36 
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3.3.4 Synthesis of the Ser22His HBD3 N-Terminal Peptide  
 
 Theoretically, HBD3 can be synthesised in a single SPPS run, however HBD3 was prepared 
from two fragments to enable the demonstration of the biocompatibility of the 
thioesterification method (Scheme 3.6).
267
 The N-terminal HBD3 fragment was assembled 
after the initial manual coupling of Fmoc-Cys(Trt)-OH onto Rink Amide MBHA resin. The 
peptide was then elongated in an automated fashion and purified by (RP)HPLC to afford the 
N-terminal HBD3(1-21)-His-Cys-NH2 peptide 30 in 50 % isolated yield, based on 100 % 
loading of the first amino acid onto the resin.  
 
 The N-terminal HBD3 fragment 30 had two other internal cysteine residues, apart from the 
cysteine within the C-terminal histidine-cysteine sequence, which were protected with an 
acetamidomethyl (Acm) group. These other cysteine residues that were Acm protected 
formed part of either a 
10
Y
11
C or 
17
R
18
C sequence, therefore side-reactions at these sequences 
were expected to be minimal during the thioesterification step.
263
 However, the internal 
cysteine residues were anticipated to decrease the rate of the initial transthioesterification step 
in NCL and potentially render thioester hydrolysis a significant side-reaction. Therefore, 
internal cysteine residues within both the N- and C-terminal fragments of HBD3 were Acm 
protected. 
 
 The solid-phase peptide synthesis of 30 was notably efficient and provided mainly the 
desired peptide carboxamide (Figure 3.9). LC-MS analysis of the isolated N-terminal HBD3 
peptide 30 confirmed the correct mass of the desired peptide. 
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m/z
500 600 700 800 900 1000 1100 1200 1300 1400 1500 1600 1700 1800 1900
%
0
100
HBD3 HC 30,31 142 (1.288) Cm (131:183) 1: Scan ES+ 
2.82e7922.6
554.1
692.3
1383.5
 
Figure 3.9 (a) (RP)HPLC purification chromatogram of 30, absorbance detected at 230 nm. 
The isolated N-terminal HBD3 peptide 30 was found to have a retention time of tR = 32.3 
min, using the gradient: 5-50 % MeCN over 45 min. (b) LC-MS analysis of isolated 30. 
Calculated average mass for [M]: 2765.3, found: 2765.0.
267
 
 
3.3.5 Synthesis of the Ser22His HBD3 C-Terminal Cysteinyl Peptide 
 
 The C-terminal HBD3(23-45) peptide 33 was synthesised on preloaded Fmoc-Lys(Boc)-
Novasyn® TGT resin 32 and extended using automated Fmoc-SPPS. After cleavage and 
(RP)HPLC purification, 33 was isolated in 37 % yield.
267
 Synthetic C-terminal HBD3(23-45) 
peptide 33 contained an equal number of amino acids to the N-terminal HBD3 peptide 30 (23 
amino acids each). However 33, which contained three Acm protected cysteine residues, was 
considerably earlier eluting during (RP)HPLC purification than 30 (Figure 3.10). This was 
32.2 min 
mass
2000 2200 2400 2600 2800 3000 3200 3400 3600 3800
%
0
100
HBD3 HC 30,31  142 (1.288) M1 [Ev-103045,It30] (Gs,1.000,500:2000,1.00,L30,R30); Cm (131:183) 1: Scan ES+ 
2.45e82765.0
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a) 
b) 
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attributed to the presence of the majority of the polar, positively charged (arginine and lysine) 
and negatively charged (glutamate), amino acid residues residing within this ―half‖. 
 
 
m/z
500 600 700 800 900 1000 1100 1200 1300 1400 1500 1600 1700 1800 1900
%
0
100
HBD3 tube 18 51 (0.462) Cm (44:67) 1: Scan ES+ 
2.46e6585.4
731.5
 
Figure 3.10 (a) (RP)HPLC purification chromatogram of 33, absorbance detected at 230 nm. 
The isolated HBD3 cysteinyl peptide 33 was found to have a retention time of tR = 18.4 min, 
using the gradient: 5-50 % MeCN over 45 min. (b) LC-MS analysis of isolated 33. Calculated 
average mass for [M]: 2921.5, found: 2922.0.
267
 
 
3.3.6 Synthesis of the N-Terminal HBD3 Thioester 
 
 Using the optimised thioesterification conditions (Section 3.2.16),
267
 the more complex 22 
amino acid thioester 31 was synthesised.
267
 Thioesterification of 15.8 mg of the histidine-
cysteine terminating N-terminal peptide 30 was conducted at a concentration of 4 mM in 6 M 
guanidine hydrochloride, which contained 10 % w/v MESNa, 10 % v/v acetic acid, and 0.5 % 
w/v TCEP, and was reacted for a period of 48 h at 60 °C.
267
 The desired 22 amino acid 
thioester 31 was co-purified with the 23 amino acid starting material 30 by semi-preparative 
(RP)HPLC purification of the reaction mixture. These two species could not be separated, 
even if the solvent gradient during (RP)HPLC purification was modified. However, it was 
18.4 min 
mass
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reasoned that the starting material 30 would not participate in the subsequent NCL reaction 
and could therefore be recovered after ligation. Thus, the lyophilised product which was 
comprised of 30 and 31 was used in the NCL reaction. 
 
 MESNa-mediated thioesterification of the longer 23 amino acid peptide 30 did not proceed 
to completion. It appeared as if the impetus for thioester formation was higher in the initial 
stages of the reaction, with a slower rate of conversion into the product thioester after the 
initial 6 h, analogous to that observed in the optimisation studies (Figure 3.6).  
 
 An attempt was also made to differentiate between the elution times of the starting material 
30 and the product thioester 31 by extending the number of amino acids within the peptide 
chain of 30. Hence, to allow for a better separation of the starting material N-terminal HBD3 
peptide and the product thioester, the N-terminal HBD3 fragment was synthesised with four 
extra C-terminal amino acids: HBD3(1-21)-HCSSGG-NH2. 
 
 The isolated yield of the longer N-terminal peptide after Fmoc-SPPS was lower than that of 
the original peptide 30 which did not contain the extra four residues. Nonetheless, the isolated 
peptide was subsequently subjected to the same optimised thioesterification conditions to 
afford two distinguishable peaks that again co-eluted though to a lesser extent (Figure 3.11b). 
Overall, the loss in yield for the synthesis of this new N-terminal peptide bearing an extra 
four amino acids compared to the simpler histidine-cysteine terminating starting peptide 30 
was considered too great, and the resulting resolution of the product thioester after 
thioesterification insufficient, to be useful. Also, separation of the two species was not 
ultimately required because 30 could be recovered after NCL. 
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Figure 3.11 (RP)HPLC purification traces compared after thioesterification of two different 
N-terminal HBD3 peptides, absorbance detected at 230 nm. (a) The co-eluting N-terminal 
Ser22His HBD3(1-21)-HC-NH2 terminating peptide 30 and product thioester Ser22His 
HBD3(1-21)-H-SCH2CH2SO3H 31. (b) The co-eluting N-terminal Ser22His HBD3(1-21)-
HCSSGG-NH2 terminating peptide with four extra amino acids and the product thioester 
31.
267 
 
 Multi-milligram MESNa-mediated thioesterification reactions conducted under a positive 
nitrogen atmosphere produced the most efficient conversion into the desired product thioester 
31, and were also coupled with the least amount of undesirable disulfide bond formation to 
give HBD3(1-21)-His-Cys(MESNa)-NH2.
267
 It was generally observed that multi-milligram 
reactions (approximately 10 mg scale) provided sufficient quantities of the co-eluting starting 
material and thioester for subsequent ligation.  
 
32.1 min 
32.5 min 
31.4 min 
32.0 min 
(a) 
(b) 
30 + 31 
 Ser22His HBD3(1-21)-HCSSGG-NH2 + 31 
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3.3.7 Synthesis of Full-Length Protected Ser22His HBD3(1-45) by NCL 
 
 The synthetic peptide thioester 31 (which was co-purified with 30) and the cysteinyl peptide 
33 were then ligated. An initial NCL was successful though the ligated product had to be re-
purified employing a shallower gradient of aqueous acetonitrile, to afford the homogenous 
full-length HBD3. Generally, it was observed that the larger the NCL reaction scale, the 
larger the imposition of the ligated product peak onto the starting material 30 peak during 
(RP)HPLC purification. Hence, the scale of the NCL reaction needed to be large enough to 
expect a multi-milligram yield but also result in minimal peak overlap during HPLC 
purification. 
 
 Therefore, multi-milligram scale NCL reactions were simultaneously conducted. The co-
purified peptide thioester 31 (10.6 mg) was ligated to excess cysteinyl peptide 33 (11.1 mg) 
under standard NCL conditions: 3.8 mM [assumed peptide thioester] in 6 M guanidine 
hydrochloride, 200 mM sodium phosphate buffer; pH 7.0, 100 mM MESNa, 40 mM TCEP, 
for 48 h at 25 °C. The reaction was not exposed to air during the ligation until after 48 h 
when it was analysed by LC-MS, which revealed the presence of the ligated product 34. The 
reaction mixture was then purified by (RP)HPLC.  
 
 Pleasingly, 34 could be isolated from the unreacted starting material 30 to afford the full-
length Acm-protected defensin (6.8 mg). A presumed single equivalent of the cysteinyl 
peptide 33 was added into the NCL reaction, and the recovered yield of this cysteinyl peptide 
(6.3 mg) and the unreacted starting material 30 (7.1 mg) allowed the yield of the consumed 
peptide thioester 31 to be estimated as a modest 22 % (40 % based on the recovered starting 
material 30),
267
 which is comparable to other less straightforward peptide thioester synthesis 
methods.
199,200,208,210,214,252-256
 This NCL also resulted in an excellent 97 % yield of the ligated 
product 34 (Figure 3.12).
267
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m/z
500 600 700 800 900 1000 1100 1200 1300 1400 1500 1600 1700 1800 1900
%
0
100
HBD3 ligated peptide 150 (1.361) Cm (141:172) 1: Scan ES+ 
1.17e7796.1
696.8
619.6
619.1
687.8
675.4
786.2
701.4
928.8
801.8
804.5
928.9
932.2
 
Figure 3.12 (a) (RP)HPLC purification chromatogram of the NCL reaction between co-
eluting (starting material 30 and thioester 31) and cysteinyl peptide 33, absorbance detected 
at 230 nm. The isolated ligated full-length HBD3 polypeptide 34 was found to have a 
retention time of tR = 29.7 min, using the gradient: 5-50 % MeCN over 45 min. (b) LC-MS 
analysis of isolated 34. Calculated average mass for [M]: 5566.6, found: 5566.0.
267 
 
3.3.8 Synthesis of Full-Length Deprotected Ser22His HBD3(1-45)  
 
 Apart from the free cysteine at position-23 of the full-length HBD3(1-45) polypeptide 34, 
the remaining cysteine residues were orthogonally protected with an Acm group. The 
32.0 min 
29.7 min 
18.4 min 
(a) 
(b) 
mass
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HBD3 ligated peptide  150 (1.361) M1 [Ev-101670,It25] (Gs,1.000,500:2000,1.00,L33,R33); Cm (141:172) 1: Scan ES+ 
9.63e75566.0
5495.0
5605.0
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presence of several free cysteine residues would have hindered the previous NCL step, 
because the side-chain sulfhydryl groups could all potentially participate in the initial NCL 
transthioesterification step but then could not subsequently undergo an S→N acyl 
rearrangement. This would be unproductive because only the cysteine at position-23 with a 
free α-amino group can rearrange through an S→N acyl shift to provide the desired ligated 
product. The reversible nature of the initial transthioesterification step would eventually lead 
to the correct ligated product, however the slower first step would likely bring into force 
thioester hydrolysis as a significant side-reaction. Thus, the Acm-protected five remaining 
cysteine residues within 34 were deprotected after NCL but before protein folding.  
 Deprotection was achieved using 10 equivalents of silver(I) acetate per each Acm group 
present within 34 in 10 % v/v acetic acid.
267
 Silver acetate was used rather than the standard 
mercury(II) acetate to avoid the toxic mercury by-product. Acetic acid acted to solubilise the 
polypeptide and the reaction mixture was shaken for 6 h, before 10 % w/v DTT was added to 
break down the silver-sulfur salts (Scheme 3.7). 
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Scheme 3.7 Mechanism of silver acetate (AgOAc)-mediated removal of an acetamidomethyl 
(Acm) protecting group from the side-chain of cysteine, the silver-sulfur salt produced is 
broken down by DTT. 
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 The reaction mixture was then centrifuged and the supernatant was concentrated under 
reduced pressure to remove the aqueous acetic acid. The concentrate was then re-dissolved in 
water and purified by semi-preparative (RP)HPLC to afford the deprotected defensin, 
Ser22His HBD3(1-45) 35 in 95 % yield. (Figure 3.13).
267
 
 
 
m/z
500 600 700 800 900 1000 1100 1200 1300 1400 1500 1600 1700 1800 1900
%
0
100
deprotected HBD3 334 (2.475) Cm (305:360) 1: Scan ES+ 
2.00e6745.4
652.7
580.1
869.3
1043.4
1303.9
 
Figure 3.13 (a) (RP)HPLC purification chromatogram of 35, absorbance detected at 230 nm. 
The isolated deprotected full-length HBD3 polypeptide 35 was found to have a retention time 
of tR = 31.6 min, using the gradient: 5-50 % MeCN over 45 min. (b) LC-MS analysis of 
isolated 35. Calculated average mass for [M]: 5211.2, found: 5211.0.
267 
 
 
 
31.6 min 
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3.3.9 Synthesis of the Folded Ser22His HBD3(1-45) Analogue 
 
 The deprotected full-length Ser22His HBD3(1-45) 35 was then oxidatively folded using 
conditions that were anticipated to form the thermodynamically most stable, native isoform 
out of a total sum of fifteen possible disulfide connectivities for the defensin.
271 
 Initially, protein folding was attempted on a small scale (using 0.6 mg of the deprotected 
defensin 35) with 20 % v/v DMSO, 5 % AcOH, ammonium carbonate (NH4)2CO3 buffer; pH 
6.0, at 25 °C for 7 days.
271
 Upon reaction completion, an LC-MS of the reaction mixture 
confirmed the loss of six daltons that corresponded to the formation of three disulfide bonds. 
However, (RP)HPLC purification showed the presence of two main oxidised species that 
corresponded to two different topological isoforms of HBD3 (Figure 3.14).  
 
Figure 3.14 (RP)HPLC purification chromatogram of a small-scale folding reaction of 
Ser22His HBD3 35 (0.6 mg, 0.12 µmol) conducted using 20 % v/v DMSO as the oxidant at 
pH 6.0 for 7 days. Two main isoforms with retention times of tR = 30.9 and 31.7 min were 
observed, using the gradient: 5-50 % MeCN over 45 min, absorbance detected at 214 nm. 
 Formation of the three native disulfide bonds present within the β-defensin was then 
attempted with the standard protocol of Wu et al.
272
 which included a cysteine-cystine redox 
pair. The oxidative folding conditions included dissolving 10.6 mg of the deprotected peptide 
35 in 0.1 M sodium bicarbonate, 1 M guanidine hydrochloride; pH 8.1, 3 mM cysteine, 0.3 
mM cystine, with shaking at 25 °C for 24 h; and a final deprotected peptide 35 concentration 
of 0.25 mg mL
-1
.
267
 Upon reaction completion, the reaction mixture was analysed by LC-MS 
30.9 min 
31.7 min 
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to show the expected loss of six daltons which corresponded to the formation of three 
disulfide bonds. The reaction mixture was then concentrated and purified by semi-preparative 
(RP)HPLC. The resulting three different oxidised forms of the folded defensin were then 
combined and lyophilised to afford 36 (Figure 3.15).
267
  
 
m/z
500 600 700 800 900 1000 1100 1200 1300 1400 1500 1600 1700 1800 1900
%
0
100
HBD3[O] 24h 178 (1.616) Cm (148:193) 1: Scan ES+ 
5.44e6868.6
744.8 1042.1
1302.4
 
Figure 3.15 (a) (RP)HPLC purification chromatogram of the Ser22His HBD3 folding 
reaction conducted using 35 (10.6 mg, 2.03 µmol) and the cysteine-cystine redox system at 
pH 8.1 for 24 h. 36 was pooled from the fractions illustrated by an asterisk, absorbance 
detected at 230 nm. 36 comprised three main isoforms with retention times of tR = 30.2, 31.1, 
and 33.5 min, respectively, using the gradient: 5-50 % MeCN over 45 min. (b) LC-MS 
analysis of isolated 36. Calculated average mass for [M]: 5205.2, found: 5205.0.
267 
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 Protein folding often results in the formation of an earlier eluting compound during 
(RP)HPLC purification. This is usually attributed to the burial of the hydrophobic amino acid 
residues within the protein, which prevents them from interacting with the C-18 HPLC 
column. Interestingly, the three major folded HBD3 species had similar HPLC retention 
times (30.2-33.5 min) to that of the unfolded species (31.6 min).
267
 This could therefore be 
the effect of exposed patches of hydrophobic amino acids within the folded molecule 
interacting with the HPLC column media. 
 
 The presence of the cysteine-cystine redox couple should have promoted the reversible 
formation of disulfide bonds until the thermodynamically most stable topological isoform 
was attained. Wu et al. have also found that whilst the β-defensins: HBD1 and HBD2 fold to 
give a single thermodynamically most stable native species; under the same oxidation 
conditions however, HBD3 folds to give more than one major topological isomer.
272
     
 
 The cysteine-cystine redox system folding procedure resulted in the formation of three major 
oxidised species, which were pooled to give 36, and the disulfide connectivities within this 
pooled mixture were then analysed by tryptic and chymotryptic digestion. However, since the 
Cys
V
 and Cys
VI
 residues have no intervening amino acid sequence between them for 
digestion to occur (Figure 3.8a), the disulfide connectivity of the defensin could not be 
precisely determined. The presence of the Cys
II
-Cys
III
 disulfide bond within 36 by tryptic 
digestion was detected by LC-MS (Figure 3.16a), and it was reduced upon addition of DTT 
and resulted in the loss of two daltons (Figure 3.16b). However, since all topological 
isoforms of HBD3 have been shown to be biologically active,
272,273
 the mixture was not 
resolved prior to its biological evaluation.  
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Figure 3.16 LC-MS data for the trypsin enzymatic digestion of the synthesised 45 amino acid 
residue folded β-defensin: Ser22His HBD3(1-45) 36. ESI+ mass spectra are shown of the 
polypeptide mapping experiments after treatment of 36 (0.5-1.0 mgmL
-1
) with trypsin (0.01 
mgmL
-1
) {and DTT (5 % w/v) added after 1 h}; pH 8.0, 37 °C. The reaction was monitored at 
regular intervals and the resulting peptide fragments of 36 suggested that disulfide bonding 
between Cys
II
-Cys
III 
existed. (a) Calculated mass for oxidised Cys
II
-Cys
III
 [M]: 981.5 Da, 
observed [M]
+
: 981.7 Da. (b) After addition of DTT, the calculated mass for reduced Cys
II
-
Cys
III
 [M]: 983.5 Da; observed [M]
+
: 983.5 Da. The digested sequences were not confirmed 
by isolation followed by sequence analysis. 
 
3.3.10 Biological Activity 
 
Antimicrobial Assays 
 
 Minimum bactericidal concentration (MBC) values, which are the lowest concentrations of 
peptide required to kill 99.99 % of bacteria, were determined against Gram-negative 
Pseudomonas aeruginosa strain PA01 and Gram-positive Staphylococcus aureus strain 
ATCC 25923 bacteria (see Experimental Section 6 for further details).
267
  
HBD3(18-26): C
2
AVLHC
3
LPK = Calc. mass: 983.5 
 
HBD3(18-26): C
2
AVLHC
3
LPK = Calc. mass: 981.5 
 
HBD3(1-8): GIINTLQK = Calc. mass: 886.5 
+ DTT 
a) 
b) 
c) 
HBD3(27-32): EEQIGK = Calc. mass: 703.4 
 
HBD3(9-12): YYC
1
R = Calc. mass: 604.3 
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 Bacterial stocks were stored at -80 °C in either glycerol or skimmed milk. Typically, 800 µL 
of bacterial cells growing in the exponential phase were frozen with 200 µL of glycerol. The 
bacterial stock from the freezer was removed and stored on ice. A sterile loop was used to 
streak out bacteria onto Iso-sensitest agar plates (the media was from Oxoid) and the plates 
were incubated at 37 °C overnight. The agar plates were comprised of: 4 × (7.85 g agar/ 250 
mL dH2O) and these mixtures were initially autoclaved, and then melted in a microwave. The 
4 × 250 mL agar solutions were then poured to provide approximately eighty agar plates. 
 
 The following morning, the plates were removed from the incubator and inspected for any 
contaminating bacterial colonies and then stored at 4 °C. In the early evening, a sterile 
toothpick was used to pick off a single colony from the plate and it was added to 10.0 mL of 
Iso-sensitest broth (ISB) (from Oxoid) in a 50.0 mL falcon tube (twice for each organism). 
The 50.0 mL falcon tube was preferred rather than a 15.0 mL falcon tube as bacteria grow 
better with a larger air supply. The falcon tubes containing the bacteria were then incubated at 
37 °C overnight, with shaking at approximately 150 rpm.  
 
 The next morning, bacterial cultures were removed for dilution; 1.0 mL of cells was added to 
fresh ISB (9.0 mL) for each organism in separate falcon tubes. The resulting suspensions 
were incubated at 37 °C for 4 h, with shaking at approximately 150 rpm, to afford the 
bacteria in the desired mid-log phase. 
 
 Meanwhile, sterile phosphate buffer (10 mM) was prepared, which was comprised of 1 M 
K2HPO4 (4.01 mL), 1 M KH2PO4 (0.99 mL), glucose (0.5 g), and dH2O (500.0 mL); and 99.0 
mL of this solution was removed and ISB (1.0 mL) was added to afford 100.0 mL of 
phosphate buffered saline (PBS) buffer. This buffer was filtered through a fritted-filter 
containing syringe into sterile falcon tubes. The defensins were also prepared for testing in 
doubling dilutions using the PBS buffer. Initially the peptides were diluted to a concentration 
of 1.0 mg/mL and then to the starting concentration of 1.0 × 10
-4
 M (100 µM). The starting 
peptide concentration of 100 µM was then further diluted to afford: 10.0 µM, 5.0 µM, 2.5 
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µM, 1.25 µM, and 0.625µM, and the negative control 0 µM. Since 100 µL of bacterial cells 
were to be added to each peptide concentration tested, the starting peptide concentration was 
ten times that of the required final concentration. The negative control contained PBS buffer 
only and 100 µL of bacterial cells.  
 The test peptide concentrations were further corroborated through an absorbance assay. The 
absorbance of each test peptide that was dissolved at a concentration of 1 mgmL
-1
 was 
measured using a spectrophotometer. The absorbance (A); molar extinction coefficient (ε, 
units = Lmol
-1
cm
-1
) taken from the web server ExPASy; and the sample path length (l = 1 
cm) were then inserted into the Beer-Lambert Law (Equation 2) to calculate the actual 
peptide concentrations (c, units = molL
-1
). These peptide concentrations were then used in the 
antimicrobial assays to determine the MBCs. 
     A = ε.c.l       (2) 
 After 4 h the organisms were removed from the incubator and centrifuged at 5000 rpm for 20 
min. The supernatant was discarded and the cells were resuspended, to remove any residual 
salts, in PBS (1.0 mL) and broth in an Eppendorf tube, and the cells were bench-top 
centrifuged at 13000 rpm for 5 min. The supernatant was again discarded and the pellet of 
cells was resuspended in fresh PBS (1.0 mL) and broth and then centrifuged and decanted 
again. The bacterial cells were then diluted with PBS and broth in the ratio 1: 1000-2000 in a 
falcon tube to afford the initial inoculum. The cells (100 µL) were then vortexed and added to 
randomised test peptides in Eppendorfs five at a time before being vortexed again. The 
Eppendorfs containing the resulting test mixtures were then briefly centrifuged and then 
incubated at 37 °C for 3 h, with low level shaking at 50 rpm. As a growth control for each 
organism, bacteria from the negative control was also incubated at 37 °C for 3 h, with low 
level shaking at 50 rpm. A second aliquot of 10 µL was removed from the negative control (1 
× 10
6
 CFU ―colony forming units‖) and diluted in a 1: 10 ratio with PBS three times to afford 
1 × 10
5
 CFU, 1 × 10
4
 CFU, and 1 × 10
3
 CFU dilutions, which were used to determine the 
number of bacterial cells present within the initial inoculum in CFU/mL. These dilutions 
were also incubated at 37 °C for 3 h, with low level shaking at 50 rpm. After incubation, each 
Eppendorf that contained a test suspension was vortexed and 10 µL of each was plated out 
using disposable sterile spreaders, and the plates were incubated at 37 °C overnight. 
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 The following day, the plates were removed from the incubator and the colonies on each of 
the plates that were less than 200 were counted using a colony counter. Where a lawn of 
bacteria was observed it was recorded as growth and indicated no bacterial killing. The MBC 
value for each peptide was determined as the peptide concentration which resulted in greater 
than 99.99 % killing of the initial inoculum (Table 3.5). This was the peptide concentration 
that resulted in less than or an equal number of colonies to those observed for the negative 
control for either P. aeruginosa or S. aureus. All antimicrobial assays were performed in 
triplicate and on three independent occasions. The MBC value was obtained by taking the 
mean of all results, and all experimental errors were within one doubling dilution. 
 
 The N-terminal HBD3 peptide 30 and C-terminal HBD3 peptide 33 ―halves‖ that were used 
to synthesise the full-length defensin; the ligated defensin with five Acm protected cysteine 
residues 35; and the folded full-length defensin 36 were all tested for bactericidal activity. Of 
those peptides tested, only the full-length folded defensin 36 was found to possess broad 
spectrum antimicrobial activity (Table 3.5).
267
 The folded defensin had MBC values 
equivalent to those previously reported for the defensin,
271
 and was found to be as potent as 
the positive control mouse orthologue of HBD3, Defb14-1Cys
V
, which had five out of its six 
cysteine residues mutated to alanine and only retained the native Cys
V
 residue.
273
 The MBC 
value for 36 against S. aureus (1.8 µM) was one-doubling dilution higher than the MBC 
against P. aeruginosa (0.9 µM).
267
  
 
Table 3.5 Minimum bactericidal concentrations (MBCs) of the synthesised defensin 
analogue Ser22His HBD3 36 and synthetic peptide fragments thereof (antimicrobial assays 
were conducted with and completed by Natalie L. Reynolds).
267 
                                                               Minimum Bactericidal concentration (µM)
a 
  
Microbial Organism 30 33 35 36 
HBD3[O] 
Defb14-
1Cys
V 
 
Pseudomonas aeruginosa 2.7 11.9 2.7 0.9 1.25 
Staphylococcus aureus >11 >11 >3.2 1.8 2.5 
a
Details of how the antimicrobial assays were conducted are described in Section 3.3.10 and in Experimental 
Section 6. 
Native Chemical Thioesterification: Synthesis of Peptide and Protein Thioesters through an N→S Acyl Shift 
 
138 
 
 Notably, the N-terminal HBD3 peptide 30 terminating in a histidine-cysteine sequence was 
active against P. aeruginosa (2.7 µM) but not S. aureus (> 11 µM), and it was less potent 
than the full-length folded defensin 36 (Table 3.5).
267
 The ligated full-length defensin with 
five Acm protected cysteine residues 35 was also found to be active against P. aeruginosa 
(2.7 µM).
267
 Conversely, the C-terminal HBD3(23-45) peptide 33 was found to not possess 
bactericidal activity against either the Gram negative (11.9 µM) or Gram positive (>11 µM) 
bacteria.
267
 This supported what was known with regards to the antibacterial activity residing 
within the N-terminal ―half‖ of HBD3.271  
 
Chemotaxis Assays 
 
 A correct three-dimensional structure is not required for the antimicrobial activity of HBD3 
however its chemoattractant ability does depend upon a correct three-dimensional 
structure.
272
 Therefore, a chemoattraction assay was conducted with the folded defensin 36 
and other defensin-derived peptides to test its chemoattractant ability (see Experimental 
Section 6 for a description of the chemotaxis assay and Figure 3.17).
267
 HBD3 chemoattracts 
cells that express the cell-surface chemokine receptor 6 (CCR6). Therefore, human 
embryonic kidney-293 (HEK293) cells that were transfected with CCR6 were used in the 
assay. Figure 3.17 illustrates the number of CCR6-expressing HEK293 cells that migrated 
towards the folded defensin preparation 36.
267 
 The chemotaxis graph is a bell-shaped curve which is characteristic
 
of chemoattraction by 
Ser22His HBD3 36 (Figure 3.17b).
267
 The optimal chemoattraction concentration was found 
to be 0.2 nM,
267
 which is equivalent to that reported for HBD3 prepared by traditional 
methodology.
272
 This suggested that introduction of the Ser22His mutation, or exposing the 
N-terminal fragment of HBD3 to the optimised thioesterification conditions, did not 
compromise the biological activity of the defensin.
267
 Neither the N- or C-terminal halves of 
the defensin (30 and 33) were found to be chemoattractant peptides, which can be attributed 
to the lack of the correct three-dimensional structure, and these findings are in agreement 
with those of previous studies on the mouse orthologue of HBD3, Defb14.
273 
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Figure 3.17 (a) The micrograph represents the chemoattraction of human embryonic kidney-293 (HEK293) cells that 
were transfected with the chemokine receptor CCR6 by the folded defensin Ser22His HBD3 synthesised 36 
(chemotaxis assays were conducted with and completed by Dr Christine Tyrrell).
267
 The assay was conducted using a 
96 well microchemotaxis chamber where the central wells were used and the outer wells (buffer zone) were filled with 
chemotactic media alone (RPMI/ 1 % bovine serum albumin). The bottom chamber central wells contained the test 
peptide in concentrations increasing from 0 (chemotactic media only) to 222 nM (30 µL each). The central wells in 
the top chamber contained the transfected HEK293 CCR6 cells at 1 × 10
5
 cells/mL in chemotactic media and the 
vacant outer wells were filled with chemotactic media alone (200 µL each). The positive control was human 
macrophage inflammatory protein-3α (hMIP-3α) and the negative control was the chemotactic media alone. The two 
chambers were separated by a collagen-coated polycarbonate filter (pore size 10 µm). [The filter was coated groove 
side down in a solution of 5 mL human collagen and 45 mL sterile water, which was then incubated at 37 °C 
overnight and then air-dried.] The chamber was placed in a humid, 5 % CO2 incubator at 37 °C for 4 h. The filter was 
then removed and the side with the non-migrating cells was washed with PBS buffer and then left to air dry. The filter 
was stained with solution A (methanol fixative) of DiffQuick for 2 min, solution B (Azure B) for 2 min, and solution 
C (Eosin) for 2 min, and then gently rinsed in sterile water and air dried. The filter was then observed under a 
microscope with three random fields of view taken per well using a high power field with × 40 magnification, and the 
migrated cells were counted in each view. The mean number of migrated cells was then calculated as well as the 
standard error of means (SEM). Each test peptide dilution was tested in triplicate and each experiment was repeated a 
minimum of three times. Data was analysed using analysis of variance (ANOVA) with post-test at p <0.05. The 
chemotactic activity was determined as the optimal chemoattraction concentration of the test peptide that produced the 
highest chemotactic index. (b) The chemotaxis graph shows the number of CCR6-transfected HEK293 cells that were 
chemoattracted at different concentrations of folded Ser22His HBD3 36. Data is presented as the numerical mean ± 
standard deviation of the number of cells per high power field of view at × 40 magnification. Each assay was repeated 
three times, in triplicate with three fields of view per repeat. (***)Asterisks represent significant chemoattraction 
compared to the positive control hMIP-3α at p <0.001. The optimal chemoattraction concentration of the folded 
defensin analogue 36 was found to be 0.2 nM. The results were approximately equivalent to those of the CCR6 
chemokine ligand hMIP-3α and murine β-defensin Defb14.
267 
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3.7 Discussion 
 
 Thioester hydrolysis was observed when MPA was used as the thioester-forming 
reagent,
263
 therefore further optimisation of the reaction was undertaken.
267
 The reaction 
of a 
13
C-labelled model peptide (H-AENITTG(
13
C-1)C-NH2) 26 with varying thiols and 
reaction conditions was followed by 
13
C NMR spectroscopy.
267
 The optimisation studies 
revealed water-soluble MESNa to be a superior transthioesterification reagent to MPA.
267
 
MESNa fully converted the starting peptide amide into the desired peptide thioester (H-
AENITTG(
13
C-1)-SCH2CH2SO3H) within 48 h, compared to only approximately 60 % 
conversion with MPA.
267
 Furthermore, no peptide thioester hydrolysis occurred when 
MESNa (at pH 2.0) was employed as the thiol.
267
 The optimal thioesterification 
conditions were found to be heating at 60 °C with excess thiol (10 %) in aqueous acidic 
media (pH 2.0-6.0), with 0.5 % (w/v) TCEP to reduce any potential disulfide bonds.
267 
 
 The concentration of the starting peptide was also important as lower concentrations (less 
than 6 mM) were found to increase the reaction rate.
267
 This was likely because of a 
reduction in unwanted intermolecular disulfide bonds, which acted to decrease the 
effective concentration of peptide available to perform the N→S acyl transfer.  
 
 The optimised thioester-forming conditions were then applied to the total chemical 
synthesis of the biologically active defensin analogue Ser22His HBD3,
267
 which was 
found to have antimicrobial and chemoattractant activity equivalent to that reported.
271 
 
 Thioesterification of the N-terminal 23 amino acid residue peptide (30) of HBD3 did not 
proceed to completion with 10 % MESNa and 1 % AcOH after 48 h at 60 °C, as was 
expected from the optimisation studies conducted with the 8 amino acid residue 
13
C-
labelled model peptide. However the 22 % yield of the 22 amino acid thioester 31 
obtained is comparable to the synthesis of such complex thioesters by other 
methods.
199,200,208,210,214,252-256
 This raised several questions about potential factors that 
may be contributing to peptide thioesterification including: the reaction time, pH, solvent, 
reducing agent, hydrophobicity, peptide chain length, peptide concentration, side-chain 
substituents, and even the decreased accessibility of the thiol due to formation of a 
hydration sphere. 
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 Overall, the initial proposed reaction route (Scheme 3.1b) appears to be an 
oversimplification and several factors appear to contribute to the formation of the 
thioester through an initial N→S acyl shift. An alternative scheme for thioester formation 
through an initial N→S acyl shift, followed by transthioesterification to give the thioester 
(NCT) is shown in Scheme 3.8.  
  
 A histidine-cysteine, glycine-cysteine, or cysteine-cysteine sequence present in I initially 
undergoes a reversible intramolecular N→S acyl shift under acidic conditions to give IV, 
the ‗S-peptide‘ (Scheme 3.8). This N→S acyl transfer can proceed through a five-
membered ring transition state, or through a proposed five-membered ring 
hydroxythiazolidine intermediate II.
266
 The intermediate II has not been observed during 
this study but it can release the amine III which is then protonated to give IV. The S-
peptide IV then undergoes intermolecular transthioesterification to afford the isolable 
thioester V and the N-terminal cysteinyl fragment VI.  
 
 Previously, the Aimoto laboratory had attempted to isolate IV but found that it rapidly 
reverted back into the ‗N-peptide‘ I, even under acidic HPLC purification conditions 
(aqueous acetonitrile containing 0.1 % trifluoroacetic acid).
236
 However, our studies have 
shown that the addition of a thiol under acidic conditions in one-pot, promotes 
thioesterification and directly generates V without the need to isolate IV.
263
 Furthermore, 
detachment of the N-terminal cysteinyl fragment VI upon transthioesterification prevents 
the reverse transformation into I, and is thus irreversible.  
 
 Certain reaction conditions were found to promote undesirable thioester hydrolysis of 
either IV or V into VII. Thioester hydrolysis was found to be favoured when the pH was 
lower than 1.0, when 10 % 2-mercaptoacetic acid (MAA) was employed as the thiol, or 
when the reaction contained aqueous trifluoroacetic acid.
267
 The starting material I was 
also found to be reversibly oxidised with the external thiol present within the one-pot 
reaction to afford VIII, which could be reduced back to I upon addition of 0.5 % w/v 
TCEP.
267
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Scheme 3.8 Proposed intermediates and products of Native Chemical Thioesterification 
involving thioester formation via an N→S acyl transfer. 
 The formation of the S-peptide is favoured by the protonation of the released α-amino group 
of cysteine, and can be further assisted by deprotonation of the cysteine sulfhydryl group 
which attacks the ‗scissile‘ amide bond. A lower pH promotes the release of the α-amino 
group of cysteine (pKa Cys -NH2 ≈ 9) to exist as the ammonium species (-NH3
+
), whereas a 
higher pH (pKa Cys -SH ≈ 8) promotes the formation of the cysteinyl thiolate (-CH2-S
-
). 
 The optimum pH for thioesterification was found to reside towards the acidic side of the pH 
scale between 2.0 and 6.0.
267
 Protonation of the α-amino group of cysteine and deprotonation 
of the sulfhydryl group of cysteine are factors that promote the shift in the N-/S-peptide 
equilibrium towards the S-peptide. The optimised thioesterification procedure deduced with 
MESNa was conducted at pH 2.0, and therefore the cysteine sulfhydryl was mostly 
protonated. However at pH 6.0 approximately 1 % of the cysteine sulfhydryl group is 
deprotonated which can assist its nucleophilic attack onto the carbonyl group of the scissile 
amide bond. 
 Thioesters are energetically less stable than amides and therefore it is reasonable to suspect 
that the equilibrium lies to the far left towards the N-peptide at neutral pH. However, under 
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acidic conditions the more basic amide nitrogen can be protonated and this shifts the 
equilibrium towards the S-peptide. Amides are stabilised by 2s-2p orbital overlap between the 
carbonyl carbon and the nitrogen atom and by resonance stabilisation. Comparatively, the 2s-
3p orbital overlap between the carbonyl carbon and the sulfur atom in thioesters is weaker 
due to the less tightly held electrons in the larger 3p orbital. The transformation from the N-
peptide to the S-peptide during the initial N→S acyl transfer step is proposed to be fast 
because it proceeds through a five-membered ring transition state or intermediate, and 
therefore the process appears to be governed by kinetics.  
 The initial N→S acyl transfer was observed to occur at room temperature, but the second 
transthioesterification step was found to require heat energy.
267
 An accumulation of the S-
peptide was also not observed during NCT. Increasing the concentration of the added thiol 
was observed to increase the reaction rate and therefore the second transthioesterification step 
was proposed to be the rate-determining step.
267 
 
During the first biological application of the new thioesterification reaction, three main 
topological isoforms of Ser22His HBD3 were observed during (RP)HPLC purification of the 
folded defensin preparation,
267
 though they were not resolved because all isoforms have been 
shown to be biologically active.
271
 However, potential future work for the preparation of the 
native topological isoform of Ser22His HBD3 could be based on the alternative strategy 
depicted in Scheme 3.9. It can be employed to reduce the number of possible disulfide 
connectivities from fifteen to three combinations. This optional synthetic route would require 
the formation of one of the three desired disulfide bonds first, whilst the remaining four 
cysteine residues are acetamidomethyl (Acm) protected. This is then followed by 
concomitant deprotection of the remaining cysteine residues and spontaneous oxidation with 
iodine at mildly acidic pH to form the remaining two disulfide bonds. As our chosen ligation 
site was between 
22
His and 
23
Cys
III
, therefore the 
23
Cys
III
-
41
Cys
VI
 disulfide bond could be 
installed first. 
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Scheme 3.9 Proposed future work: a synthetic route to reduce the number of possible 
topological isomers of HBD3 during folding from fifteen possibilities to three. ―Acm‖ 
denotes an acetamidomethyl orthogonal protecting group. 
 
3.8 Conclusion 
 
 MPA-mediated thioesterification was optimised and MESNa was identified as a superior 
transthioesterification reagent to MPA. MESNa fully converted a 
13
C-labelled model peptide 
terminating in a glycine-cysteine sequence into the thioester within 48 h and did not result in 
detectable peptide thioester hydrolysis at pH 2.0.
267
 Through a series of optimisation 
experiments, the following reaction conditions were deduced to be excellent for the 
production of stable thioesters: 10 % MESNa in combination with 1-10 % acetic acid and 0.5 
% TCEP at 60 °C for 48 h.
267
 Thus, the simple appendage of a histidine-cysteine, glycine-
cysteine, or a cysteine-cysteine sequence to the C-terminus of a peptide can potentially be 
used to synthesise the desired peptide thioester using these optimised conditions.
263,267
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 The optimised conditions were subsequently employed in the first biological application of 
the novel thioesterification method, in the assembly of Ser22His HBD3,
267
 which was found 
to have antimicrobial and chemoattractant activity equivalent to that known for HBD3.
271
 The 
simplicity of the new thioesterification method is significant, and also forms the basis of its 
potential application in the production of designed protein thioesters from recombinant 
samples. 
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4 The First Application of Native Chemical Thioesterification to the Synthesis of 
Native N-Linked Glycopeptide Thioesters 
 
4.1 Introduction 
 
 Approximately 50 % of human proteins are estimated to be glycosylated
274
 and 
appending oligosaccharides increases the structural diversity of proteins. Glycosylation is 
responsible for many biological recognition events including: cell adhesion, cell 
differentiation, and cell growth.
275,276
 Aberrant protein glycosylation has often been 
shown to alter the recognition events, and is thought to be responsible for many disorders 
including: autoimmune diseases, infectious diseases and cancer. Therefore, glycoproteins 
are highly sought-after for the development of drug therapeutics, diagnostic tools, and 
vaccines.
277
   
 O-linked glycans (oligosaccharides) are α- or β-linked to the hydroxyl group of a serine, 
threonine, or tyrosine residue within a native protein sequence, whereas N-linked glycans 
depend upon N-acetyl-D-glucosamine (GlcNAc) being β-linked to the amide side-chain of 
an asparagine residue within an Asn-Xaa-Ser/Thr consensus sequence.
275-277
 
Oligosaccharides that are attached to a native protein backbone are often complex and 
branched due to different points of attachment to the existing glycan free hydroxyl 
groups, and either α- or β-stereochemistry. A natural glycoprotein can have many 
glycosylated forms because protein glycosylation is not under direct genetic control,
275-277 
and therefore the (semi)synthesis of proteins bearing specific glycoforms allows us to 
determine the role of glycosylation at a molecular level.
156,158
 NCL is generally preferred 
for the synthesis of posttranslationally modified proteins because sufficient quantities of 
homogeneous posttranslationally modified proteins are not easily obtained from 
biological sources.
144,153,187,278,279
 
 Recombinant human erythropoietin (rhEPO) has four sites of glycosylation: O-linked glycan 
at serine 138, and three N-linked glycans at asparagines 24, 38 and 83. Erythropoietin exists 
as a heterogeneous mixture of glycoforms, which has made it difficult to analyse the effect of 
specific types of glycosylation on the structure and function of the protein.
280
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 The O-linked glycan at serine 138 in EPO has been found to not be required for in vivo or in 
vitro biological activity; however the N-linked glycans have been assessed to be essential for 
in vivo activity, because they increase the circulatory half-life of the glycoprotein by being 
sialylated. The N-linked glycans also allow the glycoprotein to fold correctly and be normally 
secreted.
281-291
  
 The Danishefsky laboratory has been engaged in the laborious, yet potentially extremely 
valuable, quest towards the total chemical synthesis of homogeneous EPO.
292-294
 We adopted 
an alternative approach that was based on the semisynthesis of EPO analogues. 
Semisynthesis allows us to employ NCL to potentially incorporate multiple specific glycans 
at pre-determined sites within the synthetic fragment to afford native glycosidic 
linkages.
190,207,295
 Our semisynthetic strategy involved the chemical synthesis of a 
glycopeptide thioester followed by an NCL reaction with a biologically expressed cysteinyl 
fragment to provide access to EPO analogues (Scheme 4.1).  
 
 
Scheme 4.1 Our semisynthetic strategy towards the 166 amino acid glycoprotein 
erythropoietin (EPO). The encircled glycosylated peptide thioester EPO(1-32) is chemically-
derived and is ligated to the biologically-derived N-terminal cysteinyl fragment EPO(33-166) 
to afford the full-length site-specifically modified EPO(1-166). 
 We began this project with the synthesis of native N-linked glycopeptide thioesters in mind 
(Chapter 2) and though we had not anticipated the discovery of a new thioesterification 
COSR
EPO(1-32) 
EPO(1-166) 
Cys
+ 
EPO(33-166) 
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reaction,
263,267
 it seemed logical to apply it to the synthesis of these highly desirable 
posttranslationally modified thioesters towards the semisynthesis of erythropoietin. Here, we 
describe the first chemical synthesis of the posttranslationally modified native N-linked 
glycopeptide thioesters via ―Native Chemical Thioesterification‖ (NCT). NCT is used to 
describe thioester synthesis through an initial N→S acyl shift which occurs site-specifically at 
histidine-cysteine, glycine-cysteine, and cysteine-cysteine sequences to afford the S-peptide 
intermediate, which is then transthioesterified to give the isolable thioester (Scheme 4.2).
296 
N
H
O
O
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H3N
O
SR
O
RSHH3O
+
 
Scheme 4.2 Native Chemical Thioesterification (NCT). One-pot peptide thioester synthesis is 
instigated by an initial N→S acyl transfer at histidine-cysteine, glycine-cysteine, or cysteine-
cysteine sequences under mildly acidic conditions. The resulting thioester-linked branched 
intermediate is transthioesterified by a small-molecular weight thiol to provide the isolable 
thioester.
296 
 
4.2  Results and Discussion 
 
4.2.1 Synthesis of the N-Linked Glycoamino Acid 
 
 The preparation of a model N-linked glycopeptide thioester containing a natural glycopeptide 
linkage began with the synthesis of the N-linked glycoamino acid 42 (Scheme 4.3). An N-
linked glycoamino acid was synthesised for incorporation into a growing peptide, rather than 
the method developed by Lansbury which involved the selective glycosylation of deprotected 
aspartic acid residues within an assembled peptide.
297 
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 Initially, N-acetyl-D-glucosamine 37 was treated with acetyl chloride to form the 
peracetylated α-chloro-glycoside 38, which was purified using silica-gel column 
chromatography in 47 % yield. Mechanistically, the sugar alcohol functional groups react 
with acetyl chloride to displace the chloride anion and produce four equivalents of 
hydrochloric acid overall. Following the complete acetylation of the sugar, acetic acid is lost 
from the anomeric carbon via an oxocarbenium ion. The chloride anions produced then 
participate in nucleophilic attack at the anomeric carbon to produce the α-chloro-glycoside 
38, which is stabilised by the anomeric effect. At best, this first step is found to provide half-
maximal conversion into the product. Ideally, escape of the hydrochloric acid produced from 
the reaction flask would be limited, in order to endorse the formation of the desired product 
by increasing the availability of chloride anions that can participate in nucleophilic attack at 
the anomeric carbon.  
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Scheme 4.3 Synthesis of the N-linked glycoamino acid 42 Fmoc-Asn(Ac3-GlcNAc)-OH for 
incorporation into the Fmoc based solid phase peptide synthesis of a native N-linked 
glycopeptide 48 (H-AEN(Ac3-GlcNAc)ITTGC-OH). N-acetyl-D-glucosamine 37 was 
initially transformed into α-chloro-glycoside 38, and then into the β-azido-glycoside 39. The 
β-azide group was then reduced to afford the β-amino-glycoside 40, which was then coupled 
to side-chain active ester of Fmoc-Asp-O
t
Bu to afford the new amide bond in 41. The tert-
butyl group was then removed from the α-carboxyl group of Asn to afford 42. 
 
37 38 
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40 41 42 
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 The peracetylated α-chloro-glycoside 38 was then subjected to a biphasic (dichloromethane/ 
aqueous saturated sodium bicarbonate) solution to react with sodium azide and afford the 
peracetylated β-azido-glycoside 39 in an excellent 95 % yield. This process is known to be an 
example of phase transfer catalysis.
298
 This is because the peracetylated 38 resides within the 
dense dichloromethane layer, and tetrabutylammonium hydrogen sulfate (TBAHS) and 
sodium azide are soluble in the aqueous layer. TBAHS initially reacts with sodium azide to 
form ―TBA-N3‖, which then transfers into the organic layer to allow the direct SN2 attack of 
the azide at the anomeric carbon to displace the chloride anion. 
 The β-azido-glycoside 39 was then hydrogenated in the presence of platinum oxide to afford 
the reduced β-amino-glycoside 40 in 97 % yield. The amino sugar 41 was then coupled to the 
side-chain of Fmoc-Asp-O
t
Bu, using standard methodology.
299,300 
The side-chain of aspartic 
acid was pre-activated with EEDQ (N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline)
301,302
 
to afford the mixed carbonic anhydride of aspartic acid, which reacted with 40 to afford the 
coupled N-linked glycoamino acid 41 after work-up. Finally, the tert-butyl group was 
removed from the α-carboxyl group of 41 with 95 % v/v aqueous TFA, to afford the desired 
N-linked glycoamino acid building block 42 in quantitative yield. Throughout this five-step 
glycoamino acid synthetic route, a single flash column chromatography purification step was 
required in the first transformation of 37 into 38. The remaining steps within this strategy are 
high-yielding, and thus render this an attractive route.  
 An alternative approach for obtaining deprotected glycosylated L-asparagine derivatives 
includes the direct coupling of a β-azido-glycoside onto the side-chain carboxylic acid of 
aspartic acid, using a tertiary phosphine. A simple three component strategy of this sort was 
reported by Inazu and co-workers for the synthesis of N-β-glycosylated L-asparagine 
derivatives through a Staudinger reaction between a carboxylic acid and a protected glycosyl 
azide, in the presence of a tertiary phosphine, to give the N-linked glycoamino acid in yields 
ranging from 23 to 77 %, depending upon the solvent used.
303,304
 Davis and co-workers 
recently reported the synthesis of N-linked glycoamino acids and glycopeptides through a 
Staudinger ligation using a deacetylated β-azido-glycoside, an activated side-chain carboxylic 
acid of aspartic acid, and tributylphosphine, using mainly acetonitrile as the solvent, in yields 
ranging from 47 to 87 %.
305
 Another recently reported approach to generate N-glycosylated 
Native Chemical Thioesterification: Synthesis of Peptide and Protein Thioesters through an N→S Acyl Shift 
 
151 
 
L-asparagine for N-glycopeptide synthesis involved the reaction of N-Fmoc aspartic 
anhydride with a per-O-acetylated glycosyl amine in dimethylsulfoxide.
306 
 
4.2.2 Synthesis of the Native N-Linked Glycopeptide 
 
 A model N-linked glycopeptide that was based on a short peptide sequence of erythropoietin 
EPO(22-29): H-AEN(Ac3-GlcNAc)ITTGC-NH2 was synthesised (Scheme 4.4). The 
glycopeptide synthesised contained a C-terminal glycine-cysteine sequence to enable 
thioesterification, and a native glycosylated asparagine at position-24 within the EPO 
sequence. 
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Scheme 4.4 Manual Fmoc-based solid phase peptide synthesis of the native N-linked 
glycopeptide 48 (H-AEN(Ac3-GlcNAc)ITTGC-OH). NovaSyn TGA® resin 43 was initially 
coupled with Fmoc-Cys(Trt)-OH using 0.45 M HOBt/HBTU, DIPEA, DMF. The peptide 
chain was manually elongated and 2 equivalents of Fmoc-glycoamino acid 42 were coupled 
under standard conditions, though for an extended coupling time of 30 h, to give 47. The α-
amino Fmoc group was removed from 47 with 20 % piperidine/DMF and peptide chain 
elongation was continued to afford 48. 
43 
42 
48 
44a 
45a 
47 
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 The glycopeptide chain was manually assembled using Fmoc-based solid phase peptide 
synthesis on NovaSyn TGA® resin 43 using the standard coupling reagents 0.45 M 
HOBt/HBTU in the presence of the tertiary amine N,N-diisopropylethylamine, and five 
equivalents of each N-Fmoc protected amino acid (except the glycoamino acid 42). The resin 
43 was chosen to furnish a C-terminal free carboxylic acid upon cleavage of the peptide after 
synthesis. This was because a peptide functionalised with a C-terminal free carboxylic acid 
had been shown to promote an increased amount of thioesterification, when compared to a 
peptide with a C-terminal carboxamide, though the reason for this was unknown.
307 
 Two equivalents of the N-Fmoc protected glycoamino acid 42 were used during coupling to 
45a, along with a prolonged reaction time of 30 h. An advantage of increasing the coupling 
reaction time is that less equivalents of the synthetic glycoamino acid can be used. Once the 
final amino acid, Boc-Ala-OH, had been coupled to 47, it was then treated with the standard 
cleavage cocktail comprised of 95 % TFA: 2.5 % ethanedithiol: 2.5 % water (v/v/v) for 3 h, 
to remove the protecting groups and concomitantly cleave it from the resin. After (RP)HPLC 
purification, the N-linked glycopeptide 48 was isolated in 18 % yield (based on 100 % 
loading of cysteine) (Figure 4.1). 
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Figure 4.1 LC-MS analysis of the synthesised N-linked glycopeptide 48 (H-AEN(Ac3-
GlcNAc)ITTGC-OH) (Scheme 4.4) for glycopeptide thioester formation. (a) TIC 
chromatogram and (b) ESI
+
 mass spectrum, calculated mass for [M]: 1136.18, observed 
[MH]
+
: 1137.38. 
a) 
b) 
48 
Native Chemical Thioesterification: Synthesis of Peptide and Protein Thioesters through an N→S Acyl Shift 
 
153 
 
4.2.3 Native N-Linked Glycopeptide Thioester Formation 
 
 The N-linked glycopeptide 48 terminating in a glycine-cysteine sequence was then reacted in 
a Native Chemical Thioesterification reaction. The reaction was conducted in the chaotropic 
reagent 6 M guanidine hydrochloride, though it was a short peptide and not prone to 
aggregation, in the presence of excess thiol 10 % w/v sodium 2-mercaptoethanesulfonate, 10 
% acetic acid, and 20 mM TCEP. The final pH of the reaction mixture was 5.0, which was 
possibly the result of a buffering effect of the slightly acidic guanidine hydrochloride reaction 
medium. Thioesterification was carried out at 60 °C and monitored by LC-MS analysis. 
 
 The glycopeptide thioester and starting material were observed to co-elute under a single 
broad peak in the LC-MS total ion count (TIC) chromatograms. However, the glycopeptide 
thioester 49 was observed to have a strong UV absorbance during LC-MS analysis at 230 nm 
relative to the starting glycopeptide 48 (Figure 4.2). After 6 h, the main component of the 
reaction mixture was the unreacted starting material. However, a small peak that could be 
attributed to the starting glycopeptide with a sodium ion [M + Na]
+
 or the glycopeptide 
thioester was also observed. After 24 h, LC-MS analysis showed an increased amount of 
glycopeptide thioester 49, which further increased after 48 h. After 48 h, 49 appeared to be 
the main product by UV absorbance at 230 nm; however the LC-MS TIC analysis showed 
unreacted starting material 48 to be the main product.  
 
 The N-linked glycopeptide thioester 49 was isolated in 20 % yield after (RP)HPLC 
purification. Unreacted 48 was also isolated in 47 % yield (based on starting material used). 
Interestingly, during LC-MS analysis the product thioester 49 was observed to elute after the 
starting material 48, however during HPLC purification 49 was earlier eluting than the 
starting peptide. This can be attributed to the increased polarity of the 7 amino acid residue 
thioester product 49 compared to the 8 amino acid residue starting material 48. This reversal 
has been frequently observed throughout the thioesterification studies. 
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Figure 4.2 Native Chemical Thioesterification of the native N-glycopeptide 48 (H-AEN(Ac3-
GlcNAc)ITTGC-OH) to afford the native N-linked glycopeptide thioester 49 (H-AEN(Ac3-
GlcNAc)ITTG-SCH2CH2SO3H). The N-glycopeptide 48 was treated with 10 % w/v MESNa 
in 6 M guanidine hydrochloride, 10 % v/v AcOH, 0.5 % w/v TCEP; pH 5.0, at 60 °C for 48 
h. The reaction was monitored by LC-MS at t = 6, 24, and 48 h, and purified after 48 h by 
semi-preparative (RP)HPLC to afford the N-linked glycopeptide thioester 49 in 20 % isolated 
yield. (a) LC-MS UV chromatograms of the thioesterification after 6, 24, and 48 h. 
Absorbance detected at 230 nm. (b) ESI
+
 mass spectra following thioester formation after 6, 
24, and 48 h. Calculated average mass for 49 [M]: 1158.21, observed [MH]
+
: 1159.36. 
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4.2.4 Native Chemical Ligation of the N-Glycopeptide Thioester 
 
 The isolated native N-linked glycopeptide thioester 49 (sequence: H-AEN(Ac3-
GlcNAc)ITTG-SCH2CH2SO3H) was then reacted in an NCL reaction with excess model N-
terminal cysteinyl peptide derived from a short sequence of erythropoietin (H-CSLNENIT-
OH) 50 (Scheme 4.5). Standard ligation conditions were employed, 2.6 mM of the 
glycopeptide thioester 49 was dissolved in 6 M guanidine hydrochloride containing 200 mM 
sodium phosphate buffer; pH 7.0, 100 mM sodium 2-mercaptoethanesulfonate, and 40 mM 
tris(2-carboxyethyl)phosphine. The reaction was conducted at 25 °C and it was monitored at 
regular intervals by LC-MS analysis. After 14 h, the expected ligated product 51 was 
observed. The 15 amino acid residue N-glycopeptide 51 was observed to have a longer 
retention time than both the cysteinyl peptide 50 and the N-glycopeptide thioester 49 by LC-
MS. 
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Scheme 4.5 An NCL reaction using typical ligation conditions between the isolated N-linked 
glycopeptide thioester 49 (H-AEN(Ac3-GlcNAc)ITTG-SCH2CH2SO3H) and excess cysteinyl 
peptide 50 EPO(33-40): H-CSLNENIT-OH, to afford the 15 amino acid residue N-linked 
glycopeptide 51 (H-AEN(Ac3-GlcNAc)ITTGCSLNENIT-OH). Calculated mass for the 
ligated product 51 [M]: 1907.83, observed [MH]
+
: 1909.17. 
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 After 62 h, LC-MS analysis of the NCL reaction still showed the presence of unreacted 
thioester 49, however the relative amount of the ligated product remained unchanged since 
the first analysis after 14 h. Therefore, the NCL reaction mixture was purified by semi-
preparative (RP)HPLC to afford the ligated N-glycopeptide 51 in 30 % yield. This 
experiment verified that the native N-linked glycopeptide thioester 49 had been formed. 
 
4.2.6 Native Chemical Thioesterification of a Fully Deprotected Native N-Linked 
Glycopeptide 
 
 Shin et al. carried out the synthesis of the antimicrobial O-linked glycoprotein diptericin 
using acetate protected O-linked monosaccharides during the Fmoc-based solid phase 
synthesis of the glycopeptide thioester, via a modified alkanesulfonamide safety-catch 
linker.
199
 This was to avoid alkylation by iodoacetonitrile of the free hydroxyl groups within 
the carbohydrate during activation of the amide nitrogen within the linker. Consequently, 
after the glycopeptide thioester had been synthesised, the carbohydrate acetate protecting 
groups were removed. This added an additional step in the synthetic route to their target 
glycoprotein, after the glycopeptide had been assembled. 
 Acetate protecting groups within a carbohydrate would at some point have to be removed. 
Whether it is before the monosaccharide has been coupled to the amino acid, or after the 
glycoamino acid itself has been synthesised, or after the glycoamino acid has been 
incorporated into the growing peptide chain. Native glycopeptides do not contain protected 
carbohydrates and therefore there are several stages at which the carbohydrate protecting 
groups can be removed. Whilst it was necessary in Shin et al.‘s thioester synthesis procedure 
to incorporate fully protected carbohydrates to avoid the alkylation side-reaction,
199
 we 
investigated the compatibility of our thioesterification method with peptides containing 
deprotected native N-linked carbohydrates. 
 For this purpose, the acetate protecting groups from the carbohydrate in the N-linked 
glycopeptide 48 were removed with 5 % v/v hydrazine in water
199
 (Scheme 4.6). An excess 
amount of 1,4-dithio-DL-threitol (DTT) was used to prevent the formation of disulfide dimers 
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as a result of oxidation of the C-terminal cysteine residue in 48.
199
 After 3 h, LC-MS analysis 
showed that the reaction was complete and therefore the reaction mixture was centrifuged 
and the supernatant was purified by semi-preparative (RP)HPLC. The deacetylated N-
glycopeptide 52 was isolated in 87 % yield. 
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Scheme 4.6 Deprotection of the peracetylated GlcNAc in 48 (H-AEN(Ac3-GlcNAc)ITTGC-
OH) was achieved with 5 % v/v aqueous hydrazine and excess 10 % w/v 1,4-dithio-DL-
threitol, to prevent dimerisation of the starting material, to afford 52 (H-
AEN(GlcNAc)ITTGC-OH) for subsequent thioesterification studies. 
 
 The deprotected N-glycopeptide 52 was thioesterified in 6 M guanidine hydrochloride which 
contained 10 % w/v MESNa, 10 % v/v acetic acid, 0.5 % w/v TCEP; pH 4.0, at 60 °C for 48 
h (Scheme 4.7). The reaction was monitored by analytical (RP)HPLC in conjunction with 
LC-MS. After 24 h, the deprotected N-glycopeptide thioester 53 was detected, and after a 
total time of 48 h unreacted starting glycopeptide 52 remained. The relative amount of the 
thioester produced after 48 h compared to that after 24 h had not increased significantly, and 
therefore the reaction was terminated. The deprotected N-glycopeptide thioester 53 was 
formed in 64 % yield (by semi-preparative (RP)HPLC integration) after 48 h.  
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Scheme 4.7 (a) Thioesterification of the deprotected N-glycopeptide 52 (H-
AEN(GlcNAc)ITTGC-OH) to afford 53 (H-AEN(GlcNAc)ITTG-SCH2CH2SO3H). (b) 
Analytical (RP)HPLC traces following the thioesterification of the deprotected N-
glycopeptide 53 at t = 0, 24, and 48 h. Absorbance was detected at 230 nm. 
 
4.3 Conclusion 
 
 N-Glycosylation of proteins is very important as it is often crucial for correct protein folding, 
protein stability, and protein function.
276
 We have demonstrated that our simple 
thioesterification method is compatible with the synthesis of the highly sought-after native N-
linked glycopeptide thioesters, which can contain either protected or deprotected sugars, in 
good yields. Glycopeptide thioester formation was verified through an NCL reaction with a 
model cysteinyl peptide to give a ligated 15 amino acid N-linked glycopeptide. Native 
Chemical Thioesterification provides a milder alternative to existing thioester synthesis 
approaches because the integrity of the attached carbohydrate is retained. Therefore, synthetic 
native N-linked glycopeptide thioesters can be prepared in this way for use in the 
semisynthesis of glycoproteins. 
t = 0 h 
t = 24 h 
t = 48 h 
52 
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53 
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integration 
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5 Overall Conclusions and Future Work 
 
 A new thioesterification reaction was discovered upon attempting to utilise peptides 
functionalised with C-terminal cysteinylprolyl esters. Peptides and a recombinant protein that 
contained histidine-cysteine, glycine-cysteine, and cysteine-cysteine sequences were found to 
selectively fragment in the presence of 3-mercaptopropionic acid (MPA) to form 
thioesters.
263
 Mechanistically, it was proposed that an initial N→S acyl transfer occurs to 
afford a thioester-linked branched intermediate, which then undergoes transthioesterification 
with a thiol to produce an isolable thioester (Scheme 5.1).
263
 However peptide thioester 
hydrolysis was also observed when MPA was used as the transthioesterification reagent.
263
 
Therefore, optimisation studies employing 
13
C NMR spectroscopy were undertaken.  
 
 Sodium 2-mercaptoethanesulfonate (MESNa) in the presence of acetic acid and tris(2-
carboxyethyl)phosphine were found to provide excellent conditions for thioesterification.
267
 
The thioesterification method discovered was then first applied to the total chemical synthesis 
of a biologically active protein.
267
 An analogue of human β-defensin 3 was synthesised using 
the optimised thioesterification conditions, and the folded defensin was found to have 
antimicrobial and chemoattractant activity equivalent to that reported.
267 
 
 The first application of the new thioesterification method to the synthesis of the highly 
sought-after native N-linked glycopeptide thioesters was also demonstrated, in which the 
glycopeptides contained either protected or deprotected monosaccharides. 
 
 Potential future work includes a detailed investigation into the mechanism of the 
thioesterification reaction, and determination of the role of the histidine, glycine, and cysteine 
residues adjacent to cysteine at the site of the N→S acyl transfer.  
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Scheme 5.1 In summary, a novel peptide and protein thioesterification reaction was 
discovered which reversed the process of Native Chemical Ligation. It was proposed to 
proceed through an initial N→S acyl shift selectively at histidine-, glycine-, and cysteine-
cysteine sequences to form a thioester-linked branched intermediate, which can then be 
transthioesterified by a small molecular-weight thiol, such as sodium 2-
mercaptoethanesulfonate (MESNa), to form an isolable thioester for use in Native Chemical 
Ligation reactions. This simple new method was termed Native Chemical Thioesterification, 
and was utilised to synthesise a biologically active analogue of the 45 amino acid residue 
human β-defensin 3, and native N-linked glycopeptide thioesters.  
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6 Experimental Section 
 
6.1 General experimental information 
 
 All protected amino acids and the preloaded resin for solid phase peptide synthesis (SPPS) 
were purchased from Novabiochem Merck Biosciences. Water and acetonitrile for 
(RP)HPLC purification were of reagent or HPLC grade and used without further purification. 
 
 
 
1
H and 
13
C NMR spectra were recorded on Bruker AMX 300 and 75, 400 and 100, 500 and 
125 MHz instruments. Reference NMR solvent signals CDCl3: δH (ppm) = 7.26 ppm, δC 
(ppm) = 77.0 ppm; D2O: δH (ppm) = 4.79 ppm, δC: sr = -32.10 Hz; (CD3)2SO: δH (ppm) = 
2.50 ppm, δC (ppm) = 39.5 ppm; CD3OD: δH (ppm) = 3.31 ppm, δC (ppm) = 49.0 ppm; unless 
otherwise stated. Electrospray ionisation was carried out by direct infusion or liquid 
chromatography on Waters uPLC/SQD-LC mass spectrometer. A linear gradient from 95 % 
solvent A (water containing 0.1 % formic acid) to 95 % solvent B (acetonitrile containing 
formic acid) over 8 min was employed. 
 
 
 Semi-preparative (RP)HPLC was carried out using a C18 column (diameter = 10 mm × 250 
mm). The HPLC method used involved a semi-preparative column: flow rate 3.0 mL/min, 
detection at 214, 230, 254, and 280 nm. Gradient: from 5 % MeCN/ 95 % H2O (0.1 % TFA) 
to 50 % MeCN/ 50 % H2O (0.1 % TFA) over 45 min. 
 
 
 Analytical thin layer chromatography (TLC) analysis was conducted by visualisation of 
Merck-aluminium backed plates coated with silica gel under ultraviolet light (254 nm), 
followed by staining with p-anisaldehdye. Flash column chromatography was carried out 
with silica, SiO2, 60 Å particle size, 35-70 μm in diameter. Where petroleum ether is stated, 
the fraction that boils at 40-60 °C was used. 
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Automated solid phase peptide synthesis 
 
 Solid phase peptide elongation, where stated, was conducted on an Applied Biosystems 
433A automated synthesiser. Fulvene conductivity was monitored as a quality control step to 
delay subsequent activation and coupling steps until the conductivity was within 10 % error. 
Coupling reagents used: 0.45 M HBTU/HOBt in DMF, NMP for washes, 20 % v/v piperidine 
in DMF for deprotection. 
 
 
Solid phase peptide synthesis 
 
 Manual SPPS on a 0.05 mmol scale was performed using MBHA Rink amide resin (loading 
= 0.64 mmolg
-1
); Fmoc-amino acids (0.50 mmol, 10 equivalents) were used with 
HBTU/HOBt (1.1 mL, 0.45 M), N, N-diisopropylethylamine (150 µL) and N, N-
dimethylformamide (1.1 mL); unless otherwise stated. The average coupling time was 3 h, 
and the reactions were monitored via Kaiser Ninhydrin test. Fmoc deprotection from the 
resin-bound peptide chain was achieved by treatment with 20 % v/v piperidine in DMF (1.0 
mL) for 5 min. The resin was washed exhaustively with N, N-dimethylformamide (1.0 mL) 
then dichloromethane (1.0 mL) for 5 min each, between each coupling and deprotection step. 
 
 
Analytical Kaiser Ninhydrin test  
 
 To the resin-bound peptide (~1.0 mg) two drops of Kaiser Ninhydrin test solutions I (0.001 
M KCN, 2 % v/v pyridine), II (5 % w/v Ninhydrin in t-BuOH), and III (80 % v/v phenol in t-
BuOH) were added and the reaction vessel placed in a heat block at 100 °C for 5 min.
115
 An 
indigo colour indicated a free amine, whereas yellow indicated a protected amine.
115
  
 
 
Analytical peptide cleavage form solid-support 
 
 A TFA solution comprised of 100 µL of trifluoroacetic acid: ethanedithiol: water = 95: 2.5: 
2.5 v/v/v was added to the resin-bound peptide (~1.0 mg) and left to stand at room 
temperature for 1 h. The beads were then filtered and diethyl ether (1.0 mL) was added to the 
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solution to initiate precipitation, which was then centrifuged. The diethyl ether was decanted 
and centrifugation was repeated with diethyl ether (1.0 mL) to afford a white solid. 
 
 
6.1 Synthesis of cysteinylprolyl esters 
 
2. H-(L)-Cys(Trt)-OH 
 
 
 
 
(L)-Cysteine hydrochloride 1 (2.00 g, 12.69 mmol) and triphenylmethyl chloride (5.40 g, 
19.37 mmol) were dissolved in anhydrous N, N-dimethylformamide (8.0 mL) and stirred 
under nitrogen for 24 h. Aqueous sodium acetate (10 % w/v) (70.0 mL) was added to the 
reaction mixture. The white precipitate that formed was filtered under vacuum and washed 
with water. The white precipitate was then stirred in acetone (50.0 mL) at 50 °C for 0.5 h. 
The resulting solution was cooled to room temperature, filtered with suction, washed with a 
small volume of acetone and dried under high vacuum to afford 2 (3.22 g, 70 %) as a white 
amorphous solid. Rf 0.1 (8: 2 ethyl acetate: methanol); 
1
H NMR (400 MHz, CDCl3 7.26 ppm, 
T = 298 K) δH (ppm) 7.34 (6 H, br asym d, J = 7.7, Trt Ph-Ha); 7.15 (6 H, br asym t, J = 6.5, 
Trt Ph-Hb); 7.08 (3 H, br asym t, Trt Ph-Hc); 2.77 (1 H, br m, Cys 
α
CH); 2.52 (1H, br m, Cys 
β
CH); 2.24 (1 H, br m, Cys 
β
CH); 
13
C NMR (125 MHz, DMSO-d6 40.5 ppm) δC (ppm) 145.2, 
130.1, 129.0, 127.7 (Ph); 67.0; 54.3; 31.6; IR (υmax) neat: 3053, 1595, 1546, 1489, 1441, 
1394, 1335, 1300 cm
-1
; ESI
+
 MS (m/z) calculated for C22H21O2NS: 363.13, observed [MH]
+
 
364.14. 
 
 
 
 
NH
2
COOH
SH
 
NH
2
COOH
S
HCl
dry DMFPh3CCl,
21  
 
a b 
c 
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4. Fmoc-Gly-Cys(Trt)-OH 
 
 
 
 
Fmoc-Gly-OH 3 (595 mg, 2.00 mmol) and N-hydroxysuccinimide (HOSu) (230 mg, 2.00 
mmol) were dissolved in anhydrous N, N-dimethylformamide (7.0 mL). N-(3-
dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (383 mg, 2.00 mmol) was then 
added, and the resulting mixture was stirred under nitrogen for 24 h. H-Cys(Trt)-OH, 2, (800 
mg, 2.20 mmol) and diisopropylethylamine (348 µL) were added to the reaction mixture and 
stirring continued for a further 6 h. The reaction was quenched with 1 M aqueous 
hydrochloric acid (2.0 mL) and the solution was concentrated in vacuo. Extraction ensued 
with ethyl acetate (50.0 mL), followed by washing with 1 M aqueous hydrochloric acid (2 × 
10.0 mL) and brine (10.0 mL). The combined organic phase was dried with anhydrous 
magnesium sulfate, filtered and concentrated in vacuo to give the crude dipeptide as an off-
white foam solid. The crude dipeptide was purified by flash column chromatography using (i) 
ethyl acetate; (ii) 8: 2 ethyl acetate: methanol to afford 4 (0.23 g, 18 %) as an off-white foam 
solid. Rf = 0.1 (8:2 ethyl acetate: methanol); 
1
H NMR (400 MHz, CDCl3 7.29 ppm) δH (ppm) 
7.66 (2 H, br m, Fmoc Ph-H); 7.48 (2 H, br m, Fmoc Ph-H); 7.27 (19 H, br m, Fmoc 4 × Ph-
H, Trt 15 × Ph-H); 4.12 (4 H, br m, Fmoc CH2, Fmoc CH, Cys 
α
CH); 3.72 (2 H, br m, Gly
 
α
CH2); 2.73 (2 H, br m, Cys 
β
CH2); IR (υmax) neat: 3371, 3058, 2960, 2925, 2853, 1711, 1654, 
1595, 1520, 1445, 1405, 1260 cm
-1
; ESI
+
 MS (m/z) calculated for C39H34O5N2S: 642.22, 
observed [MNa]
+
 665.34. 
 
 
 
 
O
O
N
H
O
N
H
S
OH
O
O
O
N
H
O
OH
NH
2
COOH
STrt
(i) HOSu, dry DMF, EDCI.HCl
(ii) 
, DIPEA
4
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6. Fmoc-Ala-Cys(Trt)-OH 
 
 
 
 
Fmoc-Ala-OH 5 (623 mg, 2.00 mmol) and N-hydroxysuccinimide (230 mg, 2.00 mmol) were 
dissolved in anhydrous N,N-dimethylformamide (7.0 mL, 0.29 M). N-(3-
dimethylaminopropyl)-N’-ethylcarbodiimide hydrochloride (383 mg, 2.00 mmol) was then 
added to the reaction mixture, which was then stirred under nitrogen for 24 h. H-Cys(Trt)-
OH, 2, (800 mg, 2.20 mmol) and diisopropylethylamine (348 µL) were then added to the 
reaction mixture and stirring continued for a further 6 h. The reaction was quenched with 1 M 
aqueous hydrochloric acid (2.0 mL) and the solution was concentrated in vacuo. Extraction 
ensued with ethyl acetate (50.0 mL), followed by washing with 1 M aqueous hydrochloric 
acid (2 × 10.0 mL) and brine (10.0 mL). The combined organic phase was dried with 
anhydrous magnesium sulfate, filtered and concentrated in vacuo to give the crude dipeptide. 
The crude dipeptide was purified by flash column chromatography using (i) ethyl acetate; (ii) 
8: 2 ethyl acetate/ methanol afforded 6 (1.02 g, 78 %) as an off-white foam solid. Rf = 0.2 
(8:2 ethyl acetate/ methanol); 
1
H NMR (400 MHz, CDCl3 7.24 ppm, T = 328 K) δH (ppm) 
7.72 (2 H, d, J = 7.9, Fmoc Ph-H); 7.52 (2 H, d, J = 6.3, Fmoc Ph-H); 7.25 (19 H, m, Fmoc 4 
× Ph-H, Trt 15 × Ph-H); 6.31 (1 H, br m, CONH); 5.28 (1 H, br m, CONH); 4.36 (3 H, br m, 
Fmoc CH2, Fmoc CH); 4.11 (2 H, br m, Cys 
α
CH, Ala 
α
CH); 2.73 (2 H, br m, Cys 
β
CH2); 
1.27 (3 H, br d, J = 6.0, Ala 
β
CH3); 
13
C NMR (100 MHz, CDCl3, T = 328 K) δC (ppm) 170.8, 
165.3 (C=O); 144.7, 144.0, 141.3, 134.0, 129.6, 129.6, 127.8, 127.5, 127.0, 126.6, 125.1, 
119.8 (Ph); 67.2; 63.0; 60.2; 47.2; 20.8; 14.1 (CH3); IR (υmax) neat: 3389, 3292, 3058, 2927, 
1711, 1670, 1491, 1446, 1319, 1243 cm
-1
; ESI
+
 MS (m/z) calculated for C40H36O5N2S: 
656.30, observed [MNa]
+
 679.52. 
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8. HO-Gc-Rink amide resin 
 
 
 
 
Fmoc-Rink amide AM resin 7 (0.156 g, 0.10 mmol) was subjected to 20 % piperidine in 
DMF (v/v) (1.0 mL) for 5 min, and then washed exhaustively with N, N-dimethylformamide 
then dichloromethane. Glycolic acid (Gc) (38 mg, 0.50 mmol) and 1-hydroxy-1H-
benzotriazole (HOBt) (40 mg, 0.50 mmol) were dissolved in anhydrous N, N-
dimethylformamide (3.0 mL) and DIC (47 µL, 0.50 mmol) was added before being 
transferred to the dry resin. The reaction mixture was shaken at 410 rpm, at room temperature 
for 3 h, then filtered and washed with N, N-dimethylformamide (1.0 mL) and 
dichloromethane (2 × 1.0 mL) to give 8.  
 
9. H-Pro-Gc-Rink amide resin 
 
  
 
 
 
 
 
Fmoc-Pro-OH (0.169 g, 0.50 mmol) was then added to 8, followed by HOBt/HBTU (1.1 mL, 
0.45 M) and N, N-diisopropylethylamine (150 µL) in N, N-dimethylformamide (1.1 mL), the 
heterogeneous mixture was shaken for 4 h. The vessel was subsequently drained and washed 
with N, N-dimethylformamide (1.0 mL) and dichloromethane (2 × 1.0 mL), and the Fmoc-
Pro-OH coupling procedure was repeated with shaking overnight. Fmoc-analysis was then 
carries out. This was achieved by measuring out (1) 2.0 mg of Fmoc-Pro-Gc-resin 
synthesised in 20 % piperidine in DMF (v/v) (3.0 mL), and (2) 2.1 mg of Fmoc-Pro-Gc-resin 
N
H
O
O
N
H
OH
OH
O
N
H
O
OH
(i) 20 % 
(ii) , HOBt, DMF, DIC
in DMF
7
8
 
N
H
O
OH
N
H
O
N
H
O
O
N O
OH
N
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synthesised in 20 % piperidine in DMF (v/v) (3.0 mL). A blank solution of 20 % piperidine 
in DMF (v/v) (3.0 mL) was initially placed in the UV spectrophotometer and the absorbance 
taken as the reference value. Sequentially the two aforementioned solutions (1) and (2) were 
also placed in the photometer until a stable reading was taken. The absorbance at 290 nm for 
solution (1) was 1.972 and for (2) was 1.929. These values were substituted in Equation 1 and 
determined the resin loading to be 0.54 mmolg
-1 
(85 %). Fmoc-Pro-Gc-Resin (0.0817 g, 0.05 
mmol), 9, was deprotected with 20 % piperidine in DMF (v/v) (1.0 mL) for 5 min, and then 
washed exhaustively with N, N-dimethylformamide then dichloromethane. 
 
10. H-Ala-Cys(Trt)-Pro-Gc-Resin 
 
 
 
 
Fmoc-Ala-Cys(Trt)-OH 6 (0.161 g, 0.25 mmol) was then coupled to the N-terminus of 9 
using HOBt/HBTU (0.55 mL, 0.45 M), N, N-dimethylformamide (0.55 mL) and 
diisopropylethylamine (75 µL), and was shaken for 5 h. The resulting mixture was then 
filtered, washed with N, N-dimethylformamide (1.0 mL) then dichloromethane (2 × 1.0 mL). 
TFA solution [100 µL of trifluoroacetic acid: ethanedithiol: water (95: 2.5: 2.5)] was added to 
the resin-bound peptide (1.0 mg), which was left to stand at room temperature for 1h. The 
beads were then filtered and diethyl ether (1.0 mL) was added to the filtrate to initiate a white 
precipitate, which was then centrifuged. The diethyl ether was decanted and centrifugation 
was repeated with diethyl ether (1.0 mL) to afford a white solid. The solid was then dissolved 
in water for analysis. ESI+ LC-MS (m/z) calculated for Fmoc-ACP-Gc-CONH2 568.2, found 
[MNa]
+
 591.3. The remaining resin-bound peptide was then subjected to 20 % piperidine in 
DMF (v/v) (1.0 mL) for 8 min, filtered and washed with N, N-dimethylformamide (1.0 mL) 
then dichloromethane (2 × 1.0 mL) to afford the deprotected, resin-bound tripeptide 10, H-
Ala-Cys(Trt)-Pro-Gc-Resin. 
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11. H-AENITTGCAEACP-Gc-CONH2: EPO(22-32)-CPE 
 
 
 
 
H-Ala-Cys(Trt)-Pro-Gc-Resin, 10, was transferred to an Applied Biosystems 433A reaction 
vessel and peptide elongation was performed in an automated fashion on an Applied 
Biosystems 433A automated synthesiser, using the Fastmoc protocol. Fmoc-Xaa-OH used 
(10 eq of each): Fmoc-Ala-OH, Fmoc-Glu(O
t
Bu)-OH, Fmoc-Asn(Trt)-OH, Fmoc-Ile-OH, 
Fmoc-Thr(
t
Bu)-OH, Fmoc-Gly-OH and Fmoc-Cys(Trt)-OH. Ile was double coupled. The 
peptide was then cleaved from the solid-support by treatment with 95 % trifluoroacetic acid 
solution [3 mL (trifluoroacetic acid: ethanedithiol: water = 95: 2.5: 2.5)] for 4.5 h. The 
mixture was filtered, and finally rinsed with neat TFA (1.0 mL). Diethyl ether (20.0 mL) was 
added to the filtrate and centrifuged (15 min), this was then repeated with diethyl ether (20.0 
mL). The crude peptide was a white precipitate and it was lyophilised from 1: 1 = 
acetonitrile: water, and then purified via semi-preparative (RP)HPLC (gradient: 5-50 % 
aqueous acetonitrile/ 45 min, tR = 23.0 min). The collections were lyophilised to afford 11, H-
AENITTGCAEACP-Gc-CONH2 (12.5 mg, 22 % calculated from resin loading) as a fluffy 
white solid. ESI
+
 LC-MS (m/z) calculated for 11 1335.5, observed [MH]
+
 1336.5. 
 
12. Attempted EPO(22-40) 
 
 
 
EPO(22-32)-CP-Gc-CONH2, 11 (3 × 1.0 mg, 0.75 µmol) and EPO(33-40)-OH (3 × 1.0 mg, 
1.12 µmol) were dissolved in 6 M guanidinium hydrochloride buffer (3 × 500 µL), adjusted 
to either pH 7.0 or 8.0, before the addition of the thiol additive 1 M MESNa (25 µL, 50 mM) 
N
O
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H
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2
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3
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N
H
S
O
H-AENITTGCAEACP-Gc-CONH2
(i) Automated Peptide Synthesis
(ii) TFA : EDT : H2O          
(10 eq) Fmoc-Xaa-OH
95 : 2.5 : 2.5 11
10  
 
H-A-E-N-I-T-T-G-C-A-E-A-C-P-Gc-CONH2
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or 1 M MPAA (25 µL, 50 mM) and reductant 1 M TCEP (5 µL,10 mM) (Table 6.1). The 
reactions were conducted in a thermomixer at 25 °C and monitored at regular intervals; from 
t = 1 to 122 h, via LC-MS. No ligation product was observed. 
 
Table 6.1 Model peptide ligation conditions 
Reagent Ligation conditions 1
* 
Ligation conditions 2
*
 Ligation conditions 3
*
 
EPO(22-32)-CPE 1.0 mg, 0.75 µmol 1.0 mg, 0.75 µmol 1.0 mg, 0.75 µmol 
EPO(33-40)-OH 1.0 mg, 1.12 µmol 1.0 mg, 1.12 µmol 1.0 mg, 1.12 µmol 
6 M Guanidinum.HCl 
(NaxHyPO4) buffer 
500 µL 500 µL 500 µL 
pH 7.0 8.0 7.0 
MPAA 25 µL, 50 mM - 25 µL, 50 mM 
MESNa - 25 µL, 50 mM - 
TCEP 5 µL, 10 mM 5 µL, 10 mM 5 µL, 10 mM 
* Ligation between EPO(22-32)CPE + EPO(33-40) at 25 °C with LC-MS monitoring from t = 1 to 122 h.  
 
13a. H-EPO(22-28)-SCH2CH2CO2H: EPO(22-28)-MPA 
 
 
 
EPO(22-32)-CP-Gc-CONH2 11 (1.0 mg, 0.75 µmol) was dissolved in 3-mercaptopropionic 
acid (MPA) (200 µL) and water (300 µL) and placed in a microwave reactor at 80 °C, 150 W, 
for 30 min. LC-MS indicated the presence of starting material and hence the reaction was 
continued for a further 25.5 h. The reaction mixture was subsequently filtered and centrifuged 
prior to purification via (RP)HPLC (gradient: 5-50 % aqueous acetonitrile/ 45 min). Fractions 
collected were lyophilised to afford 13a, EPO(22-28)-SCH2CH2CO2H (< 1 %) as a white 
solid. LC-MS ESI
+
 MS (m/z) calculated for [M] 792.3, observed [MH]
+
 793.4. 
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13b. EPO(22-28)-SCH2CH2CO2H: EPO(22-28)-MPA 
 
 
EPO(22-32)-CP-Gc-CONH2, 11 (1.0 mg, 0.75 µmol) was dissolved in 3-mercaptopropionic 
acid (MPA) (150 µL) and water (350 µL) and placed in a microwave reactor at 80 °C, 150 W, 
for 4 h. LC-MS indicated the presence of starting material and hence the reaction was 
continued for a further 12 h. The reaction mixture was subsequently filtered and centrifuged 
and then purified via (RP)HPLC (gradient: 5-50 % aqueous acetonitrile/ 45 min). Fractions 
collected were lyophilised to afford 13b, EPO(22-28)-MPA (0.5 mg, 84 %) as a white solid. 
LC-MS ESI
+
 MS (m/z) calculated for [M] 792.3, observed [MH]
+
 793.4. 
 
14. H-AENITTGCSLNENIT-OH: EPO(22-28)-(33-40) 
 
 
EPO(22-28)-SCH2CH2CO2H, 13a (< 1 %) was dissolved in guanidinium hydrochloride 
buffer (6 M, pH 7.0) (100 µL), and added to EPO(33-40) (1.0 mg, 1.12 μmol). The reaction 
was conducted in a thermomixer at 25 °C, 600 rpm, initially reacted for 24 h and monitored 
via LC-MS, which indicated presence of product at t = 25 h but also the oxidised product. 
MESNa (1 M) (2 % v/v) and TCEP (1 M) (30 mM) were added to the reaction mixture, the 
pH was adjusted to 8.0 and the reaction continued for a further 27 h. LC-MS, t = 51 h, 
indicated total consumption of the starting material, and the reaction was terminated to afford 
the sequence 14, EPO(22-28)-(33-40). LC-MS ESI
+
 MS (m/z) calculated for [MH]
+
 1578.8, 
observed [MH]
+
 1578.8. 
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16. H-AENITTGC(Acm)AEACP-Gc-CONH2: EPO(22-
29
C(Acm)-
 
32)-CPE  
 
 
 
 
H-Ala-Cys(Trt)-Pro-Gc—Resin, 15, was transferred to an Applied Biosystems 433A reaction 
vessel and peptide elongation was performed in an automated fashion on an Applied 
Biosystems 433A automated synthesiser, using the Fastmoc protocol. Fmoc-Xaa-OH used 
(10 eq of each): Fmoc-Ala-OH, Fmoc-Glu(O
t
Bu)-OH, Fmoc-Asn(Trt)-OH, Fmoc-Ile-OH, 
Fmoc-Thr(
t
Bu)-OH, Fmoc-Gly-OH, Fmoc-Cys(Acm)-OH. Ile was double coupled. The 
peptide was then cleaved from the solid-support by treatment with 95 % trifluoroacetic acid 
solution [3.0 mL (trifluoroacetic acid: ethanedithiol: water = 95: 2.5: 2.5)] for 4.5 h. The 
mixture was filtered, and finally rinsed with neat TFA (1.0 mL). Diethyl ether (20.0 mL) was 
added to the filtrate and centrifuged (15 min), and this was then repeated with diethyl ether 
(20.0 mL). The crude peptide was a white precipitate and it was lyophilised from 1: 1 = 
acetonitrile: water, and then purified via semi-preparative (RP)HPLC (gradient: 5-50 % 
aqueous acetonitrile/ 45 min, tR = 22.0 min). The collections were lyophilised to afford 16, 
EPO(22-
29
C(Acm)-
 
32)-CPE (11.7 mg, 20 % calculated from resin loading) as a fluffy white 
solid. LC-MS ESI
+
 MS (m/z) calculated for 16: 1406.6, observed [MH]
+
 1407.8. 
 
17. H-AENITTGC(Acm)AEA-COSCH2CH2CO2H: EPO(22-
29
C(Acm)-
 
32)-MPA 
 
 
 
EPO(22-
29
C(Acm)-
 
32)-CPE, 16 (1.0 mg, 0.71 µmol) was dissolved in 3-mercaptopropionic 
acid (MPA) (100 µL) and water (400 µL) and placed in a thermomixer at 80 °C, pH 1.0, until 
total consumption of starting material. The reaction mixture was subsequently filtered and 
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centrifuged and then purified via (RP)HPLC (gradient: 5 to 50 % acetonitrile in water, semi-
preparative column). Fractions collected were lyophilised to afford 17, EPO(22-
29
C(Acm)32)-
MPA (0.5 mg, 57 %) as a white solid. LC-MS ESI
+
 MS (m/z) calculated for [M] 1237.5, 
observed [MH]
+
 1238.7. 
 
18. H-AENITTGC(Acm)AEACSLNENIT = EPO(22-
29
C(Acm)-
 
40) 
 
 
 
EPO(22-
29
C(Acm)-32)-SCH2CH2CO2H, 17 (0.7 mg, 0.50 µmol) was dissolved in 
guanidinium hydrochloride buffer (6 M, pH 7) (500 µL), and added to EPO(33-40) (1.0 mg, 
1.12 μmol). MPAA (1 M) (50 mM) and TCEP (1 M) (40 mM) were added to the reaction 
mixture, the pH was adjusted to 8.0, the reaction was carried out at 25 °C in a thermomixer, 
and the reaction continued until starting material was consumed to afford the sequence 18, 
EPO(22-
29
C(Acm)-
 
40). LC-MS ESI
+
 MS (m/z) calculated for [MH2]
2+
 1013.0, observed 
[MH2]
2+
 1013.0. 
 
19. H-AENITTGC(Acm)AEACSLNENIT-OH = EPO(22-
29
C(Acm)-
 
40) 
 
 
 
EPO(22-
29
C(Acm)-32)-CPE 16 (5.0 mg, 0.36 µmol) was dissolved in guanidine 
hydrochloride buffer (6 M, pH 7.0) (500 µL), and added to EPO(33-40) (1.0 mg, 1.12 μmol). 
MPAA (1 M) (50 mM) and TCEP (1 M) (40 mM) were added to the reaction mixture, the pH 
was adjusted to 8.0, the reaction was carried out at 25 °C in a thermomixer, and it was 
continued until starting material was deemed undetectable by LC-MS to afford the sequence 
S
O
OH
O O
N
H
Acm Acm
CSLNENIT
6 M Gu.HCl buffer
EPO(33-40)
50mM MPAA 
40 mM TCEP
pH 8, 25 °C
17 18
H-AENITTGCAEA H-AENITTGCAEA
 
 
 
O
N
H
AcmAcm
CSLNENIT
6 M Gu.HCl buffer
EPO(33-40)
50mM MPAA 
40 mM TCEP
pH 8.0, 25 °C
16 19
H-AENITTGCAEAH-A-E-N-I-T-T-G-C-A-E-A-C-P-Gc-CONH2
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19, EPO(22-
29
C(Acm)-
 
40). LC-MS ESI
+
 MS (m/z) calculated for [MH2]
2+
 1013.0, observed 
[MH2]
2+
 1013.0. 
 
20. H2N-AENITTGC-NH2 
The model peptide was synthesised by solid phase peptide synthesis using MBHA Rink 
amide resin (0.15 g, 0.1 mmol), which was initially deprotected at its N-terminus by 
treatment with 20 % piperidine (v/v) in DMF (1.0 mL) and shaken for 5 min. The solution 
was then filtered and the beads were washed with DMF (1.0 mL) for 5 min and DCM (2 × 
1.0 mL) for 5 min each and the resin dried before the second addition of 20 % piperidine 
(v/v) in DMF (1.0 mL), the resulting mixture was shaken for 15 min. The deprotected resin 
was washed successively with DMF (1.0 mL) for 5 min and DCM (2 × 1.0 mL) for 5 min 
each, and dried. A Kaiser-Ninhydrin test of a sample of resin beads (< 1.0 mg) indicated 
positive for a free amine. The first amino acid was then coupled manually to the solid support 
with the addition of Fmoc-Cys(Trt)-OH (293 mg, 0.5 mmol) to the resin followed by dry 
DMF (2.0 mL), HOBt/HBTU (0.45 M solution in dry DMF) (2.2 mL) and DIPEA (300 µL), 
the resulting heterogeneous mixture was shaken for 4 h, after which it was filtered, then 
washed with DMF (1.0 mL) for 5 min and DCM (2 × 1.0 mL) for 5 min each and the resin 
dried. Ninhydrin test indicated a protected N-terminus and the resin was transferred into a 
reaction vessel for peptide elongation by automated solid phase peptide synthesis, using 10 
equivalents of the following: Fmoc-Ala-OH, Fmoc-Glu(O
t
Bu)-OH, Fmoc-Asn(Trt)-OH, 
Fmoc-Ile-OH (double coupled), Fmoc-Thr(
t
Bu)-OH and Fmoc-Gly-OH. The elongated 
peptide was then cleaved from the solid support and the orthogonal protecting groups were 
simultaneously removed by treating the resin with a cocktail of TFA: EDT: H2O = 95: 2.5: 
2.5 (total volume 5.0 mL) for 5 h. The mixture was then filtered into two tubes, one then had 
the majority of the peptide and the other contained a final rinse of the resin beads with TFA 
(1.0 mL). Diethyl ether (20.0 mL) was then added to each of the tubes containing the filtrate, 
and the resulting solutions were vortexed and centrifuged (3000 rpm, 4 °C, 15 min).The 
supernatant diethyl ether was decanted and the process was repeated with more diethyl ether 
(20.0 mL) added to both tubes, and afforded the crude peptide as a white solid. The crude 
peptide was then dissolved in H2O: MeCN (3:1) and purified by semi-preparative (RP)HPLC 
(gradient: 5-50 % MeCN/45 min), and lyophilised to afford the model peptide amide 20 (79.2 
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mg, 98 %) as a white solid. 
1
H NMR (500 MHz, D2O) δH (ppm) 4.65 (1 H, m, Cys 
α
CH); 4.45 
(1 H, dd, J = 5.1, 5.2, Asn 
α
CH); 4.38 (1 H, d, J = 4.9, Ile-Thr 
α
CH); 4.33 (1 H, dd, J = 5.8, 
Glu 
α
CH); 4.30 (1 H, d, J = 4.4, Thr-Thr 
α
CH); 4.21 (1 H, d, J = 7.7, Ile 
α
CH); 4.18 (4 H, m, 2 
× Thr 
β
CH2); 4.04 (1 H, q, J = 7.1, Ala 
α
CH); 3.94 (2 H, m, Gly 
α
CH2); 2.86 (2 H, m, Cys 
β
CH2); 2.71 (2 H, m, Asn 
β
CH2); 2.38 (2 H, m, Glu 
γ
CH2); 1.97 (2H, m, Glu 
β
CH2); 1.84 (1 H, 
m, Ile 
β
CH); 1.46 (3 H, d, J = 7.1, Ala 
β
CH3); 1.39 (1 H, m, Ile 
γ
CH2);1.12 (7 H, m, 2 × Thr 
CH3, Ile 
γ
CH2); 0.84 (3 H, d, J = 6.8, Ile 
γ
CH3); 0.79 (3 H, t, J = 7.4, Ile 
δ
CH3); LC-MS ESI
+ 
MS (m/z) calculated for C31H54N10O13S: 806.4, observed: 807.4 [MH]
+
. 
 
21. H-AENITTG-SCH2CH2CO2H = H-AENITTG-MPA 
 
The model peptide amide 20 (11.7 mg, 14.5 µmol) was dissolved in water (450 µL) and 3-
mercaptopropionic acid (50 µL, 10 % v/v) was added. The resulting acidic solution (pH 1.3) 
was vortexed and placed in a thermomixer at 60 °C for 48 h. After which the mixture was 
directly purified by (RP)HPLC (gradient: 5-50 % MeCN/45 min) and the eluted peptide 
thioester (tR = 16.1 min) and unreacted peptide 20 (tR = 17.3 min) were lyophilised to afford 
the unreacted starting peptide amide (3.1 mg, 26 % based on starting peptide amide) as a 
white solid, and the desired peptide thioester 21 (3.3 mg, 29 %) as a white solid. 
1
H NMR 
(500 MHz, D2O) δH (ppm) 4.33 (1 H, d, J = 5.2, Thr 
α
CH); 4.29 (2 H, m, Glu 
α
CH, Thr 
α
CH); 
4.15 (5 H, m, Ile 
α
CH, 2 × Thr 
β
CH2); 4.04 (1 H, br d, J = 2.8, Ala 
α
CH); 3.99 (2 H, m, Gly 
α
CH2); 3.01 (2 H, t, J = 6.5, MPA CH2); 2.70 (2 H, m, Asn 
β
CH2); 2.58 (2 H, t, J = 7.3, MPA 
CH2); 2.40 (2 H, m, Glu 
γ
CH2); 2.01 (2H, m, Glu 
β
CH2); 1.83 (1 H, m, Ile 
β
CH); 1.41 (3 H, d, 
J = 7.1, Ala 
β
CH3); 1.38 (1 H, m, Ile 
γ
CH2); 1.10 (7 H, br m, 2 × Thr CH3, Ile 
γ
CH2); 0.84 (3 
H, d, J = 6.8, Ile 
γ
CH3); 0.78 (3 H, t, J = 7.5, Ile 
δ
CH3); LC-MS ESI
+ 
MS (m/z) calculated for 
C31H52N8O14S: 792.3, observed: 793.4 [MH]
+
. 
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Optimisation and First Biological Application 
H2N
OH
O
FmocOSu in MeCN, H2O, Et3N, pH 9.0
67 %
FmocHN
OH
O
N
H
H2N
O
STrt
, i-Pr2EtN, HOBt/HBTU, 
dry DMF
2. Fmoc-SPPS
NH2
H
N
O
SH
N
H
O
H
N
N
H
H
N
N
H
H
N
H2N
O
O
O
O
O
O
HO
HOO
NH2
O OH
3. TFA: EDT: H2O (95: 2.5: 2.5)
83 %
13C
1.
FmocHN
Fmoc-Cys(Trt)-OH,
      i-Pr2EtN, HOBt/HBTU,
      dry DMF
1. 20 % (v/v) piperidine/DMF
2.
3. 20 % (v/v) piperidine/DMF  
 
23. Fmoc-Gly(
13
C-1)-OH 
H2N
OH
O
FmocOSu in MeCN,
H2O, Et3N, pH 9.0 N
H
OH
O
67 %
O
O
 
Glycine(
13
C-1) 22 (0.50 g, 6.57 mmol) was dissolved in water (6.26 mL), and triethylamine 
(0.92 mL, 6.57 mmol) was added whilst stirring. Fmoc-succinimide (2.13 g, 6.31 mmol) was 
then dissolved at 50 °C in acetonitrile (6.26 mL), and this solution was then added to the 
amino acid solution in one portion. Further triethylamine (0.50 mL) was added to maintain a 
pH between 8.5 and 9.0. The combined reaction mixture was stirred at room temperature for 
0.5 h, then it was concentrated in vacuo and the off-white concentrate was poured whilst 
stirring into 1.5 M hydrochloric acid (26.3 mL). The solution was then filtered under gravity 
and the white solid was collected. The aqueous filtrate was further extracted with 
dichloromethane (3 × 12.5 mL). To these combined organic extracts was added the white 
solid that was collected after filtration, and this organic layer was then washed with 1.5 M 
hydrochloric acid (12.5 mL), water (12.5 mL), and saturated aqueous sodium chloride (12.5 
mL). The organic extract was then dried with anhydrous magnesium sulfate and the solvent 
was removed in vacuo. Petroleum ether (5.0 mL) was added to the concentrated product and 
formed a white solid after trituration. The product was then washed with petroleum ether and 
dried under high vacuum to afford Fmoc-Gly(
13
C-1)-OH 23 (1.26 g, 67 %) as a white solid 
which was used without further purification. Rf  = 0.1 (4 : 1 ethyl acetate: petroleum ether); 
m.p. 164-165 °C; 
1
H NMR (500 MHz, CDCl3) δH (ppm) 7.77 (2 H, d, J = 7.5, Fmoc Ph-H); 
22 23 
 
22 
 
23 
 
25 
 
26 
 
24 
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7.60 (2 H, br d, J = 7.3, Fmoc Ph-H); 7.40 (2 H, t, J = 7.3, J = 7.5, Fmoc Ph-H); 7.32 (2 H, m, 
Fmoc Ph-H); 5.26 (1 H, br s, CONH); 4.43 (2 H, d, J = 6.9, Fmoc CH2-O); 4.24 (1 H, asym t, 
J = 6.8, J = 6.6, Fmoc CH-CH2); 4.06 (2 H, br m, Gly 
α
CH2); 
13
C NMR (125 MHz, CDCl3) δC 
(ppm) 172.4 (CO2H); IR (υmax) neat: 3313, 2964, 2923, 1703, 1677, 1538, 1446, 1400, 1385, 
1272 cm
-1
; calculated mass for [MH]
+
 299.10793, observed (high resolution accurate mass) 
(CI): [MH]
+
 299.10844. 
 
 26. H-AENITTG(
13
C1)C-NH2 
FmocHN
OH
O
N
H
H2N
O
STrt
, i-Pr2EtN, HOBt/HBTU, 
dry DMF
Fmoc-SPPS
NH2
H
N
O
SH
N
H
O
H
N
N
H
H
N
N
H
H
N
H2N
O
O
O
O
O
O
HO
HOO
NH2
O OHTFA: EDT: H2O (95: 2.5: 2.5)
1.
2.
3.
83 % overall yield
FmocHN
FmocHN CO2H
TrtS
 i-Pr2EtN, HOBt/HBTU, 
dry DMF
1. 20 % (v/v) piperidine/DMF
2.
3. 20 % (v/v) piperidine/DMF  
General peptide synthesis procedure: Rink amide-MBHA resin, loading = 0.64 mmolg
-1
, 
(156 mg, 0.1 mmol) was initially treated with 20 % piperidine in DMF (v/v) (1.0 mL, 5 min). 
The solution was then filtered off and the resin was washed with DMF (1.0 mL, 5min) and 
twice with DCM (1.0 mL, 5 min). This was then repeated with 20 % piperidine in DMF (v/v) 
(1.0 mL, 15 min). The dried resin was then coupled to Fmoc-Cys(Trt)-OH (293 mg, 0.5 
mmol) with DIPEA (300 µL), 0.45 M HOBt/HBTU (2.2 mL) and dry DMF (2.0 mL), and the 
mixture was left to shake for 4 h. The solution was then filtered off and the resin was washed 
once with DMF (1.0 mL, 5 min) and twice with DCM (1.0 mL, 5 min). The resin was then 
treated with 20 % piperidine in DMF (v/v) (1.0 mL, 5 min then 15 min), washed and then 
dried. The 
13
C-labelled amino acid 23 (149 mg, 0.50 mmol) was then coupled using DIPEA 
(300 µL), 0.45 M HOBt/HBTU (2.2 mL) and dry DMF (2.0 mL), and the mixture was left to 
shake overnight. The resin was washed and dried, and then transferred to an automated 
peptide synthesiser reaction vessel for peptide chain elongation employing 10 equivalents of 
Fmoc-Xaa-OH = Fmoc-Ala-OH, Fmoc-Glu(O
t
Bu)-OH, Fmoc-Asn(Trt)-OH, Fmoc-Ile-OH 
(double coupled) and Fmoc-Thr(
t
Bu)-OH. The resin was then treated with trifluoroacetic 
acid: ethanedithiol: water (95: 2.5: 2.5 = 5.0 mL) for 5 h. After which, the resin was filtered 
off and to the filtrate cold diethyl ether (20.0 mL) was added, which induced precipitation, 
and this was centrifuged at 3000 rpm, 4 °C for 15 min. The ether layer was then decanted and 
24 
 
25 
26 
23 
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this was repeated with cold diethyl ether (20.0 mL). The white precipitate was then dissolved 
in 20 % acetonitrile and purified by semi-preparative (RP)HPLC (gradient: 5-50 % 
acetonitrile/ 45 min). The labelled peptide fractions were lyophilised to afford peptide amide, 
H-AENITTG(
13
C-1)C-NH2, 26 (67 mg, 83 %; tR = 17.2 min) as a white solid. 
13
C NMR (125 
MHz, CDCl3) δC (ppm) 171.8 (CONH). LC-MS ESI
+
 MS (m/z) calculated mass for 26 807.4, 
observed [MH]
+
 808.4. 
 
28. 4-Mercaptobutyric acid (MBA) 
OH
O
HS
OH
O
Br
S
NH2H2N
 
4-Bromobutyric acid 27 (4.0 g, 24.10 mmol) was refluxed for 3 h with thiourea (2.06 g, 27.10 
mmol) in ethanol (7.30 mL). Aqueous 4 M sodium hydroxide (6.10 mL) was then added and 
refluxing was continued for another 2 h. The solution was concentrated in vacuo, extracted 
with ether and the ether extract was discarded, acidified with aqueous 6 M hydrochloric acid, 
and extracted with ether. The ethereal extract was then dried over anhydrous sodium sulfate, 
the ether was evaporated to give 28 (2.89 g, 100 %) as a pungent colourless oil in quantitative 
yield. 
1
H NMR (500 MHz, CDCl3) δH (ppm): 11.60 (1 H, br s, CO2H), 2.52 (2 H, m, CH2-
CO2H), 2.44 (2 H, asym t, J = 7.3 Hz, CH2-CH2-CH2), 1.87 (2 H, m, CH2-SH), 1.31 (1 H, t, J 
= 8.1 Hz, SH); 
13
C NMR (125 MHz, CDCl3) δC (ppm): 179.5 (CO2H), 32.2 (CH2-CO2H), 
28.4 (CH2-CH2-CH2), 23.6 (CH2-SH); LC ESI
+
 MS (m/z) calculated for C4H8O2S: 120.0, 
observed: [MNa]
+
 143.2. 
 
29. H-AENITTG(
13
C1)-COSR 
NH2
H
N
O
SH
N
H
O
H
N
N
H
H
N
N
H
H
N
H2N
O
O
O
O
O
O
HO
HOO
NH2
O OH
SR
N
H
O
H
N
N
H
H
N
N
H
H
N
H2N
O
O
O
O
O
O
HO
HOO
NH2
O OH
10 % RSH (D2O)
40-60 °C
 
General procedure for optimisation studies: 
13
C-labelled peptide amide 26 (6.0 mg, 7.43 
µmol) was dissolved in a total reaction volume of 1.2 mL, which was comprised of D2O and 
26 29 
 
27 28 
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10 % thiol (RSH = 3-mercaptopropionic acid (MPA), sodium 2-mercaptoethanesulfonate 
(MESNa), 2-mercaptoacetic acid (MAA), 4-mercaptobutyric acid (MBA), or β-
mercaptoethanol (BME)). Certain reactions also required additives: 1 % (v/v) trifluoroacetic 
acid (TFA), 1 % (v/v) acetic acid (AcOH), 0.5 % (w/v) tris(2-carboxyethyl)phosphine 
(TCEP), or 0.5 % (v/v) N-methyl imidazole (Me-Im). After acquisition of a 
13
C NMR at 0 h, 
the reaction mixture was placed in a thermomixer at 60 °C, or in a microwave reactor at 
either 40, 50, or 60 °C (150 W) with low magnetic stirring, and the reaction was monitored 
by 
13
C NMR at regular intervals: 6, 24, 48, 72 h, and analysed by LC-MS upon reaction 
completion. The 
13
C NMR spectra for the thioester optimisation studies were acquired at 125 
MHz, number of scans = 256, reference = -32.10 Hz (D2O).  
 
Biological application of novel peptide thioesterification method: synthesis of Ser22His 
human β-defensin 3 (HBD3) 
 
H
N
O
N
H
O
NH2
N
NH
HS
10 % (w/v) MESNa, 10 % (v/v) AcOH,
0.5 % (w/v) TCEP, 6 M Guanidine.HCl, 
60 °C, 48 h, N2 (g)
(83 % = 7 + 8)
Acm
HBD3 (1-21)
H
N
O
S
S
N
NH
Acm
HBD3 (1-21)
O O
OHNH2
1. FmocHN-Cys(Trt)-OH, i-Pr2EtN,
 0.45 M HOBt/HBTU, dry DMF
2. Fmoc-SPPS
3. TFA : EDT : H2O, 5 h
    (95 : 2.5 : 2.5)
Acm
O
O
NHFmoc
NHBoc
1. Fmoc-SPPS
2. TFA : EDT : H2O, 5 h
    (95 : 2.5 : 2.5)
H2N
O
HS
6 M Guanidine.HCl, 0.2 M Na phosphate, 
0.1 M MESNa, 40 mM TCEP, 
pH 7.0, 25 °C, 48 h
Acm Acm
HBD3 (24-45)
Acm
HBD3 (1-45)
Acm AcmAcmAcmAcm
1. 10 % AcOH, 50 equiv Ag(I)OAc, 
25 °C, 6 h
2. 10 % (w/v) DTT, 25 °C
HBD3 (1-45)
SH SH SHSHSH SH
0.1 M NaHCO3, 1 M Guanidine.HCl,
3.0 mM cysteine, 0.3 mM cystine,
pH 8.1, 25 °C, 24 h
HBD3 (1-45)
S
S
S
S
S
S
Acm
50 %
97 %
95 %
37 %
80 %
 
 
 
 
 
 
 
30 
 
31 
 
32 
 
33 
 
34 
 
35 
 
36 
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30. HBD3(1-21)HC-NH2: H-GIINTLQKYYC(Acm)RVRGGRC(Acm)AVLHC-NH2 
H
N
O
N
H
O
NH2
N
NH
HS
Acm Acm
HBD3 (1-21)
1. 20 % piperidine in DMF (v/v)
2. Fmoc-Cys(Trt)-OH, i-Pr2EtN,
    HOBt/HBTU, dry DMF, 4h
3. Fmoc-SPPS
4. TFA: EDT: H2O = 95: 2.5: 2.5, 5 h
50 %
NHFmoc
 
Rink amide-MBHA low loading (LL) resin (147 mg, 0.05 mmol, loading 0.34 mmolg
-1
) was 
treated with 20 % piperidine in DMF (v/v) (1.0 mL, 5 min). The resin was then filtered, 
washed once with DMF (1.0 mL, 5min) and twice with DCM (1.0 mL, 5 min), then dried and 
the process was repeated with 20 % piperidine in DMF (v/v) (1.0 mL, 15 min). The dried 
resin was then coupled to Fmoc-Cys(Trt)-OH (146 mg, 0.25 mmol) using DIPEA (150 µL), 
0.45 M HOBt/HBTU (1.1 mL) and dry DMF (1.0 mL). The resulting mixture was left to 
shake for 4 h; the resin was then filtered, washed with DMF (1.0 mL, 5 min) and twice with 
DCM (1.0 mL, 5 min). The dried resin was then transferred to an automated peptide 
synthesiser (433 A) reaction vessel for peptide elongation employing 10 equivalents of Fmoc-
Xaa-OH = Fmoc-Gly-OH, Fmoc-Ile-OH, Fmoc-Asn(Trt)-OH, Fmoc-Thr(
t
Bu)-OH, Fmoc-
Leu-OH, Fmoc-Gln(Trt)-OH, Fmoc-Lys(Boc)-OH, Fmoc-Tyr(
t
Bu)-OH, Fmoc-Cys(Acm)-
OH, Fmoc-Val-OH, Fmoc-Arg(Pbf)-OH, Fmoc-Ala-OH, and Fmoc-His(Trt)-OH. All β-
branched amino acids were double coupled. The resin was then treated with TFA: EDT: H2O 
(95: 2.5: 2.5 = 5.0 mL) for 5 h, and the solution was then filtered and precipitation was 
induced upon addition of cold diethyl ether (20.0 mL) to the filtrate, which was then vortexed 
and centrifuged (3000 rpm, 4 °C, 15 min). After decanting the ether layer, this process was 
repeated with cold diethyl ether (20.0 mL). The crude peptide was then dissolved in 20 % 
acetonitrile and purified by semi-preparative (RP)HPLC (gradient: 5-50 % acetonitrile/ 45 
min). The desired peptide fractions were lyophilised to afford the N-terminal defensin 31 (69 
mg, 50 %, tR = 32.3 min) as a white solid. LC-MS ESI
+ 
MS (m/z) calculated average mass 
[M] 2765.3, observed 2765.0. 
 
 
 
30 
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31. HBD3(1-21)H-SCH2CH2SO3H: 
H-GIINTLQKYYC(Acm)RVRGGRC(Acm)AVLH-SCH2CH2SO3H 
H
N
O
N
H
O
NH2
N
NH
HS
10 % (w/v) MESNa, 10 % (v/v) AcOH,
0.5 % (w/v) TCEP, 6 M Guanidine.HCl, 
60 °C, 48 h, N2 (g)
83 %
Acm Acm
HBD3 (1-21)
H
N
O
S
S
N
NH
Acm Acm
HBD3 (1-21)
O O
OH
 
HBD3(1-21)HC-CONH2 30 (12.5 mg, 4.52 μmol, 4.0 mM) was dissolved in a solution of 6 
M guanidine hydrochloride (1.02 mL) containing 10 % (w/v) sodium 2-
mercaptoethanesulfonate (113 mg, 0.69 mmol) and 10 % (v/v) acetic acid (113 μL). Then, 0.5 
% (w/v) tris(2-carboxyethyl)phosphine (5.7 mg, 19.88 μmol) was added and the resulting 
mixture, pH 2.0, was stirred under nitrogen at 60 °C for 48 h. LC-MS analysis at 48 h of an 
aliquot of the reaction mixture showed ~1:1 of 30: 31. The reaction mixture was then purified 
by semi-preparative (RP)HPLC (gradient: 5-50 % acetonitrile/ 45 min). The peptidic 
components were collected and lyophilised to afford a mixture of the unreacted starting 
material that co-eluted with the desired peptide thioester (30 + 31) (10.5 mg, 83 %, tR = 32.1 
and 32.5 min) as a white solid. Oxidised starting material (0.6 mg, 5 % (based on 30), tR = 
34.1 min) was also recovered as a white solid. LC-MS ESI
+ 
MS (m/z) calculated average 
mass of 31 [M] 2787.3, observed 2787.0.  
 
33. HBD3(23-45): H-CLPKEEQIGKC(Acm)STRGRKC(Acm)C(Acm)RRKK-OH 
O
1. Automated Fmoc-SPPS
2. TFA: EDT: H2O = 95: 2.5: 2.5, 5 h
O
NHFmoc
NHBoc
H2N
O
HS Acm Acm
HBD3 (24-45)
Acm
37 %
 
Preloaded Fmoc-Lys(Boc)-Novasyn® TGT resin 32 (250 mg, 0.05 mmol, loading 0.20 
mmolg
-1
) was transferred to an automated peptide synthesiser (433 A) for peptide elongation 
employing 10 equivalents of Fmoc-Xaa-OH = Fmoc-Cys(Acm)-OH, Fmoc-Leu-OH, Fmoc-
Pro-OH, Fmoc-Lys(Boc)-OH, Fmoc-Glu(O
t
Bu)-OH, Fmoc-Gln(Trt)-OH, Fmoc-Ile-OH, 
Fmoc-Gly-OH, Fmoc-Ser(
t
Bu)-OH, Fmoc-Thr(
t
Bu)-OH and Fmoc-Arg(Pbf)-OH. Boc-
Cys(Trt)-OH was incorporated at the N-terminus and β-branched amino acids were double 
30 
 
31 
 
32 
 
33 
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coupled. The resin was then treated with TFA: EDT: H2O (95: 2.5: 2.5 = 5.0 mL) for 5 h, and 
the solution was then filtered and precipitation was induced upon addition of cold diethyl 
ether (20.0 mL) to the filtrate, which was then vortexed and centrifuged (3000 rpm, 4 °C, 15 
min). After decanting the ether layer, this process was repeated with cold diethyl ether (20.0 
mL). The crude peptide was then dissolved in 20 % acetonitrile and purified by semi-
preparative (RP)HPLC (gradient: 5-50 % acetonitrile/ 45 min). The desired peptide fractions 
were lyophilised to afford the C-terminal defensin 33 (54 mg, 37 %, tR = 18.4 min) as a white 
solid. LC-MS ESI
+ 
MS (m/z) calculated average mass [M] 2921.5, observed 2922.0. 
 
34. HBD3(1-45) + Acm5:  
H-GIINTLQKYYC(Acm)RVRGGRC(Acm)AVLHCLPKEEQIGKC(Acm)STRGRKC(Acm)C(Acm)RRKK-OH 
H2N
O
HS
6 M Guanidine.HCl, 200mM Na phosphate, 
100mM MESNa, 40 mM TCEP, 
pH 7.0, 25 °C, 48 h
100 % peptide thioester ligated
H
N
O
S
S
N
NH
Acm Acm
HBD3 (1-21)
O O
OH
Acm Acm
HBD3 (24-45)
Acm
HBD3 (1-45)
Acm Acm AcmAcmAcm
 
Co-purified starting amide 30 and peptide thioester 31 (10.6 mg, 3.80 mM), and excess 
cysteinyl peptide 34 (11.1 mg, 3.80 mM) were dissolved in degassed 6 M guanidine 
hydrochloride (660 μL).To this solution 1 M sodium phosphate pH 7.0 buffer (200 μL, 200 
mM) was added, followed by 1 M sodium 2-mercaptoethanesulfonate (100 μL, 100 mM) and 
1 M tris(2-carboxyethyl)phosphine (40 μL, 40 mM). The resulting mixture was vortexed and 
placed in a thermomixer at 25 °C, 800 rpm, for 48 h. At 48 h LC-MS/MS analysis showed the 
ligated full length peptide and the reaction mixture was purified by semi-preparative 
(RP)HPLC (gradient: 5-50 % acetonitrile/ 45 min). Defensin peptide fractions were 
lyophilised to afford unreacted cysteinyl peptide 33 (6.3 mg, 57 % (based on 33), tR = 18.4 
min) as a white solid; ligated peptide 34 (6.8 mg, 97 %, tR = 29.7 min) as a white solid; and 
unreacted starting amide 30 (7.1 mg, 67 % (based on 30), tR = 32.0 min) as a white solid. LC-
MS ESI
+ 
MS (m/z) calculated average mass of 34 [M] 5566.6, observed 5566.0.  
 
 
33 
31 34 
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35. HBD3(1-45) [H]: H-GIINTLQKYYCRVRGGRCAVLHCLPKEEQIGKCSTRGRKCCRRKK-OH 
HBD3 (1-45)
Acm Acm AcmAcmAcm 1. 10 % AcOH, 50 equiv Ag(I)OAc, 
25°C, 6 h
2. 10 % (w/v) DTT, 25 °C
HBD3 (1-45)
SH SH SHSHSH SH
95 %  
To a solution of full-length peptide 34 (6.8 mg, 1.22 µmol) in 10 % (v/v) acetic acid (120 
µL), silver(I) acetate (10.2 mg, 61.11 µmol) (10 equivalents/Acm group) was added and the 
mixture was left to shake in a thermomixer at 25 °C for 6 h. Then 10 % (w/v) 1,4-dithio-DL-
threitol (120 mg, 0.78 mmol) was added and the mixture was left to shake at 25 °C overnight. 
The resulting yellow solution was centrifuged and the supernatant was concentrated under 
reduced pressure. The precipitate formed in vacuo was dissolved in water and purified by 
semi-preparative (RP)HPLC (gradient: 5-50 % acetonitrile/ 45 min). The deprotected peptide 
was lyophilised to afford 35 (6.1 mg, 95 %, tR = 31.6 min) as a white solid. LC-MS ESI
+ 
MS 
(m/z) calculated average mass [M] 5211.2, observed 5211.0. 
 
36. Ser22His HBD3(1-45) [O] 
HBD3 (1-45)
SH SH SHSHSH SH
HBD3 (1-45)
S
S
S
S
S
S0.1 M NaHCO3, 1 M Guanidine.HCl,
3.0 mM cysteine, 0.3 mM cystine,
pH 8.1, 25 °C, 24 h
80 %  
The reduced peptide 35 (10.6 mg, 2.03 µmol) was dissolved in 6 M guanidine hydrochloride 
(7.1 mL, 0.29 mM), and then further diluted 6-fold with water (35.5 mL) to give final peptide 
concentration = 0.25 mgmL
-1
, containing guanidine hydrochloride (1 M), 0.1 M sodium 
bicarbonate (358 mg, 4.26 mmol), 3.0 mM L-cysteine hydrochloride (20.1 mg, 0.13 mmol), 
0.3 mM L-cystine (3.1 mg, 12.78 µmol), pH 8.1. The solution was gently shaken at 25 °C in 
a sealed vessel for 24 h. The reaction mixture was then concentrated by size-exclusion 
filtration (molecular weight cut-off = 3 kDa) to 1.0 mL and then diluted to 3.0 mL with 
water. LC-MS/MS analysis indicated that the reduced peptide had fully oxidised with an 
observed difference of 6 mass units. The concentrate was then purified by semi-preparative 
(RP)HPLC (gradient: 5-50 % acetonitrile/ 45 min). The three major peaks corresponding to 
folded peptide were collected and lyophilised to afford 36 (8.5 mg, 80 %, tR = 30.2, 31.1, and 
34 35 
35 36 
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33.5 min) as a white solid. LC-MS ESI
+ 
MS (m/z) calculated average mass [M] 5205.2, 
observed 5205.0. 
 
Antimicrobial activity assay 
 
Test organisms (Pseudomonas aeruginosa strain PA01 and Staphylococcus aureus strain 
ATCC 25923) were grown to mid-logarithmic phase in Iso-Sensitest broth (Oxoid) growth 
media and then diluted to 1-5 × 106 colony forming units (CFU)/mL in 10 mM potassium 
phosphate containing 1 % (v/v) Iso-sensitest broth, pH 7.4. Different concentrations of test 
peptides were incubated in 100 µL of cells (1-5 × 106 CFU) at 37 °C for 3 h. Serial dilutions 
(10-fold) of the incubation mixture were spread on Iso-sensitest plates and incubated at 37 
°C, and the CFU levels were determined the following day. The minimum bactericidal 
concentration (MBC) is the concentration of peptide at which we observed >99.99 % killing 
of the initial inoculum. All assays were performed in triplicate on three independent 
occasions. The MBC was obtained by taking the mean of all results, and all experimental 
errors were within one doubling dilution. 
 
Chemotaxis assay 
 
Chemotaxis was performed using a 96 well microchemotaxis chamber (Neuro Probe Inc, 
Gaithersburg USA). 30 µL of sample was loaded into the bottom chamber. The positive 
control human macrophage inflammatory protein-3α (hMIP-3α), also known as chemokine 
ligand-20 (CCL20), was purchased from PeproTech EC (London, UK) and dissolved in 
RPMI/ 1 % bovine serum albumin (BSA). The negative control was RPMI/ 1 % BSA 
(chemotactic media) alone. Stock solutions were prepared at 1 × 10-6 M. A polycarbonate 
filter (pore size 10 µm) (Neuro Probe Inc, Gaithersburg, USA) coated overnight with 
collagen (5 µg/mL) at 37 °C, was added to the top chamber against the silicon gasket and 
carefully placed over the bottom chamber to eliminate air bubbles. Human embryonic kidney 
cells transfected with chemokine receptor CCR6 were prepared in RPMI/ 1 % BSA and 200 
µL was added to the wells in the top chamber at 1-5 × 105 cells/mL. The chamber was 
incubated in a humid 5 % CO2 incubator for 4 h. From the chamber the filter was removed 
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and the side with the non-migrating cells was washed in PBS. The filter was allowed to air 
dry and was then stained with: solution A (methanol fixative) of DiffQuick for 2 min, 
solution B (Azure B) for 2 min, solution C (Eosin) for 2 min, and gently rinsed in sterile 
water and allowed to air dry. Three random fields of view were taken per well from which the 
migrated cells were counted, which allowed the mean number of migrated cells and the 
standard error of means (SEM) to be calculated. Each dilution was tested in triplicate and 
experiments were carried out a minimum of three times. Data was analysed by ANOVA with 
post-test when p <0.05. Chemotactic activity was determined as the optimal concentration of 
test compound at which the highest chemotactic index was achieved. 
 
The First Application of Native Chemical Thioesterification to the Synthesis of Native 
N-Linked Thioesters 
 
38. 2-Acetamido-2-deoxy-3, 4, 6-tri-O-acetyl-α-D-glucopyranosyl chloride. 
 
O
OH
AcHN
HO
HO
OH
AcCl
47 %
O
Cl
AcHN
AcO
AcO
OAc
 
N-acetyl-D-glucosamine 37 (20.0 g, 90.46 mmol) was added to acetyl chloride (30.0 mL) and 
the solution was stirred overnight. The reaction was then diluted with chloroform (50.0 mL) 
and the resulting solution was washed with ice-water (50.0 mL) and ice-saturated aqueous 
sodium bicarbonate (50.0 mL). The organic phase was dried with anhydrous magnesium 
sulfate, filtered and concentrated under reduced pressure. The crude product was purified by 
flash column chromatography (the column was packed with 1:1 petroleum ether: ethyl 
acetate; mobile phase 1: 2 petroleum ether: ethyl acetate) to afford the glycosyl chloride 38 
(15.52 g, 47 %) as a flaky white solid. Rf 0.4 (ethyl acetate); 
1
H NMR (300 MHz, CDCl3) δH 
(ppm) 6.15 (1 H, d, J = 3.7, H1e); 6.03 (1 H, d, J = 8.7, NHAc); 5.30 (1 H, dd, J = 9.9, H3a); 
5.17 (1 H, dd, J = 9.9, H4a); 4.51 (1 H, ddd, J = 9.9, J = 8.7, J = 3.7, H2a); 4.24 (2 H, m, H5a, 
H6a); 4.09 (1 H, m, H6b); 2.06, 2.00, 2.00, 1.95 (12 H, 4 × s, 4 × CH3CO); 
13
C NMR (75 MHz, 
CDCl3) δC (ppm) 171.4, 170.6, 170.2, 169.1 (C=O); 93.7, 70.9, 70.1, 67.0 (CH); 61.1 (CH2); 
53.4 (CH); 23.0, 20.7, 20.7, 20.6 (CH3); ESI
+
 MS (m/z) calculated for C14H20ClO8N: 365.09, 
observed [MH]
+
 366.13.  
37 38 
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39. 2-Acetamido-2-deoxy-3, 4, 6-tri-O-acetyl-β-D-glucopyranosyl azide. 
 
O
Cl
AcHN
AcO
AcO
OAc NaN3, TBAHS, 
DCM, NaHCO3
95 %
O
AcHN
AcO
AcO
OAc
N3
 
To a solution of the glucosyl chloride 38 (10.0 g, 27.39 mmol), tetra-butylammonium 
hydrogen sulfate (9.30 g, 27.39 mmol) and sodium azide (5.34 g, 82.17 mmol) in 
dichloromethane (110.0 mL), was added saturated aqueous sodium bicarbonate solution 
(110.0 mL). The resulting biphasic solution was stirred vigorously at room temperature for 1 
h. Ethyl acetate (200.0 mL) was then added and the organic layer was separated and washed 
with saturated aqueous sodium bicarbonate (100.0 mL) and water (2 × 100 mL). The organic 
phase was then dried with anhydrous magnesium sulfate, filtered and concentrated under 
reduced pressure to afford the glycosyl azide 39 (8.36 g, 82 %) as a fluffy white solid. Rf 0.5 
(2: 8 methanol: ethyl acetate); m.p. 169-170 °C [lit.
308
 166-167 °C]; 
1
H NMR (500 MHz, 
CDCl3) δH (ppm) 5.71 (1 H, d, J = 8.9, NHAc); 5.24 (1 H, dd, J = 9.5, J = 10.5, H3a); 5.09 (1 
H, dd, J = 9.6, J = 9.8, H4a); 4.76 (1 H, d, J = 9.3, H1a); 4.26 (1 H, asym dd, J = 4.9, H6b); 
4.16 (1 H, asym dd, J = 2.3, H6a); 3.91 (1 H, ddd, J = 9.1, J = 10.5, J = 10.3, H2a); 3.79 (1 H, 
ddd, J = 10.1, J = 4.8, J = 2.3, H5a); 2.10, 2.03, 2.03 (3 H, 3 × s, 3 × CH3CO); 1.97 (3 H, s, 
CH3CONH); 
13
C NMR (125 MHz, CDCl3) δC (ppm) 171.0, 170.7, 170.4, 169.2 (C=O); 88.4, 
74.0, 72.1, 68.0 (CH); 61.8 (CH2); 54.2 (CH); 23.2, 20.7, 20.6, 20.6 (CH3); IR (υmax) neat: 
3342, 2942, 2881, 2103, 1746, 1660, 1529, 1371, 1226 cm
-1
; ESI
+ 
MS (m/z) calculated for 
C14H20O8N4: 372.30, observed [MNa]
+
 395.12.  
 
40. 2-Acetamido-2-deoxy-3, 4, 6-tri-O-acetyl-β-D-glucopyranosyl amine. 
 
H2, PtO2, THF
97 %
O
AcHN
AcO
AcO
OAc
NH2
O
AcHN
AcO
AcO
OAc
N3
 
 
A solution of the glycosyl β-azide 39 (500 mg, 1.34 mmol) in anhydrous tetrahydrofuran 
(9.05 mL) was catalytically hydrogenated at atmospheric pressure in the presence of 
platinum(II) oxide (23 mg) for 3 h. The catalyst was then removed by filtration through 
38 39 
39 40 
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Celite® and the filtrate was concentrated under reduced pressure to afford the glycosyl β-
amine 40 (448 mg, 97 %) as an off-white/grey solid. Rf 0.3 (2: 8 methanol: ethyl acetate); 
m.p. decomposed at 159 °C [lit.
308
 159 °C]; 
1
H NMR (500 MHz, CDCl3) δH (ppm) 5.83 (1 H, 
d, J = 9.2, NHAc); 5.03 (2 H, m, H3a, H4a); 4.19 (1 H, asym dd, J = 4.9, J = 12.3, H6b); 4.09 
(2 H, m, H6a, H2a); 3.98 (1 H, d, J = 9.9, H1a); 3.63 (1 H, m, H5a); 2.11 (2 H, br s, NH2); 2.07, 
2.02, 2.00, 1.95 (12 H, 4 × s, 4 × CH3CO); 
13
C NMR (125 MHz, CDCl3) δC (ppm) 171.5, 
170.7, 170.7, 169.3 (C=O); 86.6, 73.4, 72.7, 68.5 (CH); 62.4 (CH2); 54.8 (CH); 23.2, 20.7, 
20.7, 20.6 (CH3); IR (υmax) neat: 3400, 3342, 2935, 1749, 1733, 1660, 1538, 1429, 1367, 
1232 cm
-1
; high resolution accurate mass (TOF MS ES
+
) (m/z) calculated for C14H22N2O8Na: 
[MNa]
+
 369.1274, observed [MNa]
+
 369.1266. 
 
41. N-α-9-Fluorenylmethoxycarbonyl-N-β-(2-N-acetylamido-2-deoxy-β-D-gluco-
pyranosyl)-L-asparagine tert-butyl ester. 
 
EEDQ, DCM
78 %
O
AcHN
AcO
AcO
OAc
NH
O
AcHN
AcO
AcO
OAc
NH2
FmocHN CO2
tBu
O
OH
O
CO2
tBuFmocHN  
 
 The glycosyl β-amine 40 (238 mg, 0.69 mmol) was added to a solution of Fmoc-Asp-OtBu 
(293 mg, 0.69 mmol) and N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (171 mg, 0.69 
mmol) in dry dichloromethane (21.0 mL, 0.025 M). The solution was stirred at room 
temperature for 3.5 h under nitrogen. TLC analysis indicated that the reaction was complete. 
The resulting pale-yellow/grey, almost brown, reaction mixture was then concentrated to 
afford a white solid. Hot ethyl acetate: petroleum ether 1: 1 (10.0 mL) was then added to the 
white solid and the suspension was filtered. The quinoline containing filtrate was discarded 
but the filtered solid was dried under vacuum to give the desired glycoamino acid 41 (399 
mg, 78 %) as a white/ pale-grey solid. Rf 0.5 (ethyl acetate); m.p. decomposed at 210 °C; 
1
H 
NMR [500 MHz, 17 % v/v CDCl3 (7.258 ppm) + 83 % v/v MeOD (4.197 ppm)] δH (ppm) 
7.54 (2 H, br d, J = 7.2, Fmoc Ph-H); 7.39 (2 H, br d, J = 7.2, Fmoc Ph-H); 7.17 (2 H, br t, J 
40 41 
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= 7.0, J = 7.3, Fmoc Ph-H); 7.09 (2 H, br t, J = 7.0, Fmoc Ph-H); 4.90 (2 H, m, H3a, H1a); 
4.82 (1 H, asym br t, J = 9.7, H4a); 4.25 (1 H, br s, Asn 
α
CH); 4.05 (4 H, br m, Fmoc CH2, 
H6a, H6b); 3.84 (2 H, br m, Fmoc CH, H2a); 3.57 (1 H, br m, H5a); 2.48 (2 H, m, Asn 
β
CH2); 
1.81, 1.81, 1.79 (9 H, 3 × s, 3 × CH3CO); 1.66 (3 H, s, CH3CONH); 1.22 (9 H, s, O
t
Bu: 3 × 
CH3); 
13
C NMR [125 MHz, CDCl3 (78.7 ppm) + MeOD (49.9 ppm)] δC (ppm) 174.0, 172.8, 
172.5, 172.1, 171.7, 171.2 (C=O); 145.1, 145.0, 142.5; 129.0, 128.3, 126.3, 121.2 (Fmoc 
C=C); 83.6, 79.9, 74.6, 74.5, 69.7 (CH); 68.3 (CH2); 63.3 (CH2); 53.8, 52.4, 52.4, 48.3 (CH); 
38.7 (CH2), 28.9 (O
t
Bu CH3); 23.6 (CH3CONH); 21.6, 21.6, 21.5 (CH3CO); IR (υmax) neat: 
3301, 3067, 2971, 1742, 1696, 1660, 1531, 1450, 1368, 1225 cm
-1
; accurate mass (TOF MS 
ES
+
) (m/z) calculated for C37H45N3O13Na: [MNa]
+
 762.2850, observed [MNa]
+
 762.2830. 
 
42. N-α-9-Fluorenylmethoxycarbonyl-N-β-(2-N-acetylamido-2-deoxy-β-D-gluco-
pyranosyl)-L-asparagine. 
 
95 % TFA
100 % (quant.)
O
AcHN
AcO
AcO
OAc
NH
O
FmocHN
O
OH
O
AcHN
AcO
AcO
OAc
NH
O
FmocHN
O
O
 
 
The tert-butyl protecting group was removed by treating 41 (251 mg, 0.34 mmol) with 95 % 
(v/v) TFA (4.75 mL) in water (250 µL), and the resulting solution was stirred for 3 h at room 
temperature, with monitored evolution of isobutylene. T.L.C. analysis indicated that the 
reaction was complete. The solvent was then removed under reduced pressure to afford the 
desired glycoamino acid 42 (232 mg, 100 %) as an off-white solid. Crude NMR analysis 
corresponded to the pure product and hence the glycoamino acid was used without further 
purification. Rf 0.1 (2: 8 methanol: ethyl acetate); m.p. decomposed at 166-169 °C; 
1
H NMR 
[300 MHz, 22 % v/v CDCl3 (7.258 ppm) + 78 % v/v MeOD (4.097 ppm)] δH (ppm) 7.59 (2 
H, d, J = 7.5, Fmoc Ph-H); 7.45 (2 H, d, J = 7.3, Fmoc Ph-H); 7.23 (2 H, t, J = 7.4, Fmoc Ph-
H); 7.14 (2 H, t, J = 7.3, J = 7.4, Fmoc Ph-H); 4.91 (3 H, m, H1a, H3a, H4a); 4.39 (1 H, br t, J = 
4.7, Asn 
α
CH); 4.22 (2 H, m, H6a, H6b); 4.06 (2 H, d, J = 5.3, Fmoc CH2); 3.93 (2 H, m, Fmoc 
CH, H2a); 3.63 (1 H, ddd, J = 4.1, J = 2.1, J = 9.8, H5a); 2.64 (2 H, m, Asn 
β
CH2); 1.88 (3 H, 
41 42 
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s, CH3CO); 1.87 (3 H, s, CH3CO); 1.85 (3 H, s, CH3CO); 1.72 (3 H, s, CH3CONH); 
13
C 
NMR [125 MHz, CDCl3 (78.7 ppm) + MeOD (49.9 ppm)] δC (ppm) 174.8, 174.4, 173.2, 
172.9, 172.3, 171.7 (C=O); 158.6, 145.5, 145.4, 142.9, 142.9, 129.3; 128.6, 126.7, 126.6, 
121.4 (Fmoc C=C); 80.1, 75.0, 75.0, 70.2 (CH); 68.6 (CH2); 63.7 (CH2); 54.3, 52.1, 48.7 
(CH); 38.8 (Asn 
β
CH2), 23.5 (CH3CONH); 21.6, 21.6, 21.5 (CH3CO); IR (υmax) neat: 3308, 
3067, 2944, 1743, 1696, 1660, 1532, 1372, 1226 cm
-1
; LC-MS ESI
+ 
MS (m/z) calculated for 
C33H37N3O13: [M] 683.2, observed [MNa]
+
 706.5. 
 
48. H-AEN(Ac3-GlcNAc)ITTGC-OH. 
HO
Fmoc-Cys(Trt)-OH
DIPEA, HOBt/HBTU, DMF O
O
FmocHN
TrtS
1. Piperidine
2. Fmoc-Gly-OH,
DIPEA, HOBt/HBTU, DMF
O
O
H
N
O
STrt
FmocHN
1. Piperidine
2. Manual Fmoc-SPPS
FmocHN
O
OH
O
NH
O
AcHN
AcO
AcO
OAc
DIPEA, HOBt/HBTU, DMF
O
O
H
N
O
STrt
N
H
O
H
N
OtBu
O
N
H
tBuO
O
H
N
O
FmocHN
O
NH
O
AcHN
AcO
AcO
OAc
1. Piperidine
2. Manual Fmoc-SPPS
3. TFA: EDT: H2O
OH
O
H
N
O
SH
N
H
O
H
N
OH
O
N
H
HO
O
H
N
O
N
H
O
NH
O
AcHN
AcO
AcO
OAc
OH
N
CO2H
O
H2N
3.
Overall yield 18 % (based on 100 % loading of Cys)
 
 
 
HO
1. Fmoc-Cys(Trt)-OH
DIPEA, HOBt/HBTU, DMF
O
O
H2N
TrtS2. Piperidine  
 
NovaSyn® TGA resin 43 (384 mg, 0.10 mmol) was initially swollen in dichloromethane (1.0 
mL) for 15 min, the solvent was then filtered off and the resin was dried. The dry resin was 
then reacted with 5 equivalents of Fmoc-Cys(Trt)-OH (293 mg, 0.5 mmol), 
42 
48 
43 44 
43 
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diisopropylethylamine (300 µL), 0.45 M HOBt/HBTU (2.2 mL), and anhydrous N, N‘-
dimethylformamide (2.0 mL), which was left to shake for 2 h. The heterogeneous mixture 
was filtered off and washed once with DMF (1.0 mL) for 5 min, followed by twice with 
DCM (1.0 mL) for 5 min each, and the resin was then dried. The N
α
-Fmoc group was then 
removed by the addition of 20 % (v/v) piperidine/DMF (1.0 mL) to the dried resin and the 
mixture was left to shake for 5 min. The mixture was then filtered off and washed once with 
DMF (1.0 mL) for 5 min, followed by twice with DCM (1.0 mL) for 5 min each, and finally 
the resin was dried. More 20 % (v/v) piperidine/DMF (1.0 mL) was added to the dried resin 
and the mixture was shaken for 15 min. The mixture was then filtered off and washed once 
with DMF (1.0 mL) for 5 min, followed by twice with DCM (1.0 mL) for 5 min each, and 
finally the resin was dried.  
 
O
O
H2N
TrtS
1. Fmoc-Gly-OH
DIPEA, HOBt/HBTU, DMF O
O
H
N
O
STrt
H2N
2. Piperidine  
 
The resin 44 was then coupled to Fmoc-Gly-OH (74 mg, 0.25 mmol), with N, N-
diisopropylethylamine (150 µL), 0.45 M HOBt/HBTU (1.1 mL), and anhydrous N, N-
dimethylformamide (1.0 mL), and was left to shake for 2.5 h. The reaction mixture was 
filtered off and washed once with N,N-dimethylformamide (1.0 mL) for 5 min, followed by 
twice with DCM (1.0 mL) for 5 min each, and the resin was then dried. The N
α
-Fmoc group 
was then removed by the addition of 20 % (v/v) piperidine/ N, N-dimethylformamide (1.0 
mL) to the dried resin and the mixture was left to shake for 5 min. The mixture was then 
filtered off and washed once with N, N-dimethylformamide (1.0 mL) for 5 min, followed by 
twice with DCM (1.0 mL) for 5 min each, and then the resin was dried. More 20 % (v/v) 
piperidine/ N, N-dimethylformamide (1.0 mL) was added to the dried resin and the mixture 
was shaken for 15 min. The mixture was then filtered off and washed once with N, N-
dimethylformamide (1.0 mL) for 5 min, followed by twice with DCM (1.0 mL) for 5 min 
each, and finally the resin was dried. 
 
 
44 45 
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O
O
H
N
O
STrt
H2N
Manual Fmoc-SPPS
O
O
H
N
O
STrt
N
H
O
H
N
OtBu
O
N
H
tBuO
O
H2N
 
 
Manual Fmoc-SPPS was continued to afford the sequence: H-IT(
t
Bu)T(
t
Bu)GC(Trt)-resin, 
using 5 equivalents of Fmoc-Ile-OH and Fmoc-Thr(
t
Bu)-OH, with double-coupling of Fmoc-
Ile-OH. 
FmocHN
O
OH
O
NH
O
AcHN
AcO
AcO
OAc
DIPEA, HOBt/HBTU, DMF O
O
H
N
O
STrt
N
H
O
H
N
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2. Piperidine
1.
 
 
The N-linked glycoamino acid 42 (68 mg, 0.10 mmol) was then added to the peptidyl-resin 
along with diisopropylethylamine (150 µL), 0.45 M HOBt/HBTU (1.1 mL), and anhydrous 
N,N‘-dimethylformamide (1.0 mL), and the mixture was left to shake for 30 h. The reaction 
mixture was then filtered off and washed once with N, N-dimethylformamide (1.0 mL) for 5 
min, followed by twice with DCM (1.0 mL) for 5 min each, and the resin was then dried. The 
N
α
-Fmoc group was then removed by the addition of 20 % (v/v) piperidine/ N, N-
dimethylformamide (1.0 mL) to the dried resin and the mixture was left to shake for 5 min. 
The mixture was then filtered off and washed once with DMF (1.0 mL) for 5 min, followed 
by twice with DCM (1.0 mL) for 5 min each, and then the resin was dried. More 20 % (v/v) 
piperidine/ N, N-dimethylformamide (1.0 mL) was added to the dried resin and the mixture 
was shaken for 15 min. The mixture was then filtered off and washed once with N, N-
dimethylformamide (1.0 mL) for 5 min, followed by twice with DCM (1.0 mL) for 5 min 
each, and finally the resin was dried.  
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Overall yield: 18 %
 
 
Peptide synthesis was then completed manually using 5 equivalents of Fmoc-Glu(O
t
Bu)-OH 
and Boc-Ala-OH to afford: Boc-AE(O
t
Bu)N(Ac3-GlcNAc)IT(
t
Bu)T(
t
Bu)GC(Trt)-resin. The 
protected peptidyl-resins were then treated with a cleavage cocktail comprised of TFA: 
45 
46 
46 47 
42 
47 48 
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ethanedithiol: water (95: 2.5: 2.5) with total volume of 3.0 mL. The mixture was then filtered 
and ice-cold diethyl ether (20.0 mL) was added, which induced precipitation. This mixture 
was then vortexed and centrifuged (3000 rpm, 15 min, 4 °C); then the ether layer was 
carefully decanted. More diethyl ether (20.0 mL) was added and the mixture was again 
vortexed, centrifuged, and decanted to afford the crude peptide product as a white solid. The 
crude peptide was dissolved in water (1.0 mL) and acetonitrile (0.5 mL), centrifuged and the 
supernatant was then purified by (RP)HPLC (gradient: 5-50 % MeCN over 45 min). The 
desired peptide product fractions were pooled and lyophilised to afford the unlabelled 
glycopeptide 48: H-AEN(Ac3-GlcNAc)ITTGC-OH (10.1 mg, 18 %) as a fluffy white solid. 
LC-MS ESI
+ 
MS (m/z) calculated for 48 1136.18, observed [MH]
+
 1137.38. 
 
49. H-AEN(Ac3-GlcNAc)ITTG-SCH2CH2SO3H. 
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10 % MESNa, 10 % AcOH, 
TCEP, 6M Gu.HCl, 
pH 3.0, 60 °C, 48 h
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The peracetylated glycopeptide 48 (3.0 mg, 2.64 mmol) was dissolved in degassed 6 M 
guanidine hydrochloride (331 μL), 10 % (w/v) sodium 2-mercaptoethanesulfonate (43 mg, 
0.26 mmol), 10 % (v/v) acetic acid (43 μL), 1 M neutralised solution of TCEP (9 μL, 20 
mM), to give a solution with pH ~3.0. The resulting mixture was vortexed and placed in an 
Eppendorf thermomixer at 60 °C for 48 h. The reaction was monitored by LC-MS at t = 6, 
24, and 48 h. After 48 h the pH of the reaction appeared closer to 5.0, a crystal of TCEP.HCl 
was added to the reaction mixture, which was then vortexed, then centrifuged and finally 
purified by (RP)HPLC (gradient: 5-50 % MeCN over 45 min) to afford the desired 
peracetylated glycopeptide thioester 49 (0.6 mg, 20 %) as a white solid and unreacted starting 
material (1.4 mg, 47 % based on starting material) as a white solid. LC-MS ESI
+ 
MS (m/z) 
calculated for 49 1158.21, observed [MH]
+
 1159.36.  
 
50. H-CSLNENIT-OH: EPO(33-40) 
NovaSyn® TGA resin 43 (455 mg, 0.1 mmol; loading 0.22 mmolg
-1
; 90 µm) was transferred 
to an automated peptide synthesiser for peptide elongation. 10 Equivalents of each of the 
48 49 
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following Fmoc-amino acids were employed: Fmoc-Cys(Trt)-OH, Fmoc-Ser(
t
Bu)-OH, 
Fmoc-Leu-OH, Fmoc-Asn(Trt)-OH, Fmoc-Glu(O
t
Bu)-OH, Fmoc-Ile-OH, and Fmoc-
Thr(
t
Bu)-OH. The resin was then treated with TFA: EDT: H2O (95: 2.5: 2.5 = 5.0 mL) for 5 
h, and the solution was then filtered and precipitation was induced upon addition of cold 
diethyl ether (20.0 mL) to the filtrate, which was then vortexed and centrifuged (3000 rpm, 4 
°C, 15 min). After decanting the ether layer, this process was repeated with cold diethyl ether 
(20.0 mL). The crude peptide was then dissolved in 20 % aqueous acetonitrile, centrifuged, 
and the supernatant was purified by semi-preparative (RP)HPLC (gradient: 5-50 % 
acetonitrile/ 45 min). The desired peptide fractions were lyophilised to afford the N-terminal 
cysteinyl peptide 50 (63 mg, 71 %) as a white solid. LC-MS ESI
+ 
MS (m/z) calculated mass 
for C35H60N10O15S: [M] 892.4, observed 892.5. 
 
51. H-AEN(Ac3-GlcNAc)ITTGCSLNENIT-OH. 
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6M Gu.HCl, 100mM MESNa,
200mM Na phosphate, 
pH 7.0, 40mM TCEP, 25°C
30 %
SLNENIT
 
 
The peracetylated glycopeptide thioester 49 (0.6 mg, 0.52 μmol) and excess cysteinyl-peptide 
EPO(33-40) 50 (0.80 mg, 0.90 μmol) were dissolved in a solution of 6 M guanidine 
hydrochloride (132 μL), sodium phosphate buffer (40 μL, 200 mM) at pH 7.0, sodium 2-
mercaptoethanesulfonate (20 μL, 100 mM), and tris(2-carboxyethyl)phosphine (8 μL, 40 
mM). The reaction mixture was then vortexed and placed in an Eppendorf thermomixer and 
left to shake at 25 °C, 650 rpm for 48 h. The ligation reaction was monitored by removing 
aliquots of the reaction mixture and analysing the sample by analytical (RP)HPLC and LC-
MS. After 14 h the ligation product was observed, and more TCEP (5 μL of 1 M solution) 
was added to the reaction mixture. After 62 h no further progess of the reaction had occurred 
and it was terminated. A crystal of TCEP.HCl was added to the reaction mixture and it was 
purified by (RP)-HPLC (gradient: 5-50 % MeCN over 45 min) to afford the desired ligated 
glycopeptide 51 (0.3 mg, 30 %) as a white solid. LC-MS ESI
+ 
MS (m/z) calculated for 51 
C77H125O35 N19S: [M] 1907.83, observed [MH]
+
 1909.17.  
 
 
49 51 50 
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52. H-AEN(GlcNAc)ITTGC-OH. 
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The peracetylated glycopeptide 48 (6.7 mg, 5.90 μmol) was dissolved in 5 % (v/v) aqueous 
hydrazine.monohydrate (50 μL) in water (850 μL), with a 10 % (w/v) excess of 1,4-dithio-
DL-threitol (100 mg). The resulting mixture was vortexed to give a solution with pH 9.0-10.0. 
It was then placed in an Eppendorf thermomixer and allowed to shake at 25 °C, 650 rpm, for 
3 h. LC-MS analysis indicated that the reaction was complete, hence the reaction mixture was 
centrifuged and purified by (RP)HPLC (gradient: 5-50 % MeCN over 45 min) to afford the 
desired deprotected glycopeptide 52 (5.2 mg, 87 %) as a white solid. LC-MS ESI
+ 
MS (m/z) 
calculated for 52 C39H66O19N10S: 1010.42, observed [MH]
+
 1011.30.  
 
53. H-AEN(GlcNAc)ITTG-SCH2CH2SO3H. 
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The deacetylated glycopeptide 52 (4.5 mg, 2.64 μmol) was dissolved in water (800 μL), 10 % 
(w/v) sodium 2-mercaptoethanesulfonate (100 mg, 0.61 mmol), 10 % (v/v) acetic acid (100 
μL), 0.5 % (w/v) TCEP.HCl (5.0 mg, 17.44 μmol), to give a solution with pH 1.0. To the 
mixture was added 10 M sodium hydroxide (20 μL) to raise the pH to 4.0. The resulting 
mixture was vortexed and placed in an Eppendorf thermomixer at 60 °C for 48 h. The 
reaction was monitored by LC-MS, and analytical (RP)HPLC, at regular intervals: t = 0, 24, 
and 48 h. After 48 h, a crystal of TCEP.HCl was added to the reaction mixture which was 
then vortexed, centrifuged and purified by (RP)HPLC (gradient: 5-50 % MeCN over 45 min) 
to afford the deacetylated glycopeptide thioester 53 (64 % by semi-preparative HPLC 
integration) and unreacted starting material 52 (0.8 mg, 18 % based on 52) as a white solid.  
 
48 52 
53 52 
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